

ACCESSION NUMBER:		0001165527-18-000037
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		58
CONFORMED PERIOD OF REPORT:	20171130
FILED AS OF DATE:		20180314
DATE AS OF CHANGE:		20180314
FILER:
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Trident Brands Inc
		CENTRAL INDEX KEY:			0001421907
		STANDARD INDUSTRIAL CLASSIFICATION:	METAL MINING [1000]
		IRS NUMBER:				261367322
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1130
	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-53707
		FILM NUMBER:		18688988
	BUSINESS ADDRESS:	
		STREET 1:		200 SOUTH EXECUTIVE DRIVE
 SUITE 101
		CITY:			BROOKFIELD
		STATE:			WI
		ZIP:			53005
		BUSINESS PHONE:		262-789-6689
	MAIL ADDRESS:	
		STREET 1:		200 SOUTH EXECUTIVE DRIVE
 SUITE 101
		CITY:			BROOKFIELD
		STATE:			WI
		ZIP:			53005
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sandfield Ventures Corp.
		DATE OF NAME CHANGE:	20071220










    Document created using EDGARfilings PROfile 4.3.3.2


















































































 as defined in Rule&#160;405 of the Securities Act.&#160;Yes&#160;




 and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;Yes&#160;


 if any
 every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes



 and will not be contained
 to the best of registrant&#8217;s knowledge
 in definitive proxy or information statements incorporated by reference in Part&#160;III of this Form&#160;10-K or any amendment to this Form&#160;10-K.&#160;


 an accelerated filer
 a non-accelerated filer
 or a smaller reporting company. See the definitions of &#8220;large accelerated filer



































 2018
 the registrant had 32
311
887 shares of common stock issued and outstanding.&#160; No market value has been computed based upon the fact that no active trading market had been established as of March 12



























































































































































































































































































































































&#160;






 all references in this Annual Report on Form 10-K for the fiscal year ended November 30
 2017 (&#8220;Form 10-K&#8221;) to the &#8220;Company&#8221;
 &#8220;we&#8221;
 &#8220;us&#8221;
 &#8220;our&#8221;
 &#8220;Trident&#8221; and &#8220;Trident Brands&#8221; or similar words and phrases are to Trident Brands Incorporated . and its subsidiaries




 all currency amounts are expressed in thousands of United States (&#8220;U.S.&#8221;) dollars (&#8220;$&#8221;)
 except per share data
 unless otherwise stated.&#160; Amounts expressed in other than U.S. dollars are noted accordingly.&#160; For example







 forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as &#8220;anticipate&#8221;
 &#8220;estimate&#8221;
 &#8220;intend&#8221;
 &#8220;project&#8221;
 &#8220;potential&#8221;
 &#8220;continue&#8221;
 &#8220;believe&#8221;
 &#8220;expect&#8221;
 &#8220;could&#8221;
 &#8220;would&#8221;
 &#8220;should&#8221;
 &#8220;might&#8221;
 &#8220;plan&#8221;
 &#8220;will&#8221;
 &#8220;may&#8221;
 &#8220;predict&#8221;
 the negatives of such terms
 and words and phrases of similar impact and include
 but are not limited to references to expected increases in revenues and margins
 growth opportunities
 the success of new product launches and line extensions
 our ability to finance our business
 potential strategic investments
 business strategies
 competitive strengths
 goals
 references to key markets where we operate and the market for our securities.&#160; These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on certain assumptions and analyses we make in light of our experience and our interpretation of current conditions
 historical trends and expected future developments




 there are or will be important factors that could cause our actual results to differ materially from our expectations and predictions. We believe these factors include
 but are not limited to

























 accumulated deficit and insufficient cash resources to meet our business objectives





















































































































































































































 some of our products could fail in the marketplace
 which could negatively impact our revenues






























 if these third parties fail to reliably supply products to us at required levels of quality and which are manufactured in compliance with applicable laws








































































































 which could lead to wide fluctuations in our share price. Our shareholders may be unable to sell their common stock at or above their purchase price if at all




































































 officers and employees under Nevada law and the existence of indemnification rights of our directors
 officers and employees may result in substantial expenditures by our company and may discourage lawsuits against our directors






















 you should read our risk factors in Item 1A
 Risk Factors























 2007.&#160; The Company was initially formed to engage in the acquisition
 exploration and development of natural resource properties




 Brain Armor&#174; and P2N Peak Performance Nutrition brands
 and functional food ingredients under the Oceans Omega brand. The Company also provides a range of private label nutritional and supplement products to retailers. These products are focused on the fast growing supplements and nutritional product and heart and brain health categories
 supported by an established contract manufacturing
 supply chain and research and development infrastructure
 and a solid and proactive management team














 is 94.8% owned by Trident Brands and is organized to develop






 is 100% owned by Trident Brands Incorporated and holds various banking facilities
 and licenses associated with the manufacturing







 Suite 101
 Brookfield
 Wisconsin















000
000 common shares with a par value of $0.001 per share. 32
311
887 common shares were issued and outstanding as of November 30
 2017 and 32
311
887 as of March 











 2013 the Board of Directors approved an agreement and plan of merger with a wholly-owned subsidiary called Trident Brands Incorporated.&#160; At that point we changed our name from Sandfield Ventures Corp. to Trident Brands Incorporated and Mark Holcombe assumed the role of Chief Executive Officer
 President



 on July 9
 2013
 our Board of Directors approved a resolution to affect a 4 for 1 forward stock split. Upon effect of the forward split
 our authorized capital increased from 75
000
000 to 300
000
000 shares of common stock and correspondingly
 our issued and outstanding shares of common stock increased from 7
000
000 to 28
000
000 shares of common stock



 2013
 our directors approved the adoption of our 2013 Stock Option Plan which permits us to issue up to 4
200
000 shares of our common stock to directors
 officers



 2013
 we signed a 15 year license agreement (including a ten year extension option) with Everlast&#174; World&#8217;s Boxing Headquarters Corp.
 International Brand Management &amp; Licensing



 2014



























 Chair of the Corporate Governance Committee















 Chief Financial Officer






















 President
 Secretary and Treasurer
 and was appointed as Chair of the Board of Directors and Chair of the Compensation Committee. Mr. Holcombe's resignation as Chief Executive Officer
 President
 Secretary and Treasurer was not the result of any disagreement with our Company regarding its operations
 policies



 2014



 2014
 we granted an aggregate of 2
875
000 stock options to directors
 officers
 employees and consultants of our company pursuant to our 2013 Stock Plan. The stock options are exercisable for five years from the date of grant at exercise prices of $0.75 per share for shares vesting 12 months from the date of issuance













 2015
 we entered into a securities purchase agreement with a non-US institutional investor whereby we agreed to sell an aggregate principal amount of $2
300
000 of senior secured convertible debentures
 convertible into shares of the Company's common stock. We&#160; received the funds from the transaction in two tranches
 $1
800
000 on February 5
 2015 and $500
000 on May 14
 2015.&#160; The convertible debentures are convertible into shares of the Company's common stock at an initial conversion price of $.71 per share
 for an aggregate of up to 3
239
437 shares. The debentures bear interest at 6% per annum



 2015
 we acquired
 through a licensing agreement with DSM Nutritional Products LLC (&#8220;DNP&#8221;)
 the exclusive global rights to Brain Armor&#174; dietary supplements
 a plant-based DHA supplement designed specifically for the needs of athletes.&#160; At the same time
 a wholly-owned subsidiary
 Brain Armor Incorporated was registered to hold the trademark license and all costs and revenue associated with commercial development of the Brain Armor&#174; brand. As per the agreement
 DNP shall be the sole source of the Company's omega-3 oil requirements which will be DNP's life's DHATM oil and will supply the soft gel capsules in finished form to us. In order to maintain exclusivity to the license
 we are required to meet certain targets with respect to product launches and sales volume.&#160; Also under the terms of the agreement we have the opportunity to exercise an option to purchase the Brain Armor(R) dietary supplement brand. The term of the Agreement and the license rights is for five (5) years and shall be subject to successive one (1) year automatic renewal periods




&#160;2015
 we appointed Dr. Neilank K. Jha
 MD
 FRCS (C) as a Special Advisor to its&#160;Brain Armor&#174; subsidiary.&#160;&#160;On September&#160;29
 2015 the&#160;Board of Directors of Brain Armor Inc. allotted 100
000 shares of&#160;common stock representing 10% of the issued and outstanding capital of Brain&#160;Armor&#160;Inc. to KONKUSSION Inc.
 a company controlled by Dr. Jha. Dr. Jha is a&#160;board certified Neurosurgeon FRCS(C) and a fellowship trained Spine&#160;Surgeon.&#160;With the issuance of Brain Armor&#160;shares to Trident on December 1
 2017 to settle an inter-company debt




 2015
 we entered into a consulting agreement with Dr. Julian Bailes wherein&#160;Dr. Bailes has agreed to provide consulting services as a&#160;Special Advisor to&#160;our Company and/or our subsidiary
 Brain Armor Inc. for a period of 12&#160;months. &#160;Pursuant to the consulting agreement
 we agreed to&#160;issue to&#160;Dr. Bailes 5% of the issued and outstanding shares of Brain Armor Inc.&#160;effective November 30
 2015.&#160; Dr. Bailes is a&#160;nationally recognized leader in the field of neurosurgery and conducts&#160;research&#160;on the impact of brain injury on neurological function. Dr. Bailes is the&#160;Chairman of the Department of Neurosurgery at North Shore&#160;University Health&#160;System
 Co-Director of the North Shore Neurological Institute
 and a Clinical&#160;Professor of Neurosurgery at the University of Chicago&#160;Pritzker School of&#160;Medicine.&#160;&#160;The Company is working with Dr.&#160;Bailes to research and develop line extensions and new products that support&#160;cognitive health and performance&#160;under the Brain Armor&#174; brand.&#160;With the issuance of Brain Armor&#160;shares to Trident on December 1
 2017 to settle an&#160;inter-company debt



 2015
 Michael Browne signed a service contract with the company to serve as Brand Director of Trident Brands Inc.&#160;&#160; At that time his stock options were amended from a total of 1
125
000 which were issued May 5
 2014 to 625



 2016
 we issued 3
000
000 common shares pursuant to a Deed of Assignment dated effective January 20
 2015 among our Company
 Oceans Omega LLC
 and the assignor 2298107 Ontario Inc.
 pursuant to which the assignor assigned to our Company the assignor&#8217;s non-exclusive rights to purchase
 market
 sell and distribute certain Omega 3 nutritional emulsions produced by Oceans Omega LLC to the food and beverage industries and exclusive rights to purchase
 market




 2016
 we entered into a Securities Purchase Agreement with a non-US institutional investor&#160;&#160; pursuant to which
 in consideration for proceeds of $4
100
000
 we issued a secured convertible promissory note in the amount of $4
100
000.&#160; Pursuant to the Securities Purchase Agreement
 the investor has agreed
 from time to time after January 1
 2017
 to make additional investments at our request of up to $5
900
000 ($10
000
000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4
100
000 which has been funded) is subject to the mutual agreement of the parties as to the use of funds. The parties have agreed to negotiate in good faith to pre-approve use of funds with 120 days following September 26













100
000 secured promissory note for general working capital purposes including
 without limitation
 settlement of accounts payable and repayment of mature loans. In consideration of each advance made by the investor pursuant to the Securities Purchase Agreement
 we will issue to the investor a convertible promissory note of equal value
 maturing three years after issuance
 and bearing interest at the rate of 8% per annum. Each note will be secured in first priority against the present and after acquired assets of the Company



 2016
 we entered into a Convertible Promissory Note Amendment Agreement with the same non-US institutional investor whereby we agreed to extend the maturity date and interest payable on $2
300
000 of senior secured convertible debentures which were initially funded on February 5
 2015 and on May 14
 2015.&#160; Under the terms of the amendment the maturity date of the notes were extended through September 30



















 Chair of the Audit Committee and as President and Chief Executive Officer













































 our Director and Chair of the Corporate Governance Committee















 Chief Financial Officer























 2017
 we entered into a Letter of Intent (the &#8220;LOI&#8221;) with The Activation Group
 Inc.
 an integrated marketing and advertising agency incorporated in Ontario
 Canada.&#160; Pursuant to the LOI
 we will seek to enter into a definitive agreement to purchase all the issued and outstanding common shares of The Activation Group in consideration for a purchase price consisting of $200
000 cash
 and $800
000 payable in common shares of Trident.&#160; The cash consideration is inclusive of a $100
000 deposit paid to The Activation Group upon execution of the LOI
 and $100
000 payable upon closing a definitive agreement. Stock payments shall be payable in four $200
000 installments
 subject to the achievement of earnings targets.&#160; The transaction contemplated by the LOI will be subject to the satisfactory completion of due diligence




 on February 15
 2017 our board of directors appointed Mark Cluett as the Chief Operating Officer at Trident Brands Incorporated




 2017 the Company entered into a note purchase agreement with Fengate Trident LP (Fengate) pursuant to which
 in consideration for the issuance of 811
887 of our common shares to Fengate
 we purchased outstanding secured convertible promissory notes of Mycell Technologies LLC (Mycell) having an aggregate balance due and payable of $511
141 in&#160;principal and $94
526 in&#160;interest accrued as at September 12
 2017.&#160; The purchased notes
 which were originally issued to LPF (MCTECH) Investment Corp. on January 22
 2016
 February 5
 2016
&#160;and May 19
 2016
 bear simple interest on unpaid principal at the rate of ten percent per annum.&#160; The outstanding principal and accrued interest is convertible at the option of the note holder into securities of Mycell.&#160;We issued the 811
887 common shares to one (1) non-US person (as that term is defined in Regulation S of the Securities Act of 1933)
 in an offshore transaction relying on Regulation S of the Securities Act of 1933















 2017 we entered into a Share Purchase Agreement&#160;dated September 6
 2017&#160;among our wholly owned subsidiary
 Trident Brands International Ltd. (&#8220;Trident International&#8221;)
 a Bahamas corporation
 StreamPak Ltd. (&#8220;StreamPak&#8221;)
 an Anguilla corporation
 and&#160;the sole shareholder of StreamPak
 pursuant to which
 in consideration for the payment of $125
000 in cash and 500
000 of our common shares
 Trident International purchased 100% of the issued and outstanding common shares of StreamPak.&#160; As a result of the share purchase StreamPak became a wholly owned subsidiary of Trident International.&#160;We issued the 500
000 common shares to one (1) non-US person (as that term is defined in Regulation S of the Securities Act of 1933)
 in an offshore transaction relying on Regulation S of the Securities Act of 1933



 2017 Mr. Michael Browne resigned as Chief Financial Officer and Treasurer of the Company.&#160; Mr. Browne&#8217;s resignation did not result from any disagreement with the Company regarding our operations
 policies
 practices
 or otherwise.&#160; In light of the resignation
 Mark Holcombe
 our President and Director



 2017 our Board of Directors appointed Mr. Brian Rola as Vice-President of Trident and General Manager of our wholly owned subsidiary
 Trident Sports Nutrition Inc.
 and Mr. Nick Pili as Vice-President of Trident and General Manager of our wholly owned subsidiary



 Trident advanced approximately $478
539 and $886
999
 respectively
 in working capital loans with an interest rate of 6% per annum to its 85% owned and controlled subsidiary
 Brain Armor Inc.&#160; As at December 1st 2017 Brain Armor owed an aggregate of approximately $1
394
251 to the Company in respect of the advances.&#160; On December 1
 2017
 the boards of directors of Trident and Brain Armor approved the settlement of the inter-company debt by the issuance to Trident of 1
859
001 common shares of Brain Armor at the price of $0.75 per share.&#160; As a result of the settlement



 2017
 our Board of Directors authorized the issuance to its members and management stock options to purchase up to 2
615
000 share of our common stock.&#160; 1
307
500 of the options vest upon issuance and are exercisable for up to five years at $0.85 per share
 while the remaining 1
307
500 will vest 12 months following issuance and be exercisable for up to five years at $1.00 per share.&#160; The Options were issued pursuant to the Company&#8217;s 2013 Stock Option Plan
 which was registered with the Securities and Exchange Commission on Form S-8 in January



 2017
 the Board of Directors authorized the issuance of 250
000 stock options to Sanitas
 LLC
 a consultant and founding shareholder of Brain Armor.&#160; The options vest immediately and are exercisable for a period of five (5) years to purchase common shares of Brain armor at $0.75 per share.&#160; The options were issued to one US person






 supply chain
 product development and corporate finance. Our team has experience in developing and commercializing consumer products








































































































&#174;
 P2N Peak Performance Nutrition and private label product lines have demonstrated solid potential in the markets where they compete leading to significant revenue growth. The development of Oceans Omega as an ingredient for food and beverage products is ongoing
 and given the longer sales cycle for ingredients
 we expect to realize revenues in 2018 both through external customer product development and also internally via potential 


















































































































 we will seek to acquire positions in businesses to support our strategy through the use of common and/or preferred equity
 senior secured
 unsecured
 and convertible debt in organizations who meet our investment goals. Through our management and directors vast expertise in both the consumer branded segment and strategic investment experience













































































 we acquired
 through a licensing agreement
 the exclusive global rights to Brain Armor&#174;
&#160;a plant-based Omega-3 dietary supplement designed to improve cognitive health and well-being on every field of play. Brain Armor&#174; helps optimize cognitive
 visual and cardiovascular performance by supplying a meaningful amount of DHA
 an important Omega-3 clinically proven to support brain
 eye and heart health.












 with a 10 year extension option
 to market and sell products in the nutritional foods and supplements category under the Everlast&#174; brand. The US Dietary Supplement Segment continues to experience dynamic growth driven by favorable demographic trends
 increased media coverage of dietary issues and greater emphasis on preventive health/wellness practices in the healthcare industry







 market
















 large and small
 competing for market share. The nutritional products market is one of the fastest growing markets in the world producing close to 32 billion dollars in revenue in 2012
 and is projected to double
 producing revenues exceeding 60 billion dollars by 2021 according to the Nutritional Business Journal. With the combination of high quality
 scientifically designed and cost competitive products
 and the equity in our brands







 supply chain and products are subject to a wide range of governmental regulations and policies in various regions where we operate
 including the U.S. and Canada.&#160; These laws
 regulations and policies are implemented
 as applicable in each jurisdiction
 on the national
 federal
 state














Patents
 Trademarks
 Franchises
 Concessions
 Royalty Agreements
 or Labor Contracts































































































870
















































































































































































































































































































































































































































































































































































































































Human Resources
 Contract Service Providers
 Employees


We presently do not have pension
 health
 annuity
 insurance
 profit sharing or similar benefit plans; however
 we may adopt such plans in the future. Except for our stock option plan
 there are presently no personal benefits available to our officers and directors.






 including filing Form 10K annually and Form 10Q quarterly.&#160; In addition
 we will file Form 8K and other proxy and information statements from time to time as required.&#160; We do not intend to voluntarily file the above reports in the event that our obligation to file such reports is suspended under the Exchange Act.&#160; The public may read and copy any materials that we file with the Securities and Exchange Commission
 (SEC)
 at the SEC's Public Reference Room at 100 F Street NE
 Washington
 DC 20549.&#160; The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330.&#160; The SEC maintains an Internet site (http://www.sec.gov) that contains reports
 proxy and information statements










 our business
 financial condition or results of operations could be harmed. In that case
 the trading price of our common stock could decline






We have yet to establish a history of profitable operations and
 as at November 30
 2017
 have an accumulated deficit of $13
751
420
since our inception on November 5
 2007.&#160; In the prior years we have generated only nominal revenues since our inception and thus have incurred operating losses.&#160; Our profitability will require the successful commercialization and sales of our planned products at acceptable margins.&#160;We may not be able to successfully achieve any of these requirements or ever become profitable.







 we could lose existing customers and more importantly fail to win new and retain any future customers. In order to compete effectively in the food and nutritional products industry
 we must continually design
 develop implement and market new and/or enhanced products and strategies. Our future success will depend
 in part





































 operating and financial resources.&#160;To manage possible growth and change







 which cannot be guaranteed. Our operations will be subject to all the risks inherent in the uncertainties arising from the absence of a significant operating history. We may be unable profitably sell our food and nutritional products and thus operate on a profitable basis. Potential investors should be aware of the difficulties normally encountered by enterprises in the development stage. If our business plan is not successful
 and we are not able to operate profitably






 in part
 on obtaining and maintaining patent protection
 trade secret protection and regulatory protection of our technologies and products as well as successfully defending third-party challenges to such technologies and products. We will be able to protect our technologies and product from use by third parties only to the extent that valid and enforceable patents
 trade secrets or regulatory protection cover them and we have exclusive rights to use them. The ability of our licensors
 collaborators and suppliers to maintain their patent rights against third-party challenges to their validity




 and the patent situation outside the United States is even more uncertain. Changes in either the patent laws or in interpretations of patent laws in the United States or other countries may diminish the value of our intellectual property. Accordingly



 especially where we do not believe patent protection is appropriate or obtainable. However
 trade secrets are difficult to protect. While we seek to protect confidential information
 in part
 through confidentiality agreements with our employees
 consultants and scientific and other advisors
 they may unintentionally or willfully disclose our information to competitors. Enforcing a claim against a third party related to the illegal acquisition and use of trade secrets can be expensive and time consuming
 and the outcome is often unpredictable. If we are not able to maintain patent or trade secret protection on our technologies and products
 then we may not be able to exclude competitors from developing or marketing competing products
















 and we believe that there will continue to be
 significant litigation and demands for licenses in our industry regarding patent and other intellectual property rights. Although we anticipate having a valid defense to any allegation that our current products
 production methods and other activities infringe the valid and enforceable intellectual property rights of any third parties
 we cannot be certain that a third party will not challenge our position in the future. Other parties may own patent rights that we might infringe with our products or other activities
 and our competitors or other patent holders may assert that our products and the methods we employ are covered by their patents. These parties could bring claims against us that would cause us to incur substantial litigation expenses and
 if successful
 may require us to pay substantial damages. Some of our potential competitors may be better able to sustain the costs of complex patent litigation
 and depending on the circumstances
 we could be forced to stop or delay our research
 development












 which presently are based upon a combination of copyright
 trade secret and trademark laws



 the laws of foreign countries may provide inadequate protection of such intellectual property rights. We may need to bring legal claims to enforce or protect such intellectual property rights. Any litigation
 whether successful or unsuccessful
 could result in substantial costs and diversions of resources. In addition
 notwithstanding any rights we have secured in our intellectual property
 other persons may bring claims against us that we have infringed on their intellectual property rights
 including claims based upon the content we license from third parties or claims that our intellectual property right interests are not valid. Any claims against us
 with or without merit
 could be time consuming and costly to defend or litigate
 divert our attention and resources







 we expect to experience significant and rapid growth in the scope and complexity of our business. We will need to add resources to market our services
 manage operations
 handle sales and marketing efforts and perform finance and accounting functions. We will be required to hire a broad range of additional personnel in order to successfully advance our operations. This growth is likely to place a strain on our management and operational resources. The failure to develop and implement effective systems
 or to hire and retain sufficient personnel for the performance of all of the functions necessary to effectively service and manage our potential business
 or the failure to manage growth effectively







 our products may quickly become obsolete and unmarketable. Our future success will depend on our ability to adapt to and anticipate market demands
 develop new products and enhance our current products on a timely and cost-effective basis. Further
 our products must remain competitive with those of other companies with substantially greater resources. We may experience technical or other difficulties that could delay or prevent the development
 introduction or marketing of new products or enhanced versions of existing products. Also




















 some of our products could fail in the marketplace
 which could negatively impact our revenues




 including various prescription drugs
 which may rapidly capture a significant share of the market. These market segments include numerous manufacturers
 distributors
 marketers








 manufacturing
 packaging
 labeling
 distribution
 advertising
 licensing




 resulting in loss of revenues.&#160; We are subject to FDA rules for current good manufacturing practices
 or GMPs
 for the manufacture
 packing








 if these third parties fail to reliably supply products to us at required levels of quality and which are manufactured in compliance with applicable laws




&#160; reliably supply products to us at the levels of quality
 or the quantities
 we require
 and in compliance with applicable laws
 including under the FDA&#8217;s GMP regulations.&#160; Additionally
 while we are not presently aware of any current liquidity issues with our suppliers







 we may be subjected to various product liability claims
 including that the products contain contaminants
 the products include inadequate instructions as to their uses
 or the products include inadequate warnings concerning side effects and interactions with other substances. It is possible that widespread product liability claims could increase our costs
 and adversely affect our revenues and operating income. Moreover
 liability claims arising from a serious adverse event may increase our costs through higher insurance premiums and deductibles
















 and we generally do not have long-term agreements with or commitments from these customers for the purchase of products.&#160; We cannot provide assurance that our customers will maintain or increase their sales volumes or orders for the products supplied by us or that we will be able to maintain or add to our existing customer base.&#160; Decreases in our customers&#8217; sales volumes or orders for products supplied by us may have a material adverse effect on our business








 processing
 packaging and distribution of many of our products. &#160;The inability of any of these suppliers to deliver or perform for us in a timely or cost-effective manner could cause our operating costs to rise and our margins to fall. &#160;We must continuously monitor our inventory and product mix against forecasted demand or risk having inadequate supplies to meet consumer demand as well as having too much inventory that may reach its expiration date. &#160;If we are unable to manage our supply chain efficiently and ensure that our products are available to meet consumer demand








The stock markets have experienced significant price and trading volume fluctuations
 quotation system in which shares of our common stock are listed
 have been volatile in the past and have experienced sharp share price and trading volume changes. The trading price of our common stock is likely to be volatile and could fluctuate widely in response to many factors
 including the following
 some of which are beyond our control:









































































 as well as general economic and political conditions unrelated to our performance











 including the fact that we are a small company in its development phase which is relatively unknown to stock analysts
 stock brokers
 institutional investors and others in the investment community who generate or influence sales volume. Even if we came to the attention of such persons
 those persons may be reluctant to follow
 purchase
 or recommend the purchase of shares of an unproven company such as ours until such time as we become more seasoned and viable. As a consequence












 as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous trades without an adverse effect on share price. We cannot be assured that a broader or more active public trading market for our common stock will develop or be sustained




 which could lead to wide fluctuations in our share price. Our shareholders may be unable to sell your common stock at or above your purchase price if at all




 according to SEC Release No. 34-29093
 the market for penny stock/over the counter stocks has suffered in recent years from patterns of fraud and abuse. Such patterns include (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (3) boiler room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (4) excessive and undisclosed bid-ask differential and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level







 it would be contingent upon our revenues and earnings
 if any
 capital requirements
 and general financial condition. The payment of any common stock dividends will be within the discretion of our Board of Directors. We presently intend to retain all earnings to implement our business plan; accordingly












 and we expect that our share price will continue to be more volatile than a seasoned issuer for the indefinite future. In the past
 plaintiffs have often initiated securities class action litigation against a company following periods of volatility in the market price of its securities. We may
 in the future



 officers and employees under Nevada law and the existence of indemnification rights of our directors
 officers and employees may result in substantial expenditures by our company and may discourage lawsuits against our directors















 which we may be unable to recoup. These provisions and resultant costs may also discourage our company from bringing a lawsuit against directors and officers for breaches of their fiduciary duties
 and may similarly discourage the filing of derivative litigation by our shareholders against our directors and officers even though such actions
 if successful






 we are subject to certain rules and regulations of federal
 state and financial market exchange entities charged with the protection of investors and the oversight of companies whose securities are publicly traded. These entities
 including the Public Company Accounting Oversight Board
 the SEC and FINRA
 have issued requirements and regulations and continue to develop additional regulations and requirements in response to corporate scandals and laws enacted by Congress
 most notably the Sarbanes-Oxley Act of 2002. Our efforts to comply with these regulations have resulted in
 and are likely to continue resulting in
 increased general and administrative expenses and diversion of management time and attention from revenue-generating activities to compliance activities. Because new and modified laws
 regulations and standards are subject to varying interpretations in many cases due to their lack of specificity












currently have no investment policies as they pertain to real estate





























Item 5. Market for Common Equity
 Related Stockholder Matters and Issuer Purchases of Equity Securities



 2013 our shares have been approved for trading under the symbol &#8220;TDNT&#8221;.&#160;&#160;As of the date of this filing
 there has been no active trading of our securities
 and
 therefore




 last sale prices and volume information in over-the-counter (OTC) securities.&#160; The OTCBB is not an issuer listing service
 market or exchange. Although the OTCBB does not have any listing requirements per se
 to be eligible for quotation on the OTCBB




 2017
 we had 32
311
887 Shares of $0.001 par value common stock issued and outstanding held by



311
887 shares of common stock outstanding as of November 30
 2017
 8
441
724 shares are owned by Anthony Pallante
 CEO and director










 we intend to retain any earnings to finance the development and expansion of our business
 and we do not anticipate paying any cash dividends on our common stock. Any future determination to pay dividends will be at the discretion of the Board of Directors and will be dependent upon then existing conditions
 including our financial condition and results of operations
 capital requirements
 contractual restrictions
 business prospects







 as amended that imposes additional sales practice requirements on broker/dealers who sell such securities to persons other than established customers and accredited investors (generally institutions with assets in excess of $5
000
000 or individuals with net worth in excess of $1
000
000 or annual income exceeding $200
000 or $300
000 jointly with their spouses). For transactions covered by the Rule
 the broker/dealer must make a special suitability determination for the purchase and have received the purchaser's written agreement to the transaction prior to the sale. Consequently




 such as bid and offer quotes
 a dealers spread and broker/dealer compensation; the broker/dealer compensation
 the broker/dealers duties to its customers






 2017





















































































































































 Director



















































































































































 CFO


























































































































































































































025



















































 2017 and includes information available to March 12
 2018




 business strategy
 budgets
 litigation
 projected costs
 capital expenditures
 financial results
 taxes
 plans and objectives.&#160; In some cases
 forward-looking statements can be identified by terms such as &#8220;anticipate&#8221;
 &#8220;estimate&#8221;
 &#8220;intend&#8221;
 &#8220;project&#8221;
 &#8220;potential&#8221;
 &#8220;continue&#8221;
 &#8220;believe&#8221;
 &#8220;expect&#8221;
 &#8220;could&#8221;
 &#8220;would&#8221;
 &#8220;should&#8221;
 &#8220;might&#8221;
 &#8220;plan&#8221;
 &#8220;will&#8221;
 &#8220;may&#8221;
 &#8220;predict&#8221;
 or other similar expressions concerning matters that are not historical facts. To the extent any forward-looking statements contain future-oriented financial information or financial outlooks
 such information is being provided to enable a reader to assess our financial condition
 material changes in our financial condition
 our results of operations
 and our liquidity and capital resources.&#160; Readers are cautioned that this information may not be appropriate for any other purpose




 results of operations
 performance
 and business prospects and opportunities.&#160; While we consider these assumptions to be reasonable
 based on information currently available
 they may prove to be incorrect.&#160; Forward-looking statements are also subject to certain factors







 related revenues and expenses






























 to include intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include





































































 more likely than not








 the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset. To date
 no such impairment has occurred. To the extent such events or circumstances occur that could affect the recoverability of our long-lived assets









 b) the price to the customer is fixed and determinable














 directors and service providers.&#160; For grants of stock options
 we are required to estimate a number of inputs at each grant date
 such as the estimated life of the option
 future stock price volatility
 and the forfeiture rate used in the Black-Scholes option-pricing model to determine a fair value for the options granted to employees or non-employee directors.&#160;&#160; Once determined at the grant date







 investment and other tax credits
 as well as the provision for income taxes at different rates in various jurisdictions.&#160; In making an estimate of our income tax liability
 we first assess which items of income and expense are taxable in a particular jurisdiction.&#160; This process involves a determination of the amount of taxes currently payable as well as the assessment of the effect of temporary timing differences resulting from different treatment of items for accounting and tax purposes.&#160; These differences in the timing of the recognition of income or the deductibility of expenses may result in deferred income tax balances that are recorded as assets or liabilities as the case may be on our balance sheet.&#160; We also estimate the amount of valuation allowance to maintain relating to loss carry forwards and other balances that can be used to reduce future taxes payable.&#160;&#160; We assess the likelihood of the ultimate realization of these tax assets by looking at the relative size of the tax assets in relation to the profitability of the businesses and the jurisdiction to which they can be applied












Results of Operations for the Fiscal Years Ended November 30
 2017 and November 30
 2016






































































743














































323









681














125




















521























874









187









902





336







While still in the early stages of commercialization
 our revenues increased 2
723% in 2017 to $4
743
421 versus $168

399 or 2.0% of revenues versus $70












































































964









293





























































































































125











 2017 were $5
448
369 as compared to $2
681
358 for the comparative period in 2016



125

















 2017 were $1
521
211 versus $576
073 in the comparative period in 2016









 2017 was $6
874
181 compared to $3
187
127 in the comparative period in 2016. After deducting non-cash amounts of interest
 depreciation and amortization including impairment loss
 EBITDA for the year ended November 30
 2017 was $2
902
637 compared to $2
336







 2017 was $3
143




000 loan plus outstanding interest bearing interest at 10% per annum was repaid in full on March 3




 2015
 we entered into a securities purchase agreement with a non-US institutional investor whereby we agreed to sell an aggregate principal amount of $2
300
000 of senior secured convertible debentures
 convertible into shares of the company&#8217;s common stock.&#160; We received $1
800
000 of the funds from the transaction on February 5
 2015 and the balance of $500
000 on May 14
 2015.&#160; On September 26
 2016
 we entered into a Convertible Promissory Note Amendment Agreement with this investor whereby we agreed to extend the maturity date and amend the interest payable on the senior secured convertible debentures
 whereby we extended the term of the notes through September 30
 2019 and interest rate was increased from 6% per annum to 8% per annum.&#160;&#160; The convertible debentures are convertible into shares of the Company&#8217;s common stock at an initial conversion price of $.71 per share for an aggregate of up to 3
239




 2016
 we entered into a Securities Purchase Agreement with a non-US institutional investor&#160;&#160; pursuant to which
 in consideration for proceeds of $4
100
000
 we issued a secured convertible promissory note in the amount of $4
100
000.&#160; Pursuant to the Securities Purchase Agreement
 the investor has agreed
 from time to time after January 1
 2017
 to make additional investments at our request of up to $5
900
000 ($10
000
000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4
100
000 which has been funded) is subject to the mutual agreement of the parties as to the use of funds. The parties have agreed to negotiate in good faith to pre-approve use of funds within 120 days following September 26
 2016.&#160; On May 9
 2017
 the Company received the second tranche of funding with proceeds of $4
400
000 for a total investment by the investor of $8
500
000. Under the terms of the securities purchase agreement
 the Company has an additional $1
500
000 of available funding. We intend to use the proceeds of the secured convertible note for general working capital purposes including
 without limitation
 settlement of accounts payable and repayment of mature loans. In consideration of each advance made by the investor pursuant to the Securities Purchase Agreement
 we will issue to the investor a convertible promissory note of equal value
 maturing three years after issuance
 and bearing interest at the rate of 8% per annum. Each note will be secured in first priority against the present and after acquired assets of the Company
 and will be convertible in whole or in part at the option of the holder into common shares of the Company at a conversion price per share of $.60
 equal to a 25% discount to the 10 day average closing price of the Company&#8217;s common stock for the period immediately preceding the issuance of the applicable note. Due to the notes being convertible to the Company common shares
 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $1
366
667 and $1
466
667 respectively and which was recognized as debt discount. As of November 30
 2017
 $878
740 of debt discount was amortized of which $797
909 was amortized during the current year and $80
831 in the prior year. The unamortized discount is $1
954







































































300













500




































300







300






 changes in financial condition
 revenues or expenses
 results of operations
 liquidity






























 processed
 summarized and reported within the time periods specified in the SEC&#8217;s rules and forms
 and that such information is accumulated and communicated to management
 including the Company&#8217;s principal executive officer and principal financial officer
 and Board
 as appropriate



 including the Company&#8217;s principal executive officer and the principal financial officer
 the Company has conducted an evaluation of the effectiveness of the design and operation of the Company&#8217;s disclosure controls and procedures
 as defined in Rule 13a-15(e) under the Exchange Act
 as of November 30
 2017. Based on this evaluation
 the Company&#8217;s principal executive officer and principal financial officer concluded as of November 30








 as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act
 for the Company.&#160; Internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance of records that
 in reasonable detail












 and that our receipts and expenditures are being made only in accordance with authorizations of its management and directors; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition




 and accordingly
 even effective internal control can provide only reasonable assurance with respect to financial statement preparation and may not prevent or detect material misstatements. In addition




 or combination of significant deficiencies




 management conducted an evaluation of the effectiveness of our internal control over financial reporting
 as of November 30
 2017
 based on the framework set forth in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).&#160; Based on its evaluation under this framework
 management concluded that our internal control over financial reporting was not effective as of November 30









We do not have a financial expert on our audit committee or a fully independent Board of Directors


















 2017 that have materially affected
 or are reasonably likely to materially affect




















Item 10. Directors
 Executive Officers and Corporate Governance














































 CFO
































































 Director and Chair of the Board of Directors on December 2












 was appointed&#160; President on December 2
 2016. He was appointed as a Director of our company on November 5
 2007 and served as Chief Executive Officer
 President
 Secretary and Treasurer through March 21
 2014.&#160; He also serves as 
























 was appointed as Chair of the Audit Committee on December 2
 2016 and as a&#160; Director and Chair of the Governance Committee of our company on March 21
 2014.











 was appointed as a Controller of our company on March 21
 2014.








Anthony Pallante




 Mr. Pallante served as a Senior Vice President and Officer at Cott Beverages. Prior to Cott
 he served as the President and Principle of Exclusive Beverage
 the Ontario Royal Crown Cola franchise


Mark Holcombe

 CFO




 corporate development and asset management. Mr. Holcombe has over 23 years of banking and corporate finance experience. He has significant experience in M&amp;A advisory
 corporate restructurings and public and private debt and equity financings. Formerly




 he was a Senior Advisor to Providence Advisors Limited
 Managing Director and Head of Asset Management for Madison Williams Holdings
 LLC in New York City and Head of Corporate Development/Private Equity of GEM Global Equities Management S.A. Also
 He has worked as a senior investment banker at Global Hunter Securities
 Donaldson
 Lufkin and Jenrette
 Gleacher NatWest/NatWest Markets




















 he applied these skills in the successful growth of The Activation Group (TAG)
 a strategic marketing and communications agency. Mr. Cluett founded TAG in 2014 and continues to serve as its president. Prior to founding TAG
 he served as a Business Director with Ogilvy
 a global advertising agency where he was responsible for a multinational business portfolio and was based out of New York City
 Toronto and Montreal. This was preceded by experience as Director of Strategy with 141 Worldwide



Scott Chapman





 Bahamas); and in institutional
 retail sales with Midland Walwyn (Montreal




 Mr. Chapman&#8217;s responsibilities have included corporate finance
 venture capital




 Mr. Chapman has been the owner of Hyperion Management. Hyperion is in the business of venture capital
 marketing












 most notably in the automotive industry. Mr. Salvo has served in many capacities











 food and nutritional products
 marketing



 operational and business experience give them the qualifications and skills necessary to serve as directors of our company. Our board of directors consists solely of Mr. Pallante
 Mr. H









 none of our directors or executive officers has









































 or of any partnership
 corporation or business association of which he was a general partner or executive officer























 judgment
 or decree
 not subsequently reversed
 suspended or vacated
 of any court of competent jurisdiction or federal or state authority
 permanently or temporarily enjoining
 barring
 suspending or otherwise limiting
 his involvement in any type of business
 securities
 futures
 commodities
 investment
 banking
 savings and loan
 or insurance activities























 and the judgment has not been reversed
 suspended














 or a party to
 any federal or state judicial or administrative order
 judgment
 decree
 or finding
 not subsequently reversed
 suspended or vacated (not including any settlement of a civil proceeding among private litigants)
 relating to an alleged violation of any federal or state securities or commodities law or regulation
 any law or regulation respecting financial institutions or insurance companies including
 but not limited to
 a temporary or permanent injunction
 order of disgorgement or restitution
 civil money penalty or temporary or permanent cease-and-desist order
 or removal or prohibition order























 or a party to
 any sanction or order
 not subsequently reversed
 suspended or vacated
 of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26)))
 any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29)))
 or any equivalent exchange
 association









 as amended
 requires our executive officers and directors and persons who own more than 10% of a registered class of our equity securities to file with the SEC initial statements of beneficial ownership
 reports of changes in ownership and annual reports concerning their ownership of our shares of common stock and other equity securities
 on Forms 3
 4 and 5
 respectively. Executive officers



 or written representations from certain reporting persons
 we believe that during fiscal year ended November 30
 2016
 all filing requirements applicable to our officers




that applies to our officers
 directors and employees. When we do adopt a code of ethics
 we will disclose it in a Current Report on Form 8-K.




 and is &#8220;independent&#8221; as the term is used in Item 7(d)(3)(iv) of Schedule 14A under the Securities Exchange Act of 1934

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Our officers and directors have written service contracts with us. We presently do not have pension
 health
 annuity
 insurance
 profit sharing or similar benefit plans; however
 we may adopt plans in the future. Except for our stock option plan
 of which no options were issued in 2017










































































































































































































































































































































































441


































































































393
































000
























000
























000





































000































 2018 of 32
311






















Certain Relationships and Related Transactions
 and Director Independence



 2017 fiscal year
 or any currently proposed transaction
of $120
000 or one percent of the average of our total assets at year end for the last two completed fiscal years
 and in which any related person had or will have a direct or indirect material interest (other than compensation described under &#8220;Executive Compensation&#8221;). We believe the terms obtained or consideration that we paid or received
 as applicable
 in connection with the transactions described below were comparable to terms available or the amounts that would be paid or received
 as applicable











 who is one of three directors of our company
 was our only promoter in the past five fiscal years. Mr. Holcombe has not received
 nor will he receive
 anything of value from us
 directly or indirectly in his capacity as promoter. However
 he holds 500
000 or approximately 1.55% of our issued and outstanding common shares.&#160; Additionally
 Mr. Holcombe receives fees for his service on our Board of Directors plus fees as a contracted service provider for the Company.&#160; As of November 30





































































































































 consisting of Mark Holcombe








 all of the members of the committees are not independent. We believe that our board of directors is capable of analyzing and evaluating our financial statements and understanding internal controls and procedures for financial reporting. The board of directors of our company does not believe that it is necessary to have a completely independent audit
 compensation or corporate governance committee at this time because we believe that the functions of such committees can be adequately performed by the existing board of directors. Additionally







500 and for other services were $Nil during the year ended November 30
 2017.&#160; 



450 and for other services were $Nil during the year ended November 30
























































































































 the registrant caused this report to be signed on its behalf by the undersigned










































































































































 the &#8220;Company&#8221;) as of November 30
 2017 and 2016
 and the related consolidated statements of operations




 nor were we engaged to perform
 an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances
 but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly
 we express no such opinion. An audit includes examining
 on a test basis
 evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management




 the consolidated financial statements referred to above present fairly
 in all material respects
 the financial position of Trident Brands Incorporated and subsidiaries as of November 30
 2017 and 2016 and the results of their operations and their cash flows for the years then ended




/s/ MaloneBailey
 LLP&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; 













































































































143









527







 net of allowance of $29
852 and $0






071

























































584







879




































































425

























714









304






























































388





















454














 net of discount of $0 and $8
812
























843

























 net of discount of $1
954
594 and $1
285
836






845







114























688







843































 $0.001 par value
 300
000
000 shares authorized; 32
311














 2017 and 31
000
000 as of November 30
 2016

























869







431



































751









936














973









538



























714









304









































































































743
































648







































































323









681














125




















352









611







































521


































521




































874











187

























815









135












































































































295







696






















































































































































 November 30






000


















177









800






















609





















































366



















366












000














697



















700





























































































&#160; November 30
























135


















187




































 November 30






000


















431









936






















538





















































466



















466










































































































































&#160; November 30
























815


















874




































 November 30






311


















869









751






















973














































































































874











187


















































































125


















































018























































































305



















416









480







































































































































































































400







100












200







820























616







339























527
































143









527






































466









366



















700


































































































































































 &#8220;our&#8221;
 &#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on November 5
 2007.&#160; The Company was formed to engage in the acquisition




 life sciences and food and beverage categories. The Company is in its early growth stage and has transitioned out of its shell status with the Super-8 filing at the end of August
 2014. Activities to date have focused on capital formation
























 2017 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd
 Sports Nutrition Products Inc.
 Brain Armor Inc.







 &#8220;Earnings Per Share&#8221;
 specifies the computation




 2017 and 2016











As of November 30
 2017 and 2016
 the Company&#8217;s accounts receivable was netted against an allowance of $29
852 and $0 respectively.&#160;&#160;































 including intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include



























































 more likely than not











 2015 the Company entered into a long-term Emulsion Supply Agreement (the &#8220;License&#8221;) with Oceans Omega LLC for the rights to purchase
 market
 sell and distribute patented nutritional emulsions produced by Oceans Omega LLC. Subsequently
 the Company initiated research and development to formulate a range of novel product applications. However
 related product applications have not yet been commercialized and as a result the Company has taken a one-time impairment charge of $2
125







 which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion
 is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term
 the unamortized discount is expensed in the period of retirement to interest expense. In general
 the beneficial conversion feature is measured by comparing the effective conversion price
 after considering the relative fair value of detachable instruments included in the financing transaction
 if any







 &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820 clarifies the definition of fair value
 prescribes methods for measuring fair value








 which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions
 including&#160; quoted forward prices for commodities
 time value
 volatility factors




















 Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument
 can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps
 interest rate swaps







 accounts receivable
 accounts payable and note payable. The fair value of the Company&#8217;s long-term debt is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value. As of November 30
 2017 and 2016











 compared to 48.9% and 27.2% in the prior year. Two customers accounted for 82.3% and 16.4% of total accounts receivable




 b) the price to the customer is fixed and determinable










 2017 and two vendors provided 76% and 11% of the Company's services for the year ended November 30







 &#8220;Compensation-Stock Compensation&#8221;. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments
 including stock options
 based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award







 &#8220;Equity Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;)





























 in the opinion of management
 it is more likely than not that some portion of all of the deferred tax assets will not be realized.&#160; Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company includes interest and penalties arising from the underpayment of income taxes in the statements of operation in the provision for income taxes. As of November 30
 2017 and 2016







 controls
 is controlled by




 its management









 the FASB issued ASU 2016-12
&#160;Revenue from Contracts from Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&#160;The amendments in this update affect the guidance in ASU 2014-09
 which is not yet effective. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments in ASU 2016-12 do not change the core principle of the guidance in Topic 606
 but instead affect only the narrow aspects noted in Topic 606.&#160;ASU 2016-12 is effective January 1



 the FASB issued ASU 2017-09
 Compensation-Stock Compensation (Topic 718)
 Scope of Modification Accounting. The amendments in this Update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The amendments in this Update are effective for all entities for annual periods
 and interim periods within those annual periods
 beginning after December&#160;15
 2017. Early adoption is permitted
 including adoption in any interim period



 the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No.&#160;2017-11
 Earnings Per Share (Topic 260)
 Distinguishing Liabilities from Equity (Topic 480)
 Derivatives and Hedging (Topic 815). The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments
 a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&#8217;s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result



















 the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20
 Debt&#8212;Debt with Conversion and Other Options)
 including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification
 to a scope exception. Those amendments do not have an accounting effect. For public business entities
 the amendments in Part I of this Update are effective for fiscal years
 and interim periods within those fiscal years
 beginning after December&#160;15
 2018. For all other entities
 the amendments in Part I of this Update are effective for fiscal years beginning after December&#160;15
 2019
 and interim periods within fiscal years beginning after December&#160;15
 2020. Early adoption is permitted for all entities
 including adoption in an interim period. If an entity early adopts the amendments in an interim period






 which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board
 or the FASB
 Accounting Standards Update No. 2014-15
 Presentation of Financial Statements - Going Concern (Subtopic 205-40)
 our management evaluates whether there are conditions or events
 considered in aggregate




 2017
 we had an accumulated deficit of $13
751




 as disclosed in Note 10
 on September 26
 2016
 the Company completed a long term financing with a non-US institutional investor
 receiving proceeds of $4
100.000 and $4
400
000 through the issuance of secured convertible promissory notes. The investor has agreed to make additional investments at the Company&#8217;s request of up to $1
500
000 ($10
000
000 in the aggregate). On November 30
 2017 the Company had $3
143
788 in cash and has access to $1
500







 2017 the Company issued 500
000 of our common shares
 valued at $360
000
 for the acquisition of StreamPak Ltd. On September 12
 2017 the Company also issued 811
887 of our common shares
 valued at $605
667
 to Fengate for the purchase of the secured convertible promissory notes of Mycell Technologies LLC. In 2016
 the Company issued 3
000
000 of our common shares
 valued at $2
700
000 to acquire the right and license to purchase
 market
 promote
 sell and distribute Oceans Omega LLC&#8217;s omega-3 emulsions for use in the development
 production
 processing
 manufacture and sale of food and beverages and exclusive rights to purchase
 market
 promote
 sell and distribute Oceans Omega emulsions for meats







 2014
 Trident granted an aggregate of 2
875
000 stock options to directors
 officers
 employees and consultants of the Company pursuant to Trident&#8217;s 2013 Stock Plan. The stock options are exercisable for five years from the date of grant at exercise prices of $0.75 per share for shares vesting 12 months from the date of issuance
 $1.00 per share for shares vesting 24 months from the date of issuance and $1.50 for shares vesting 36 months from the date of issuance. Of the 2
875
000 stock options granted
 Trident granted 1
125



















 Michael Browne; 300
000 stock options to each of its directors at the time
 Donald MacPhee
 Scott Chapman
 Mark Holcombe; 150
000 stock options to its controller
 Peter Salvo; and 350
000 stock options to each of its special advisors
 Robert Campbell and Karen Arsenault. The stock options expire on May 5




 2015
 Michael Browne&#8217;s stock options were amended to 625




 2016 Karen Arseneault resigned as a special advisor to the company. As a result
 the unvested 116
667 options were immediately terminated and the remaining 233
333 options expired on December 31




 2016
 100
000 stock options were granted to Steve Bromley
 a Special Advisor to the Company and Chair of our Advisory Committee
 with 50
000 of the options exercisable at a price of $1.25 per share
 vesting May 1
 2017 and the remaining 50
000 options exercisable at a price of $1.50 per share
 vesting May 1
 2018. All 100
000 options expire on May 1
 2021.&#160; On June 1
 2016 the Company issued to Mr. Bromley an additional 200
000 stock options under the 2013 Stock Option Plan
 with 100
000 of the options exercisable at a price of $1.25 per share
 vesting June 1
 2017 and the remaining 100
000 options exercisable at a price of $1.50 per share
 vesting June 1
 2018. All 200
000 options were to expire on June 1
 2021. On November 1
 2016 an amended service contract with Steve Bromley was completed and the 200
000 stock options issued on June 1
 2016 were withdrawn. The original 100
000 stock options granted on May 1




 2017 Steve Bromley was terminated as a special advisor to the Company. As a result
 the unvested 100
000 options were immediately terminated. The total outstanding stock options as of November 30
 2017 are 2
025




610. In 2017
 the Company expensed $6
964 as compensation expense compared to $111
994 in the previous year. Following are the assumptions used for the shares vested 12
 24 and 36 months from the date of issuance: Discount rate .9%
 1.29%
 1.29%; Volatility 68.35%
 67.35%
 65.50%; and Term 3.0
 3.5



























































375
























































































































































358






























666





























































































































025































025































 2016
 the Company issued 125
000 warrants to purchase common shares of the Company along with the $250
000 secured third party promissory note. The relative fair value of the warrants is $43
526 which is recognized as debt discount. As of November 30
 2016
 the promissory note was paid and the full $43






















 2016
 the Company issued 100
000 warrants to purchase common shares of the Company along with the $200
























































































































































































































































































































































































 2017 we entered into a Share Purchase Agreement&#160;dated September 6
 2017&#160;among our wholly owned subsidiary
 Trident Brands International Ltd. (&#8220;Trident International&#8221;)
 a Bahamas corporation
 StreamPak Ltd. (&#8220;StreamPak&#8221;)
 an Anguilla corporation
 and&#160;the sole shareholder of StreamPak
 pursuant to which
 in consideration for the payment of $125
000 in cash and 500
000 of our common shares valued at $360
000 based on our stock price on September 6
 2017
 Trident International purchased 100% of the issued and outstanding common shares of StreamPak.&#160; As a result of the share purchase StreamPak became a wholly owned subsidiary of Trident International. The acquisition was not deemed an acquisition of a business but rather an acquisition of a finite-lived intangible asset. The total consideration of $485
000 was recognized as an intangible asset related to intellectual property with an estimated useful life of 10 years. The amortized amount for 2017 was $12








 2017 the Company entered into a note purchase agreement with Fengate Trident LP (&#8220;Fengate&#8221;) pursuant to which
 in consideration for the issuance of 811
887 of our common shares to Fengate
 we purchased outstanding secured convertible promissory notes of Mycell Technologies LLC (Mycell) having an aggregate balance due and payable of $511
141 in&#160;principal and $94
526 in&#160;interest accrued as at September 12
 2017.&#160; The purchased notes
 which were originally issued to LPF (MCTECH) Investment Corp. on January 22
 2016
 February 5
 2016
&#160;and May 19
 2016
 bear simple interest on unpaid principal at the rate of ten percent per annum.&#160; The outstanding principal and accrued interest is convertible at the option of the note holder into securities of Mycell.&#160;The accrued interest as at November 30
 2017 is $105





















000 bearing interest at the rate of 10.0% per annum
 payable on March 4
 2017. The Company issued 100
000 common stock warrants with the loan. The relative fair value of the warrants is $35
250 which was recognized as a debt discount. As of November 30
 2017 the promissory note was paid and the full $35
250 of debt discount was amortized. Amortization of the debt discount charged to interest amounted to $8
812 and $26
438 for the years ended November 30
 2017 and 2016
 respectively. The loan was fully repaid on March 3







 2015
 the Company entered into a securities purchase agreement with a non-US institutional investor whereby it agreed to sell an aggregate principal amount of $2
300
000 of senior secured convertible debentures




800
000 of the funds from the transaction on February 5
 2015. The balance of $500
000 was received on May 14




 for an aggregate of up to 3
239
437 shares. The debentures originally accrued interest at 6% per annum. On September 26
 2016 the Company entered into an amendment agreement related to these convertible debentures whereby the applicable interest rate was increased from 6% to 8% and provisions added to allow the investor to transfer
 sell or hypothecate the convertible notes subject to applicable securities laws. The maturity date of the notes was also extended through September 30
 2019. We considered ASC Topic 470-50
 Debt Modifications and Extinguishments
 and determined that the modification was not deemed substantial
 consequently
 extinguishment accounting does not apply. 



 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $647
888 which was recognized as debt discount. As of November 30
 2017




 2016
 the Company entered into a securities purchase agreement with a non-US institutional investor
 pursuant to which
 in consideration for proceeds of $4
100
000
 the Company issued a secured convertible promissory note in the amount of $4
100
000. Pursuant to the securities purchase agreement
 the investor has agreed
 from time to time after January 1
 2017
 to make additional investments at the Company&#8217;s request of up to $5
900
000 ($10
000
000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4
100




 2017
 the Company received the second tranche of funding with proceeds of $4
400
000 for a total investment by the investor of $8
500
000. Under the terms of the securities purchase agreement
 the Company has an additional $1
500




 without limitation




 the Company issued to the investor a convertible promissory note of equal value
 maturing three years after issuance
 and bearing interest at the rate of 8% per annum. Each note is secured in first priority against the present and after acquired assets of the Company and is convertible in whole or in part at the option of the holder into common shares of the Company at a conversion price of $0.60 per share
 for an aggregate of up to 14
166
























 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature of the notes amounted to $2
833
334 and was recognized as a debt discount. Amortization of the debt discount charged to interest amounted to $797
909 and $80
831 for the years ended November 30
 2017 and 2016
 respectively. As of November 30
 2017 and 2016 the unamortized discount amounted to $1
954
594 and $1
285
836










 2015
 pursuant to a Deed of Assignment dated effective January 20
 2015
 the Company entered into an Emulsion Supply Agreement with Oceans Omega LLC which represents the rights acquired pursuant to the Deed of Assignment. The Emulsion Supply Agreement provides the Company with the non-exclusive right and license (without the right to sublicense) to purchase
 market
 promote
 sell and distribute Oceans Omega LLC&#8217;s omega-3 emulsions for use in the development
 production
 processing
 manufacture and sale of food and beverages and exclusive rights to purchase
 market
 promote
 sell and distribute Oceans Omega emulsions for meats
 for human or animal consumption. On January 6
 2016 the Company issued 3
000
000 shares to mark the closing of the Deed of Assignment and the Emulsion Supply Agreement
 which did not specify the amount of consideration payable by the Company when they were executed on January 20
 2015. The consideration payable was subsequently established by the parties at a market value of $2
700
000 and common shares issued as compensation based on the closing price of the common shares as quoted on the OTC Markets quotation systems on January 6
 2016. The value of the license is being amortized over the remaining contractual life which is 9 years. As of November 30
 2017
 the net value of the license was $0 after amortizing $300
000 in 2017 and $275
000 in the prior year and the recognition of an impairment loss of $2
125
000 during the year ended November 30










 2013
 the Company entered into a Deed of Assignment Agreement with Everlast&#160; World&#8217;s Boxing Headquarters Corporation
 International Brand Management Limited
 Sports Nutrition Products Incorporated and Manchester Capital Incorporated wherein Everlast
 International Brand
 Sports Nutrition and Manchester Capital are parties to a trade mark license and Sports Nutrition
 a New York corporation
 has assigned its interest in the trade mark license to the Company. Pursuant to the terms of the assignment agreement
 Sports Nutrition Products Incorporated
 a wholly owned subsidiary of Trident Brands Incorporated
 assigned all of its rights
 title
 interest and benefit to the trade mark license to the Company effective December 23
 2013 and the Company assumed all of the obligations of Sports Nutrition Products Incorporated under the license agreement. The Company shall remain responsible to Everlast and International Brand for all acts and omissions of the subsidiary




 or arising from its termination




 as per the terms of the agreement
&#160;are as follows: In 2013
 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014
 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015
 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards
 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed&#160;Royalty is $120
000 in 2014
 $235
000 in 2015
 $320
000 in 2016
 $345
000 in 2017 and in 2018 onwards
 if the&#160;Agreement remains in force
 will be 75% of the previous Year's Royalty Calculation or the&#160;previous Year's Annual Minimum Guaranteed Royalty plus 10%























 that may arise
 were resolved against the Company in a reporting period for amounts in excess of management&#8217;s expectations
















































915









313

































120







859












120









859































 2017















 2017
 Brain Armor
 a subsidiary of the Company
 issued 1
859
001 shares to Trident Brands Incorporated to convert the $1
394
251 loan to Brain Armor to equity at $0.75. As a result




 2017
 our Board of Directors authorized the issuance to its members and management stock options to purchase up to 2
615
000 share of our common stock.&#160; 1
307
500 of the options vest upon issuance and are exercisable for up to five years at $0.85 per share
 while the remaining 1
307
500 will vest 12 months following issuance and be exercisable for up to five years at $1.00 per share.&#160; The Options were issued pursuant to the Company&#8217;s 2013 Stock Option Plan
 which was registered with the Securities and Exchange Commission on Form S-8 in January



 2017
 the Board of Directors authorized the issuance of 250
000 stock options to Sanitas
 LLC





















    Document created using EDGARfilings PROfile 4.3.3.2











 Anthony Pallante






















 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made













 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for

























 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure that material information relating to the registrant
 including its consolidated subsidiaries
 is made known to me by others within those entities













 or caused such internal control over financial reporting to be designed under our supervision


























 or is reasonably likely to materially affect













 based on our most recent evaluation of internal control over financial reporting













 process













 whether or not material


























































    Document created using EDGARfilings PROfile 4.3.3.2












 Mark Holcombe






















 this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made
 in light of the circumstances under which such statements were made













 the financial statements
 and other financial information included in this report
 fairly present in all material respects the financial condition
 results of operations and cash flows of the registrant as of
 and for

























 or caused such disclosure controls and procedures to be designed under our supervision
 to ensure that material information relating to the registrant
 including its consolidated subsidiaries
 is made known to me by others within those entities













 or caused such internal control over financial reporting to be designed under our supervision


























 or is reasonably likely to materially affect













 based on our most recent evaluation of internal control over financial reporting













 process













 whether or not material




























































    Document created using EDGARfilings PROfile 4.3.3.2












 2017
 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;)
 Anthony Pallante
 as Chief Executive Officer and Director of the Company
 hereby certifies
 pursuant to 18 U.S.C. &#167;1350
 as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002




























 in all material respects


















































 except to the extent required by the Sarbanes-Oxley Act of 2002
 be deemed filed by the Company for purposes of &#167;18 of the Securities Exchange Act of 1934



















    Document created using EDGARfilings PROfile 4.3.3.2













 2017
 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;)
 Mark Holcombe
 as Chief Financial Officer of the Company
 hereby certifies
 pursuant to 18 U.S.C. &#167;1350
 as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002




























 in all material respects
















































 except to the extent required by the Sarbanes-Oxley Act of 2002
 be deemed filed by the Company for purposes of &#167;18 of the Securities Exchange Act of 1934























 March 14















2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05














2014-05-01


2014-05-05













2014-05-01


2014-05-05









2014-11-30













2015-01-01


2015-01-20













2015-01-29













2015-01-01


2015-01-29













2015-02-01


2015-02-05













2015-05-01


2015-05-14









2014-12-01


2015-11-30














2014-12-01


2015-11-30









2015-11-30














2016-01-01


2016-01-06














2016-01-01


2016-01-06












2016-01-29












2016-01-29












2016-01-01


2016-01-29












2016-03-04












2016-03-04












2016-03-01


2016-03-04












2016-03-01


2016-03-04















2016-05-01















2016-05-01















2016-04-30


2016-05-01















2016-04-30


2016-05-01














2016-04-30


2016-05-01















2016-06-01















2016-06-01















2016-05-31


2016-06-01















2016-05-31


2016-06-01














2016-05-31


2016-06-01













2016-09-26













2016-09-26













2016-09-01


2016-09-26













2016-09-01


2016-09-26









2015-12-01


2016-11-30













2015-12-01














2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30












2015-12-01


2016-11-30











2015-12-01


2016-11-30












2015-12-01


2016-11-30













2015-12-01


2016-11-30













2015-12-01


2016-11-30













2015-12-01


2016-11-30













2015-12-01


2016-11-30













2015-12-01


2016-11-30













2015-12-01


2016-11-30









2016-11-30













2016-11-30












2016-11-30











2016-11-30













2017-05-09













2017-05-01


2017-05-09













2017-05-01


2017-05-09









2017-05-31













2017-09-12













2017-09-01


2017-09-12














2017-09-01


2017-09-12














2017-09-01


2017-09-12









2016-12-01


2017-11-30













2016-12-01


2017-11-30












2016-12-01


2017-11-30












2016-12-01


2017-11-30












2016-12-01


2017-11-30












2016-12-01


2017-11-30














2016-12-01


2017-11-30













2016-12-01


2017-11-30











2016-12-01


2017-11-30












2016-12-01


2017-11-30












2016-12-01


2017-11-30












2016-12-01


2017-11-30












2016-12-01


2017-11-30













2016-12-01


2017-11-30













2016-12-01


2017-11-30













2016-12-01


2017-11-30













2016-12-01


2017-11-30













2016-12-01


2017-11-30














2016-12-01


2017-11-30












2016-12-01


2017-11-30












2016-12-01


2017-11-30












2016-12-01


2017-11-30












2016-12-01


2017-11-30









2017-11-30













2017-11-30














2017-11-30














2017-11-30













2017-12-01













2017-11-01


2017-12-01















2017-12-06















2017-12-06














2017-12-06














2017-12-06















2017-12-02


2017-12-06















2017-12-02


2017-12-06













2017-12-02


2017-12-06














2017-12-02


2017-12-06









2018-03-12












2015-11-30












2016-11-30












2015-11-30












2016-11-30












2015-11-30












2016-11-30












2015-11-30












2016-11-30












2017-11-30












2017-11-30












2017-11-30












2017-11-30
























































































































































































&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;NOTE 1. ORGANIZATION AND DESCRIPTION OF BUSINESS&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Trident Brands Incorporated (f/k/a Sandfield Ventures Corp.) (&amp;#8220;we&amp;#8221;
 &amp;#8220;our&amp;#8221;
 &amp;#8220;the Company&amp;#8221;) was incorporated under the laws of the State of Nevada on November 5
 2007.&amp;#160; The Company was formed to engage in the acquisition
 exploration and development of natural resource properties.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company is now focused on the development of high growth branded and private label consumer products and ingredients within the nutritional supplement
 life sciences and food and beverage categories. The Company is in its early growth stage and has transitioned out of its shell status with the Super-8 filing at the end of August
 2014. Activities to date have focused on capital formation
 organizational development and execution of its branded and private label consumer products and ingredients business plan.&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Basis of Accounting&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The Company&amp;#8217;s financial statements are prepared using the accrual method of accounting.&amp;#160; The Company has elected a November 30
 year-end.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Use of Estimates and Assumptions&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The preparation of financial statements in conformity with generally accepted accounting principles&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. In accordance with ASC No. 250 all adjustments are normal and recurring.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Principal of Consolidation&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The Company consolidated financial statements as of November 30
 2017 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd
 Sports Nutrition Products Inc.
 Brain Armor Inc.
 Trident Sports Nutrition Inc. and Trident Brands International Ltd.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Earnings (Loss) Per Share&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;ASC No. 260
 &amp;#8220;Earnings Per Share&amp;#8221;
 specifies the computation
 presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock.&amp;#160;&amp;#160; The Company has adopted the provisions of ASC No. 260.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding. Due to net losses during the years ended November 30
 2017 and 2016
 diluted earnings (loss) per share are the same as the basic earnings (loss) per share since inclusion of common stock equivalents would have been anti-dilutive.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Cash Equivalents&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Accounts receivable are recorded at their original invoice amounts. We regularly review collectability and establish an allowance for uncollectible amounts as necessary.&amp;#160;&lt;font style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;As of November 30
 2017 and 2016
 the Company&amp;#8217;s accounts receivable was netted against an allowance of $29
852 and $0 respectively.&amp;#160;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Inventory&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Inventories are stated at the lower of cost or net realizable value. Cost is principally determined using the first-in
 first-out (FIFO) method. We regularly review inventory for obsolete and slow moving inventory and write it off as necessary.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Long-Lived Assets&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;We review our long-lived assets
 including intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include
 but are not limited to:&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; class=dspflisttable border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#183;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;a significant decrease in the market price of the asset;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; class=dspflisttable border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#183;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;a significant change in the extent or manner in which the asset is being used;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; class=dspflisttable border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#183;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;a significant change in the business climate that could affect the value of the asset;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; class=dspflisttable border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#183;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;a current period loss combined with projection of continuing loss associated with use of the asset; and&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;
&lt;table style=font-family: 'times new roman', times, serif; font-size: 10pt; class=dspflisttable border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#183;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;a current expectation that
 more likely than not
 the asset will be sold or otherwise disposed of before the end of its previously estimated useful life.&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;We continually evaluate whether such events and circumstances have occurred. When such events or circumstances exist
 the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;On January 20
 2015 the Company entered into a long-term Emulsion Supply Agreement (the &amp;#8220;License&amp;#8221;) with Oceans Omega LLC for the rights to purchase
 market
 sell and distribute patented nutritional emulsions produced by Oceans Omega LLC. Subsequently
 the Company initiated research and development to formulate a range of novel product applications. However
 related product applications have not yet been commercialized and as a result the Company has taken a one-time impairment charge of $2
125
000 to write-off the underlying book value of the License. The Company and Management remain committed to developing the commercial potential associated with the license.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;font style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;&amp;#160;&lt;/font&gt;&lt;font style=font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;&lt;u&gt;Beneficial Conversion Features&lt;/u&gt;&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The intrinsic value of a beneficial conversion feature inherent to a convertible note payable
 which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion
 is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term
 the unamortized discount is expensed in the period of retirement to interest expense. In general
 the beneficial conversion feature is measured by comparing the effective conversion price
 after considering the relative fair value of detachable instruments included in the financing transaction
 if any
 to the fair value of the common shares at the commitment date to be received upon conversion.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Fair Value of Financial Instruments&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820
 &amp;#8220;Fair Value Measurements and Disclosures&amp;#8221;. ASC 820 clarifies the definition of fair value
 prescribes methods for measuring fair value
 and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Level 1&amp;#160; &amp;#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives
 marketable securities and listed equities.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Level 2&amp;#160; - Pricing inputs are other than quoted prices in active markets included in level 1
 which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions
 including&amp;#160; quoted forward prices for commodities
 time value
 volatility factors
 and current market and&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;contractual prices for the underlying instruments
 as well as other relevant economic measures.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument
 can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps
 interest rate swaps
 options and collars.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Level 3&amp;#160; &amp;#8211; Pricing inputs include significant inputs that are generally less observable from&amp;#160; objective sources. These inputs may be used with internally developed methodologies that result&amp;#160; in management&amp;#8217;s best estimate of fair value.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents
 accounts receivable
 accounts payable and note payable. The fair value of the Company&amp;#8217;s long-term debt is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value. As of November 30
 2017 and 2016
 the Company did not have any financial liabilities measured and recorded at fair value on the Company&amp;#8217;s balance sheets on a recurring basis.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Revenue&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The Company maintains a portfolio of branded and private label consumer products including nutritional products and supplements under the Everlast&amp;#174; and Brain Armor&amp;#174; brands
 and functional food ingredients under the Oceans Omega brand.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Two customers accounted for 94.3% and 3.7% of total revenue
 compared to 48.9% and 27.2% in the prior year. Two customers accounted for 82.3% and 16.4% of total accounts receivable
 compared to 86.1% and 5.1% in the prior year.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The Company records revenue when all of the following criteria are met: a) persuasive evidence of an arrangement with the customer exists
 b) the price to the customer is fixed and determinable
 c) product is shipped or delivery is complete (depending on the terms) and collection probability is reasonably assured.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Cost of Sales&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Cost of sales includes the direct purchase cost of the product based on the FIFO method.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The Company purchased 99% of its products from one vendor for the year ended November 30
 2017 and two vendors provided 76% and 11% of the Company's services for the year ended November 30
 2016.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Employee Stock-Based Compensation&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The Company accounts for employee stock-based compensation in accordance with ASC-718
 &amp;#8220;Compensation-Stock Compensation&amp;#8221;. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments
 including stock options
 based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award
 usually the vesting period.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Non-Employee Stock-Based Compensation:&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The Company accounts for non-employee stock-based compensation in accordance with the provision of ASC 505-50
 &amp;#8220;Equity Based Payments to Non-Employees&amp;#8221; (&amp;#8220;ASC 505-50&amp;#8221;)
 which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Income taxes are provided in accordance with ASC No. 740
 Accounting for Income Taxes.&amp;#160; A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards.&amp;#160; Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Deferred tax assets are reduced by a valuation allowance when
 in the opinion of management
 it is more likely than not that some portion of all of the deferred tax assets will not be realized.&amp;#160; Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company includes interest and penalties arising from the underpayment of income taxes in the statements of operation in the provision for income taxes. As of November 30
 2017 and 2016
 the Company had no accrued interest or penalties related to uncertain tax positions.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Related Parties&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries
 controls
 is controlled by
 or is under common control with the Company.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;Related parties also include principal owners of the Company
 its management
 members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&lt;u&gt;Recent Accounting Pronouncements&lt;/u&gt;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;The Company has evaluated the following recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that none of them will have a material effect on the Company&amp;#8217;s financial statements:&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;In May 2016
 the FASB issued ASU 2016-12
&amp;#160;Revenue from Contracts from Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&amp;#160;The amendments in this update affect the guidance in ASU 2014-09
 which is not yet effective. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments in ASU 2016-12 do not change the core principle of the guidance in Topic 606
 but instead affect only the narrow aspects noted in Topic 606.&amp;#160;ASU 2016-12 is effective January 1
 2018 to be in alignment with the effective date of ASU 2014-09. Management evaluated ASU 2016-12 and does not believe the adoption of ASU 2016-12 will have a material impact on the Company&amp;#8217;s consolidated financial statements.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;In May 2017
 the FASB issued ASU 2017-09
 Compensation-Stock Compensation (Topic 718)
 Scope of Modification Accounting. The amendments in this Update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The amendments in this Update are effective for all entities for annual periods
 and interim periods within those annual periods
 beginning after December&amp;#160;15
 2017. Early adoption is permitted
 including adoption in any interim period
 for (1)&amp;#160;public business entities for reporting periods for which financial statements have not yet been issued and (2)&amp;#160;all other entities for reporting periods for which financial statements have not yet been made available for issuance.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;In July 2017
 the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) No.&amp;#160;2017-11
 Earnings Per Share (Topic 260)
 Distinguishing Liabilities from Equity (Topic 480)
 Derivatives and Hedging (Topic 815). The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments
 a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&amp;#8217;s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result
 a freestanding equity-linked financial instrument (or embedded conversion option) &lt;/font&gt;&lt;font style=font-family: times new roman,times; size=2&gt;no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments
 the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20
 Debt&amp;#8212;Debt with Conversion and Other Options)
 including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification
 to a scope exception. Those amendments do not have an accounting effect. For public business entities
 the amendments in Part I of this Update are effective for fiscal years
 and interim periods within those fiscal years
 beginning after December&amp;#160;15
 2018. For all other entities
 the amendments in Part I of this Update are effective for fiscal years beginning after December&amp;#160;15
 2019
 and interim periods within fiscal years beginning after December&amp;#160;15
 2020. Early adoption is permitted for all entities
 including adoption in an interim period. If an entity early adopts the amendments in an interim period


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;NOTE 3. LIQUIDITY&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern
 which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board
 or the FASB
 Accounting Standards Update No. 2014-15
 Presentation of Financial Statements - Going Concern (Subtopic 205-40)
 our management evaluates whether there are conditions or events
 considered in aggregate
 that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;We will need to continue to improve margins and revenue by optimizing supply chain metrics and commercializing higher-value branded and control brand distribution agreements.&amp;#160; As of November 30
 2017
 we had an accumulated deficit of $13
751
420 and we expect to incur net losses for the foreseeable future.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;However
 as disclosed in Note 10
 on September 26
 2016
 the Company completed a long term financing with a non-US institutional investor
 receiving proceeds of $4
100.000 and $4
400
000 through the issuance of secured convertible promissory notes. The investor has agreed to make additional investments at the Company&amp;#8217;s request of up to $1
500
000 ($10
000
000 in the aggregate). On November 30
 2017 the Company had $3
143
788 in cash and has access to $1
500
000 available from the investor. We believe that our present financial resources including access to available financing will be sufficient to meet the Company&amp;#8217;s obligations and fund our operations at least through the next twelve months from the date these financial statements were issued.&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;NOTE 5. WARRANTS AND OPTIONS&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On May 5
 2014
 Trident granted an aggregate of 2
875
000 stock options to directors
 officers
 employees and consultants of the Company pursuant to Trident&amp;#8217;s 2013 Stock Plan. The stock options are exercisable for five years from the date of grant at exercise prices of $0.75 per share for shares vesting 12 months from the date of issuance
 $1.00 per share for shares vesting 24 months from the date of issuance and $1.50 for shares vesting 36 months from the date of issuance. Of the 2
875
000 stock options granted
 Trident granted 1
125
000 stock options to its president at&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; margin-top: 10pt; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; margin-bottom: 10pt; letter-spacing: normal; color: #000000; clear: both; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; &gt;the time
 Michael Browne; 300
000 stock options to each of its directors at the time
 Donald MacPhee
 Scott Chapman
 Mark Holcombe; 150
000 stock options to its controller
 Peter Salvo; and 350
000 stock options to each of its special advisors
 Robert Campbell and Karen Arsenault. The stock options expire on May 5
 2019.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On November 30
 2015
 Michael Browne&amp;#8217;s stock options were amended to 625
000.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On September 30
 2016 Karen Arseneault resigned as a special advisor to the company. As a result
 the unvested 116
667 options were immediately terminated and the remaining 233
333 options expired on December 31
 2016.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On May 1
 2016
 100
000 stock options were granted to Steve Bromley
 a Special Advisor to the Company and Chair of our Advisory Committee
 with 50
000 of the options exercisable at a price of $1.25 per share
 vesting May 1
 2017 and the remaining 50
000 options exercisable at a price of $1.50 per share
 vesting May 1
 2018. All 100
000 options expire on May 1
 2021.&amp;#160; On June 1
 2016 the Company issued to Mr. Bromley an additional 200
000 stock options under the 2013 Stock Option Plan
 with 100
000 of the options exercisable at a price of $1.25 per share
 vesting June 1
 2017 and the remaining 100
000 options exercisable at a price of $1.50 per share
 vesting June 1
 2018. All 200
000 options were to expire on June 1
 2021. On November 1
 2016 an amended service contract with Steve Bromley was completed and the 200
000 stock options issued on June 1
 2016 were withdrawn. The original 100
000 stock options granted on May 1
 2016 remain in place.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform:
 none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On April 30
 2017 Steve Bromley was terminated as a special advisor to the Company. As a result
 the unvested 100
000 options were immediately terminated. The total outstanding stock options as of November 30
 2017 are 2
025
000.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company used the Black-Scholes model to value the stock options at $601
610. In 2017
 the Company expensed $6
964 as compensation expense compared to $111
994 in the previous year. Following are the assumptions used for the shares vested 12
 24 and 36 months from the date of issuance: Discount rate .9%
 1.29%
 1.29%; Volatility 68.35%
 67.35%
 65.50%; and Term 3.0
 3.5
 4.0.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The following table represents stock option activity as of and for the years ended November 30
 2017 and 2016:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;table style=widows: 2; text-transform: none; background-color: #ffffff; text-indent: 0px; width: 90%; font-family: 'times new roman', times, serif; orphans: 2; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;  border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Number of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Options&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Weighted Average&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Exercise Price&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Contractual&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Life in Years&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Intrinsic&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Value&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align:
 left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding - November 30
&amp;#160; 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
375
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.15&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.5&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;983
334&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.00&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.4&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;300
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.73&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;5.0&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align:
 bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Forfeited or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;316
667&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding - November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
358
333&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times
 new roman', times, serif; font-size: 10pt;&gt;0.96&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.51&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1
666
667&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.17&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.43&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;57
500&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td
 style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Forfeited or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;333
333&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 732px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 127px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding - November 30
 2017&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
025
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.96&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom;
 valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.43&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2017&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
025
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.96&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.43&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;84
167&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On January 29
 2016
 the Company issued 125
000 warrants to purchase common shares of the Company along with the $250
000 secured third party promissory note. The relative fair value of the warrants is $43
526 which is recognized as debt discount. As of November 30
 2016
 the promissory note was paid and the full $43
526 of the debt discount is amortized and the unamortized discount is $0.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On March 4
 2016
 the Company issued 100
000 warrants to purchase common shares of the Company along with the $200
000 secured third party promissory note. See Note 9.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400;
 word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The exercise price of both warrants is $1.35 with a term of 3 years and these are vested immediately. The Company uses the Black-Scholes model to value the warrants. Following are the assumptions used: Discount rate .9%; Volatility 76.25% and 77.30% respectively.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The following table represents warrant activity for the years ended November 30
 2017 and 2016:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;table style=widows: 2; text-transform: none; background-color: #ffffff; text-indent: 0px; width: 90%; font-family: 'times new roman', times, serif; orphans: 2; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;  border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Number of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Warrants&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Weighted&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Average&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Exercise Price&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Contractual&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Life in Years&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Intrinsic&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Value&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td
 style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable &amp;#8211; November 30
 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;225
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.00&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom;
 valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 732px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 127px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
&amp;#160; 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;225
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;1.35&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;2.21&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width:
 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom;
 valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 732px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 127px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 732px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
 2017&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 127px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;225
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.20&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width:
 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 126px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;NOTE 6. RELATED PARTY TRANSACTIONS&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company neither owns nor leases any real or personal property. The Company is paying a director $750 per month rent for use of office space and services.&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;NOTE 9. LOAN PAYABLE &amp;#8211; THIRD PARTY&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;During 2016 the Company had one short term loan for $200
000 bearing interest at the rate of 10.0% per annum
 payable on March 4
 2017. The Company issued 100
000 common stock warrants with the loan. The relative fair value of the warrants is $35
250 which was recognized as a debt discount. As of November 30
 2017 the promissory note was paid and the full $35
250 of debt discount was amortized. Amortization of the debt discount charged to interest amounted to $8
812 and $26
438 for the years ended November 30
 2017 and 2016
 respectively. The loan was fully repaid on March 3
 2017.&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On January 29
 2015
 the Company entered into a securities purchase agreement with a non-US institutional investor whereby it agreed to sell an aggregate principal amount of $2
300
000 of senior secured convertible debentures
 convertible into shares of the company&amp;#8217;s common stock.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company received $1
800
000 of the funds from the transaction on February 5
 2015. The balance of $500
000 was received on May 14
 2015.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The convertible debentures are convertible into shares of the Company&amp;#8217;s common stock at an initial conversion price of $0.71 per share
 for an aggregate of up to 3
239
437 shares. The debentures originally accrued interest at 6% per annum. On September 26
 2016 the Company entered into an amendment agreement related to these convertible debentures whereby the applicable interest rate was increased from 6% to 8% and provisions added to allow the investor to transfer
 sell or hypothecate the convertible notes subject to applicable securities laws. The maturity date of the notes was also extended through September 30
 2019. We considered ASC Topic 470-50
 Debt Modifications and Extinguishments
 and determined that the modification was not deemed substantial
 consequently
 extinguishment accounting does not apply.&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Due to the note being convertible to common shares of the Company
 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $647
888 which was recognized as debt discount. As of November 30
 2017
 the full amount of the debt discount has been amortized.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On September 26
 2016
 the Company entered into a securities purchase agreement with a non-US institutional investor
 pursuant to which
 in consideration for proceeds of $4
100
000
 the Company issued a secured convertible promissory note in the amount of $4
100
000. Pursuant to the securities purchase agreement
 the investor has agreed
 from time to time after January 1
 2017
 to make additional investments at the Company&amp;#8217;s request of up to $5
900
000 ($10
000
000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4
100
000 which has been funded) is subject to the mutual agreement of the parties as to the use of funds.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On May 9
 2017
 the Company received the second tranche of funding with proceeds of $4
400
000 for a total investment by the investor of $8
500
000. Under the terms of the securities purchase agreement
 the Company has an additional $1
500
000 of available funding.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company intends to use the proceeds of the secured convertible note for general working capital purposes including
 without limitation
 settlement of accounts payable and repayment of mature loans.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;In consideration of each advance made by the investor pursuant to the securities purchase agreement
 the Company issued to the investor a convertible promissory note of equal value
 maturing three years after issuance
 and bearing interest at the rate of 8% per annum. Each note is secured in first priority against the present and after acquired assets of the Company and is convertible in whole or in part at the option of the holder into common shares of the Company at a conversion price of $0.60 per share
 for an aggregate of up to 14
166
667 shares.&lt;br  /&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Due to the notes being convertible to common shares of the Company
 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature of the notes amounted to $2
833
334 and was recognized as a debt discount. Amortization of the debt discount charged to interest amounted to $797
909 and $80
831 for the years ended November 30
 2017 and 2016
 respectively. As of November 30
 2017 and 2016 the unamortized discount amounted to $1
954
594 and $1
285
836
 respectively.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;NOTE 11. INTANGIBLE ASSETS&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On January 22
 2015
 pursuant to a Deed of Assignment dated effective January 20
 2015
 the Company entered into an Emulsion Supply Agreement with Oceans Omega LLC which represents the rights acquired pursuant to the Deed of Assignment. The Emulsion Supply Agreement provides the Company with the non-exclusive right and license (without the right to sublicense) to purchase
 market
 promote
 sell and distribute Oceans Omega LLC&amp;#8217;s omega-3 emulsions for use in the development
 production
 processing
 manufacture and sale of food and beverages and exclusive rights to purchase
 market
 promote
 sell and distribute Oceans Omega emulsions for meats
 for human or animal consumption. On January 6
 2016 the Company issued 3
000
000 shares to mark the closing of the Deed of Assignment and the Emulsion Supply Agreement
 which did not specify the amount of consideration payable by the Company when they were executed on January 20
 2015. The consideration payable was subsequently established by the parties at a market value of $2
700
000 and common shares issued as compensation based on the closing price of the common shares as quoted on the OTC Markets quotation systems on January 6
 2016. The value of the license is being amortized over the remaining contractual life which is 9 years. As of November 30
 2017
 the net value of the license was $0 after amortizing $300
000 in 2017 and $275
000 in the prior year and the recognition of an impairment loss of $2
125
000 during the year ended November 30
 2017.&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: bold; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;NOTE 13. INCOME TAXES&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;u&gt;Deferred tax assets consist of:&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;table style=widows: 2; text-transform: none; background-color: #ffffff; text-indent: 0px; width: 90%; font-family: 'times new roman', times, serif; orphans: 2; letter-spacing: normal; font-size: 10pt; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;  border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; width: 1014px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: top; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;As of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;November 30
 2017&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: top; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;As of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 1014px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Deferred tax assets:&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 1014px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Net operating tax carryforwards&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 154px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;8
915
112&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 154px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;5
313
340&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 1014px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Tax Rate&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 154px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif;
 font-size: 10pt;&gt;%&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 154px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;%&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 1014px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Gross deferred tax assets&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 154px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3
120
289&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 154px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1
859
669&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 1014px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Valuation allowance&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 154px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;(3
120
289&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;)&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 154px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;(1
859
669&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;)&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 1014px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Net deferred tax assets&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 15px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 154px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 154px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 14px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;As of November 30
 2017
 the Company has a net operating loss carryforward of approximately $9 million. Net operating loss carryforwards expires twenty years from the date the loss was incurred.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal;
 text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Realization of deferred tax assets is dependent upon sufficient future taxable income during the period that deductible temporary differences and carryforwards are expected to be available to reduce taxable income.&amp;#160; As the achievement of required future taxable income is uncertain
 the Company has recorded a valuation allowance.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Due to the enactment of the Tax Reform Act of 2018
 the corporate tax rate for those tax years beginning with 2018 will be reduced to 21%.&lt;/div&gt;


&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;&lt;font size=2&gt;NOTE 14.&amp;#160; SUBSEQUENT EVENTS&lt;/font&gt;&lt;/div&gt;
&lt;div&gt;&lt;font size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;&lt;font size=2&gt;On December 1
 2017
 Brain Armor
 a subsidiary of the Company
 issued 1
859
001 shares to Trident Brands Incorporated to convert the $1
394
251 loan to Brain Armor to equity at $0.75. As a result
 the Company&amp;#8217;s ownership interest in Brain Armor&amp;#160;increased to&amp;#160;94.8%.&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;&lt;font size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;
&lt;div style=text-align: justify; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font size=2&gt;On December 6
 2017
 our Board of Directors authorized the issuance to its members and management stock options to purchase up to 2
615
000 share of our common stock.&amp;#160; 1
307
500 of the options vest upon issuance and are exercisable for up to five years at $0.85 per share
 while the remaining 1
307
500 will vest 12 months following issuance and be exercisable for up to five years at $1.00 per share.&amp;#160; The Options were issued pursuant to the Company&amp;#8217;s 2013 Stock Option Plan
 which was registered with the Securities and Exchange Commission on Form S-8 in January
 2015.&amp;#160; The 2013 Stock Option Plan authorizes Trident to issue incentive and non-qualified stock options to employees and consultants of the Company to purchase a number of shares not to exceed 15% of the Company&amp;#8217;s currently issued and outstanding securities.&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font size=2&gt;Also on December 6
 2017
 the Board of Directors authorized the issuance of 250
000 stock options to Sanitas
 LLC
 a consultant and founding shareholder of Brain Armor.&amp;#160; The options vest immediately and are exercisable for a period of five (5) years to purchase common shares of Brain armor at $0.75 per share.&lt;/font&gt;&lt;/div&gt;
&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company&amp;#8217;s financial statements are prepared using the accrual method of accounting.&amp;#160; The Company has elected a November 30


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company consolidated financial statements as of November 30
 2017 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd
 Sports Nutrition Products Inc.
 Brain Armor Inc.


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;ASC No. 260
 &amp;#8220;Earnings Per Share&amp;#8221;
 specifies the computation
 presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock.&amp;#160;&amp;#160; The Company has adopted the provisions of ASC No. 260.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding. Due to net losses during the years ended November 30
 2017 and 2016


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Accounts receivable are recorded at their original invoice amounts. We regularly review collectability and establish an allowance for uncollectible amounts as necessary.&amp;#160;&lt;font style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;As of November 30
 2017 and 2016
 the Company&amp;#8217;s accounts receivable was netted against an allowance of $29


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Inventories are stated at the lower of cost or net realizable value. Cost is principally determined using the first-in


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;We review our long-lived assets
 including intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include
 but are not limited to:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;
&lt;table style=width: 100%; font-family: 'times new roman', times, serif; font-size: 10pt; class=dspflisttable border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a significant decrease in the market price of the asset;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;
&lt;table style=width: 100%; font-family: 'times new roman', times, serif; font-size: 10pt; class=dspflisttable border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a significant change in the extent or manner in which the asset is being used;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;
&lt;table style=width: 100%; font-family: 'times new roman', times, serif; font-size: 10pt; class=dspflisttable border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a significant change in the business climate that could affect the value of the asset;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;
&lt;table style=width: 100%; font-family: 'times new roman', times, serif; font-size: 10pt; class=dspflisttable border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a current period loss combined with projection of continuing loss associated with use of the asset; and&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;
&lt;table style=width: 100%; font-family: 'times new roman', times, serif; font-size: 10pt; class=dspflisttable border=0 cellspacing=0 cellpadding=0&gt;
&lt;tr&gt;
&lt;td style=width: 72pt; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: symbol, serif; margin-left: 36pt; font-size: 10pt;&gt;&amp;#183;&lt;/div&gt;
&lt;/td&gt;
&lt;td style=width: auto; vertical-align: top;&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;a current expectation that
 more likely than not
 the asset will be sold or otherwise disposed of before the end of its previously estimated useful life.&amp;#160;&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/table&gt;
&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;We continually evaluate whether such events and circumstances have occurred. When such events or circumstances exist
 the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On January 20
 2015 the Company entered into a long-term Emulsion Supply Agreement (the &amp;#8220;License&amp;#8221;) with Oceans Omega LLC for the rights to purchase
 market
 sell and distribute patented nutritional emulsions produced by Oceans Omega LLC. Subsequently
 the Company initiated research and development to formulate a range of novel product applications. However
 related product applications have not yet been commercialized and as a result the Company has taken a one-time impairment charge of $2
125


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The intrinsic value of a beneficial conversion feature inherent to a convertible note payable
 which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion
 is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term
 the unamortized discount is expensed in the period of retirement to interest expense. In general
 the beneficial conversion feature is measured by comparing the effective conversion price
 after considering the relative fair value of detachable instruments included in the financing transaction
 if any


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820
 &amp;#8220;Fair Value Measurements and Disclosures&amp;#8221;. ASC 820 clarifies the definition of fair value
 prescribes methods for measuring fair value
 and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Level 1&amp;#160; &amp;#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives
 marketable securities and listed equities.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Level 2&amp;#160; - Pricing inputs are other than quoted prices in active markets included in level 1
 which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions
 including&amp;#160; quoted forward prices for commodities
 time value
 volatility factors
 and current market and&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;contractual prices for the underlying instruments
 as well as other relevant economic measures.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;br  /&gt;Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument
 can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps
 interest rate swaps
 options and collars.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Level 3&amp;#160; &amp;#8211; Pricing inputs include significant inputs that are generally less observable from&amp;#160; objective sources. These inputs may be used with internally developed methodologies that result&amp;#160; in management&amp;#8217;s best estimate of fair value.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents
 accounts receivable
 accounts payable and note payable. The fair value of the Company&amp;#8217;s long-term debt is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value. As of November 30
 2017 and 2016


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company maintains a portfolio of branded and private label consumer products including nutritional products and supplements under the Everlast&amp;#174; and Brain Armor&amp;#174; brands
 and functional food ingredients under the Oceans Omega brand.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Two customers accounted for 94.3% and 3.7% of total revenue
 compared to 48.9% and 27.2% in the prior year. Two customers accounted for 82.3% and 16.4% of total accounts receivable
 compared to 86.1% and 5.1% in the prior year.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company records revenue when all of the following criteria are met: a) persuasive evidence of an arrangement with the customer exists
 b) the price to the customer is fixed and determinable


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Cost of sales includes the direct purchase cost of the product based on the FIFO method.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company purchased 99% of its products from one vendor for the year ended November 30
 2017 and two vendors provided 76% and 11% of the Company's services for the year ended November 30


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company accounts for employee stock-based compensation in accordance with ASC-718
 &amp;#8220;Compensation-Stock Compensation&amp;#8221;. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments
 including stock options
 based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company accounts for non-employee stock-based compensation in accordance with the provision of ASC 505-50
 &amp;#8220;Equity Based Payments to Non-Employees&amp;#8221; (&amp;#8220;ASC 505-50&amp;#8221;)


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Income taxes are provided in accordance with ASC No. 740
 Accounting for Income Taxes.&amp;#160; A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards.&amp;#160; Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Deferred tax assets are reduced by a valuation allowance when
 in the opinion of management
 it is more likely than not that some portion of all of the deferred tax assets will not be realized.&amp;#160; Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company includes interest and penalties arising from the underpayment of income taxes in the statements of operation in the provision for income taxes. As of November 30
 2017 and 2016


&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries
 controls
 is controlled by
 or is under common control with the Company.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;Related parties also include principal owners of the Company
 its management


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company has evaluated the following recent accounting pronouncements through the date the financial statements were issued and filed with the Securities and Exchange Commission and believe that none of them will have a material effect on the Company&amp;#8217;s financial statements:&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;In May 2016
 the FASB issued ASU 2016-12
&amp;#160;Revenue from Contracts from Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&amp;#160;The amendments in this update affect the guidance in ASU 2014-09
 which is not yet effective. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments in ASU 2016-12 do not change the core principle of the guidance in Topic 606
 but instead affect only the narrow aspects noted in Topic 606.&amp;#160;ASU 2016-12 is effective January 1
 2018 to be in alignment with the effective date of ASU 2014-09. Management evaluated ASU 2016-12 and does not believe the adoption of ASU 2016-12 will have a material impact on the Company&amp;#8217;s consolidated financial statements.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;In May 2017
 the FASB issued ASU 2017-09
 Compensation-Stock Compensation (Topic 718)
 Scope of Modification Accounting. The amendments in this Update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The amendments in this Update are effective for all entities for annual periods
 and interim periods within those annual periods
 beginning after December&amp;#160;15
 2017. Early adoption is permitted
 including adoption in any interim period
 for (1)&amp;#160;public business entities for reporting periods for which financial statements have not yet been issued and (2)&amp;#160;all other entities for reporting periods for which financial statements have not yet been made available for issuance.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;In July 2017
 the Financial Accounting Standards Board (&amp;#8220;FASB&amp;#8221;) issued Accounting Standards Update (&amp;#8220;ASU&amp;#8221;) No.&amp;#160;2017-11
 Earnings Per Share (Topic 260)
 Distinguishing Liabilities from Equity (Topic 480)
 Derivatives and Hedging (Topic 815). The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments
 a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&amp;#8217;s own stock. The amendments also
 clarify existing disclosure requirements for equity-classified instruments. As a result
 a freestanding equity-linked financial instrument (or embedded conversion option)&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments
 the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20
 Debt&amp;#8212;Debt with Conversion and Other Options)
 including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification
 to a scope exception. Those amendments do not have an accounting effect. For public business entities
 the amendments in Part I of this Update are effective for fiscal years
 and interim periods within those fiscal years
 beginning after December&amp;#160;15
 2018. For all other entities
 the amendments in Part I of this Update are effective for fiscal years beginning after December&amp;#160;15
 2019
 and interim periods within fiscal years beginning after December&amp;#160;15
 2020. Early adoption is permitted for all entities
 including adoption in an interim period. If an entity early adopts the amendments in an interim period


&lt;tr&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Number of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Options&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Weighted Average&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Exercise Price&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Contractual&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Life in Years&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; font-weight: bold; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Intrinsic&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Value&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding - November 30
&amp;#160; 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
375
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.15&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.5&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div
 style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;983
334&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.00&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.4&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;300
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.73&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;5.0&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Forfeited or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;316
667&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td
 style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding - November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
358
333&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.96&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.51&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1
666
667&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.17&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2.43&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom;
 valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;57
500&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Forfeited or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;333
333&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom
 nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 509px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding - November 30
 2017&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
025
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.96&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.43&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2017&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;2
025
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;0.96&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.43&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width:
 88px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;84
167&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;


&lt;tr&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Number of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Warrants&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Weighted&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Average&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Exercise Price&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Contractual&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Life in Years&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: bottom; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Intrinsic&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt; font-weight: bold;&gt;Value&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; vertical-align: bottom; valign=bottom&gt;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable &amp;#8211; November 30
 2015&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff;
 vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;225
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3.00&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align:
 left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 509px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
&amp;#160; 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;225
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;1.35&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;2.21&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercisable - November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom;
 valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Granted&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Exercised or Vested&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Cancelled or Expired&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left;
 background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 509px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 89px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #cceeff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 509px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Outstanding &amp;#8211; November 30
 2017&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;225
000&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 89px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 10px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1.20&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 88px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;


&lt;tr&gt;
&lt;td style=padding-bottom: 2px; width: 704px; vertical-align: top; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: top; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;As of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;November 30
 2017&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 2px; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; vertical-align: top; valign=bottom colspan=2&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;As of&lt;/div&gt;
&lt;div style=text-align: center; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;November 30
 2016&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #cceeff; width: 704px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Deferred tax assets:&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #cceeff; vertical-align: top; valign=bottom colspan=2&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #cceeff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 704px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Net operating tax carryforwards&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 107px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;8
915
112&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 107px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;5
313
340&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 704px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Tax Rate&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 107px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;%&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 107px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;35&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;%&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=background-color: #ffffff; width: 704px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Gross deferred tax assets&lt;/div&gt;
&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 107px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;3
120
289&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=text-align: right; background-color: #ffffff; width: 107px; vertical-align: bottom; valign=bottom&gt;
&lt;div
 style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;1
859
669&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; background-color: #ffffff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 704px; vertical-align: top; valign=bottom&gt;
&lt;div style=text-align: justify; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Valuation allowance&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 107px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;(3
120
289&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;)&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 2px; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: left; background-color: #cceeff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 2px solid; text-align: right; background-color: #cceeff; width: 107px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;(1
859
669&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 2px; background-color: #cceeff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;)&lt;/div&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 704px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=text-align: left; font-family: 'times new roman', times, serif; font-size: 10pt;&gt;Net deferred tax assets&lt;/div&gt;
&lt;/td&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 107px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;td style=padding-bottom: 4px; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;&amp;#160;&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: left; background-color: #ffffff; width: 9px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;$&lt;/div&gt;
&lt;/td&gt;
&lt;td style=border-bottom: #000000 4px double; text-align: right; background-color: #ffffff; width: 107px; vertical-align: bottom; valign=bottom&gt;
&lt;div style=font-family: 'times new roman', times, serif; font-size: 10pt;&gt;-0-&lt;/div&gt;
&lt;/td&gt;
&lt;td style=text-align: left; padding-bottom: 4px; background-color: #ffffff; width: 12px; vertical-align: bottom; valign=bottom nowrap=nowrap&gt;&amp;#160;&lt;/td&gt;
&lt;/tr&gt;
















































































































































































































 if the&amp;#160;Agreement remains in force
 will be 75% of the previous Year's Royalty Calculation or the&amp;#160;previous Year's Annual Minimum Guaranteed Royalty plus 10%










&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On September 12
 2017 the Company issued 500
000 of our common shares
 valued at $360
000
 for the acquisition of StreamPak Ltd. On September 12
 2017 the Company also issued 811
887 of our common shares
 valued at $605
667
 to Fengate for the purchase of the secured convertible promissory notes of Mycell Technologies LLC. In 2016
 the Company issued 3
000
000 of our common shares
 valued at $2
700
000 to acquire the right and license to purchase
 market
 promote
 sell and distribute Oceans Omega LLC&amp;#8217;s omega-3 emulsions for use in the development
 production
 processing
 manufacture and sale of food and beverages and exclusive rights to purchase
 market
 promote
 sell and distribute Oceans Omega emulsions for meats


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;&amp;#160;&lt;/font&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;font style=font-family: times new roman,times; size=2&gt;On September 12
 2017 we entered into a Share Purchase Agreement&amp;#160;dated September 6
 2017&amp;#160;among our wholly owned subsidiary
 Trident Brands International Ltd. (&amp;#8220;Trident International&amp;#8221;)
 a Bahamas corporation
 StreamPak Ltd. (&amp;#8220;StreamPak&amp;#8221;)
 an Anguilla corporation
 and&amp;#160;the sole shareholder of StreamPak
 pursuant to which
 in consideration for the payment of $125
000 in cash and 500
000 of our common shares valued at $360
000 based on our stock price on September 6
 2017
 Trident International purchased 100% of the issued and outstanding common shares of StreamPak.&amp;#160; As a result of the share purchase StreamPak became a wholly owned subsidiary of Trident International. The acquisition was not deemed an acquisition of a business but rather an acquisition of a finite-lived intangible asset. The total consideration of $485
000 was recognized as an intangible asset related to intellectual property with an estimated useful life of 10 years. The amortized amount for 2017 was $12


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&lt;u&gt;Everlast License Agreement&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On December 23
 2013
 the Company entered into a Deed of Assignment Agreement with Everlast&amp;#160; World&amp;#8217;s Boxing Headquarters Corporation
 International Brand Management Limited
 Sports Nutrition Products Incorporated and Manchester Capital Incorporated wherein Everlast
 International Brand
 Sports Nutrition and Manchester Capital are parties to a trade mark license and Sports Nutrition
 a New York corporation
 has assigned its interest in the trade mark license to the Company. Pursuant to the terms of the assignment agreement
 Sports Nutrition Products Incorporated
 a wholly owned subsidiary of Trident Brands Incorporated
 assigned all of its rights
 title
 interest and benefit to the trade mark license to the Company effective December 23
 2013 and the Company assumed all of the obligations of Sports Nutrition Products Incorporated under the license agreement. The Company shall remain responsible to Everlast and International Brand for all acts and omissions of the subsidiary
 Sports Nutrition Products Inc.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Everlast Licence Agreement includes a clause stating that Manchester Capital Incorporated will guarantee that the Licensee shall perform all of its obligations and duties under the Licence Agreement. If the Licensee defaults in the payment when due of any amount it is obliged to pay to Licensor under the Licence Agreement
 or arising from its termination
 Manchester Capital is unconditionally responsible to pay that amount to Licensor in the manner prescribed in the Licence Agreement as if it were the Licensee.&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Royalty Calculation
 as per the terms of the agreement
&amp;#160;are as follows: In 2013
 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014
 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015
 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards
 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed&amp;#160;Royalty is $120
000 in 2014
 $235
000 in 2015
 $320
000 in 2016
 $345
000 in 2017 and in 2018 onwards
 if the&amp;#160;Agreement remains in force
 will be 75% of the previous Year's Royalty Calculation or the&amp;#160;previous Year's Annual Minimum Guaranteed Royalty plus 10%
 whichever is greater.&lt;br /&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial;
 text-decoration-color: initial;&gt;&lt;u&gt;Contingencies&lt;/u&gt;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;The Company may be subject to various legal proceedings and claims that arise in the ordinary course of business. The Company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. There is significant judgment required in both the probability determination and as to whether an exposure can be reasonably estimated. If any legal matter
 that may arise
 were resolved against the Company in a reporting period for amounts in excess of management&amp;#8217;s expectations


&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;&amp;#160;&lt;/div&gt;
&lt;div style=text-align: left; widows: 2; text-transform: none; background-color: #ffffff; font-style: normal; text-indent: 0px; font-family: 'times new roman', times, serif; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 10pt; font-weight: 400; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;&gt;On September 12
 2017 the Company entered into a note purchase agreement with Fengate Trident LP (&amp;#8220;Fengate&amp;#8221;) pursuant to which
 in consideration for the issuance of 811
887 of our common shares to Fengate
 we purchased outstanding secured convertible promissory notes of Mycell Technologies LLC (Mycell) having an aggregate balance due and payable of $511
141 in&amp;#160;principal and $94
526 in&amp;#160;interest accrued as at September 12
 2017.&amp;#160; The purchased notes
 which were originally issued to LPF (MCTECH) Investment Corp. on January 22
 2016
 February 5
 2016
&amp;#160;and May 19
 2016
 bear simple interest on unpaid principal at the rate of ten percent per annum.&amp;#160; The outstanding principal and accrued interest is convertible at the option of the note holder into securities of Mycell.&amp;#160;The accrued interest as at November 30
 2017 is $105





	








	





















 March 14


























































































































































































































































































































































 March 14





































































 March 14

































































































































































































































































































































































































































































































































































































































































































 March 14




































































 at Carrying Value







 Net


 net of allowance of $29
852 and $0














 Loans and Financing Receivable
 Net





































 net of discount of $0 and $8
812











 net of discount of $1
954
594 and $1
285
836












 Value


 $0.001 par value
 300
000
000 shares authorized; 32
311
887 shares issued and outstanding as of November 30
 2017 and 31
000
000 as of November 30
 2016
































 Unamortized Discount






 Unamortized Discount

















 Shares






 Shares






























































































































 Shares











 Shares






 Value






 Shares






 Value
 Share-based Compensation

















































































 Plant






























































 Convertible





































































 Notes
 Loans and Financing Receivable
 Gross
 Allowance




 Notes








































































 Trade and Other Accounts Receivable
 Allowance for Doubtful Accounts










 Finite-Lived


















































 Stock Options









 Notes





































 Notes




 Shares





 Periodic Payment





 Periodic Payment


































 Goods
















 or purchases) for the specified product line for the period after providing for returns
 allowances and discounts






























 as defined by the entity
 such as total cost of sales or services
 product line cost of sales or services





































































 Options





 Options
 Outstanding









 Options
 Exercisable









 Options
 Grants in Period






 Options





 Options





 Options
 Outstanding





 Options
 Outstanding








 Options
 Exercisable









 Options
 Grants in Period






 Options
 Outstanding







 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months




 Options
 Exercisable





 Options
 Exercisable


















































































































































































 Options
 Nonvested Options Forfeited

















































 Fair Value Assumptions










 Fair Value Assumptions





 Fair Value Assumptions





 Unamortized Discount (Premium)




























































































































































 Commitments






































 Converted Instrument







 Interest Rate






















 Convertible












 Value






























































































 Options
 Vested















 Plant and Equipment
 Net






 Basic and Diluted

































































 March 14












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































begin 644 pg7.jpg

# P
!PD.#PT
#@L
# S_

# P
# P
# P
# P
# P
# P
# P
# P
M# P
# P
# P
# P
# P
# P
# P

;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** B
MBB@ HHHH **** BBB@ HHHH **** BBB@ HHHH **** BBB@ HHHH ***
M* BBB@ HHHH **** BBB@ HHHH **** BH=1U&WTC3Y[N[GAM;6UC::::

LS
!BO)I/^A'P#A@CE;XX?!8Y<^6Y\9:<%?'!P?.YQ5Q


M^#G_ (6FF_\ QZCZM6_E?W









+

1_\$_?@9X)U?]@S
MX)75UX.\+7-U<^ =FFFETF!Y)7;3HS,Q3)))))/))KUW]H7_D@7CC_ +%^
M_P#_ $FDKC/^=G_ C\^!?_ &3W0/\ TVV]=O\ S?]O?H3]H[/_AGOP#_T
M(_A#_P $UO\ _$4?\


M_A#_ 
$UO_\ $4?\


M_AGOP#_T(_A#_P $UO\ _$4?\



O5?DQ=3Z+HHHK 8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%





9

WC.\1O&S1J9)-HCBU!$55#QJ/E5@

M?[1_QGT[X''4]3O=\UX]W*MC9Q/MFNI _8_PJ
@ER
#CN0#M2HSJR5.FKMBE

M=RK(J2
J9=1O79QU-?FY^U'_ 





20#YO_;+_PROQG_8I\??%G


0
M^(O UGX;TWP_IM@YBMK[2+Y#&U^AN&ABEPLJHK2%MA7(^K4_9W_8?\$?MI+I
MUSXF\(P_& ^.F\9Q^$]2^)M]

MC]A3]DJR\-Z3\([B+2;*'X-^$M:6/0H_'&H07VAZ!K2/'J1NBMV)VM9P#EIV






MW;D#G=M*YYS7AFJ?\$F/V=/B'\*/!FAZ;X3FTSPSX9TXT'1Y/WBC4](:ZT

\&^#M+^'?A#2O#^AV%KI6B:'

M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%




M
(=%3((((P6G89V1@@G&254%AT?_  6E_P4WC+]FCQQ?\ Q
T?4]5\=^ 9

MP\.:.MS+=FUM(MBO-*V^20D\L23U).  HP% '.^)/#T7BW4M2TNXM8;VVU%Y


M222SLS$DDY)KK*
TQOUO$RK=.GHMOF&'I.G#EEJ^OJ?


M7NISS:M)I5P@WVUA;7



-A!)'O^DJ /Q+^
M&O\ P3V^
MU\5?ACHD5CXB\-^.K7XV?$?4?%_CG5?A]!J/AZX-SI$$-KJMO8



1BQ'JGP'^&7QXTG_@I?H7[2&M_!G4[7PK\4_B)XA\
M




O_


MHHHH **** BBB@ HHHH **** BBB@ HHHH **** BBB@ HHHH **** B







MM-TW%-;ZW_1H5M;GS9_PT#^TW_T;AX
_\.LG_P K:/\ AH']IO\ Z-P\&?\




MO@B#P[X
)?\$M?#EGXA_P"
M7GP?TS5+.TU'3[_PA;17-K<Q+-#<1.AW(Z,&4@X((P:/K6!NYQPZY4TOBE?

RH&7]G'P4RL
@CXKH01_X+:P/BG_P2
MVTRQT&6U^%.KZ?X7TAI/M$O@3Q-I
?B7P+?OEF(_L^X.^R+%L;K*6%5 SY;'
D_O\ :)\
Z/'JG@'X




4(GV)YA6*ZC!;8OS \5[=12E63AR**7W_JV%@HHHK$84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444

M@J?\






#
A!P^V_X)^2?&J\34_V@?%]


?M7[0GQ$F\56$K[_^$&\))-H7






MWU;P?/DA=\\@'VG3N67/VN(1#/$[[6(^FZ*ZOK+EI67-Y]?O_P [F?LTOAT_





M[0'@3X[::;SP1XU\)^

MNR9UU%%%8%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%?!G[87[0'Q%^%








M]9MOU%.,%:L@HKD?C_ *]K/A7X#^-M3\.W.EV?B#3M!OKK2[C4R190726\




MU[9VEG9[/B#JFI:WI&FWEM.ODL=OEW3JJ6_E;);^-LY6/;B?#O\ :Y_:#UOP



MC*7:TE3:F0L\J-YF5*X*UZ716L



M=BUM%^T1VTER97DMVB

MGTF_NO$-I;VNJ7%[97$MG=//%;DP(YG@D.(B4P1MXH ]690ZD$ @C!!'6O'/

MU32()[F(K]TI

M_P!MO]H?3_A;\






M_:5O73\[&?MH='?TUV]#Z/IKR!$+'@ 9)/&*^;T^!'[1_P 4E'_7_'#P]X#
MM)8RDME\.O47VI
XY6^U1KH$@9&1:KG@X&ZV_X)6?C7UC?Q^OC#XQ7D



M&E^%/#F@^&-



NUCS'7_P!B?X

W$NBO<Y-PUJ^S
!EW-O

M_E)OE\J
G
MI!BMAYNGZ?\ *3AIFNWW#F%

2K/''*'V[@Z*P.X UV=%
M]#OK?P]:1W.C+


O9-2\/Q6?ABR@30KJ3;YEQ:!8

$J
5:.1+25E8$$$$


MMS*(U4/



W-Q;YEI_7]=
M3Z=HKS']GK]L+X??M._;K;PMKH.OZ-A=7\.ZE!)IVNZ(_'RW5C.%GAY. 63:



MZA:7^DC0;FYTJ6.XTX$D63JRD-;@LV(C\G)XYKJ** *7AWP[I_@_P_8Z3I




Z?X7\1W'B*77]3T]]6@L=&\-ZAK
WV1)5A:9A:0R[

M_P /0/A=_P ^?Q4_\-GXB_\ D*CZM6_E?W

MA3I?@&'X3::6(
WB?P5XL\2ZF!V/V2QL((!GG_E\.
C@]*Z(9=7DN9JR\_\

#K CGY=UGIYO<<]#=D

MX' XX%4\$H[W?I%_K;\@YY/96]7_ )7_ #7^?M-Q_P %2OAAX@


PZ




MP_B)_P %;/AWX*\(W6HZ=X2^-?BJ]@'[K3-

M5'UI.R@_N)G4C+E)Z(^HZ\?^/O[='P[_9Z\36_AK4-2O/$/CN_0O8^#_#5

M

@K=&O7?@/^U/^SC^S'X;ETOP+X
^

M'/*2]W3U_P O\SJ;KPM^T%^U= R:OJD/[.W@RXW(]AHTD&K^
KV
Y'SWI#66
MGD@_=ACN7!P5F0CGU#X!?LB_#W]F?[;/X2\/16^L:J2VIZY?3RZCK6K
3DFY

-GXB_^0J/^'H'PN_Y\_BI_X;/Q

8IW;N^_P#7Z'T/17SQ_P /0/A=_P ^?Q4_



-GXB_^0J/JU;^5


[OVC=]+?YGU317SQ_P] ^%

M'_#T#X7?\^?Q4_\ #9^(O_D*C_AZ!\+O^?/XJ?\ AL_$7_R%1]6K?RO[F%T?
M0]%?/'_#T#X7?\^?Q4_\-GXB_P#D*C_AZ!\+O^?/XJ?^&S\1?_(5'U:M_*_N
8UM
M.%#$$^4WH:SC4W:*N

5T?0]%?/'_#T#X7?\^?Q4_\-GXB_P#D*C_A
MZ!\+O^?/XJ?^&S\1?_(5'U:M_*_N871WOQ^_9#^'W[3/V*X\5Z DNM:2=VEZ



MU/49P2*\JL/V[_%G[*BQCPCK_P 4?CUX


M 



M





FI^ ?CWX
N5S_HNL_#?5))& (&0UI'/&1S_

MPN_Y\_BI_P&S\1?_(58_5JW\K^YFET?0]%?/'_#T#X7?\^?Q4_\-GXB_P#D
M*C_AZ!\+O^?/XJ?^&S\1?_(5'U:M_*_N871]#T5\\?\ #T#X7?\ /G\5/_#9
M^(O_ )H_P'H'PN_P?/XJ?^&S\1?\ R%1]6K?RO[F%T?0]%?/'_#T#X7?\


U]'5\YW



I#*PR#D$5R
M':.HKY^_:Y_;5M_V;?B'X-TS]Q):7-]&^OLZY-M929B#+[AF\SZ18_BKWZ=





'-:

M? UMI'B;4)/&?A2.P\%3-;^(KEM7MQ#H
JJ'9+M]^+=@K*Q$A4@
#T- '645

M ';45P]K^TY\-[WXH:GX(A^('@F7QGHELUYJ.@IKEJVIV$@,TLMOO\ ,1 

MC.
X- 'D&M

M*WJ_##T_5B1\V?\ !(;_ )1W_#W_ +B7_ISNZ^DZ^;/^0W_ CO^'O_ '$O
M_3G=U])UMF7^]U?\4OS8H?@HJ.6[B@$F^2-/*3S'W,!L7GD^@X//L:^6?V=
MO^U'[.7[5'[2=S\*?!?C^#4O%JO+%9*]K+#:ZR\2L\JVDS*%E*JCMQ]X*2N


MJ

LBL2'3Y@#]0:*_$;]FO\ X*A_'/6OB+\/OASX
MS\0ZZ+_Q%XG\=^(= UJ 9A\0^&[73O$=LEI/)MQ]HL=4L(VV]?+EM#T!)]T_

M*15E8//&6*$%990




M6DS_ !/O[;0[+5XO*NM!LAIVFR#3V3^$P32SH1S\P;!((KT#_@JI_P FF6/_
M &4CX?\ _J9Z)6V&_C1]5^8GL?1U?-WP;_Y2M_'W_LG/@+_TN\5U](U\W?!O

MD1@=OJ:T*;36XDT]@HHHI#BBB@ HHHH **** BBB@ KYK_ .0@V_\$[OA
M[R3SJ1Y_[=W7TI7S9_P2&_Y1W_#W_N)?^G.[KMA_ND_\4/RF3]I?UV+G[?D


M*XK]G?XTV'[0GP9T#Q;IY15U:U5YX5;)M)P
2PGOE7##GJ #WKK-4U2+2+0R
MRGCHJCJY[ 4 6:*@TYYI;16G79(_S%/[GH*_.WQS_P %G_BW\(]0_:+7Q3\


!_B3%XGUWCU-G
WVF*.UC^SSP1A2L+$F5BR[EV[JW?C




M 
%8=4_9(\17WP6^.$]U'I/ARYGTNQU.XW/-H4\#

M1J!SM/N9;E/UJG.O)I1@ORU^2MU_X-N'%XF4&H0W=OQ=M/ZTZ[G](O@#2Y)O
M


M^(O@SXJ^/?'_ (&TW2;OQ3\6V\:6NHO






M;OQ!JOQ

N/E%_P /^$_'

EMHH\0


)C*37#2(CF5P7+(K$Y - 'B?_  1N^+3?


_B!\.[



K\U






N99W%W9W49C5OM2;=MO;QB([Y6X4R1#/SKG


M&U*&)]BZ

U35KR?



M^'G[2.K?%SQ5X(\7ZO\ #?0?VJ]?\4R:%X?^&
\OC!OLZ7%UIFJ07JPRW%SI


EI&E5
M?EP2/I']G/XYZ9^TQ\_OC[1K+6=
TWQ9IT6HPV6KVAM+^RWCYH9XCG9(C9



?&_BIO!]Y!;7^D27

MM% 'S/K7_*8SPW_V1K5O_3WIM?3%?
^M?\IC/#?_ &1K5O\ T]Z;7TQ6U7X8

=



MN!@!F7?

:Q*JO$P1HV9TDV\A^P+X2^#7[$]_X)_:J
M\0?%BP\36OA;4V_L;X;:1:




MTW3[NU0F&U

M'*+^ -X:\*2JJ/=Q


M_ F;0O$OPN^('B[4_B5^RSJGPJT^#PO8OKRZ!KEUJ^K75MIEY)&6%O!!;:G;


TC3/D*=Y+5N?L9?#_]

7T=P_B7Q/X:EMA90QVP





M$O[+'Q(\=^./AY\7?%GQ(N_&






-
MW;\=-%UMU?1?A^[O@71O[


DGM7ARDV[L],
M5%61^'6OZ=X]^'W[.'QTU'1?BA\??%&N:3^TS9_32+*7XEWT-Q+HO\ :.E%

?BMH]MH.J






B?:H=LBQN &)#85L6?B/^TO\ L;_\$V/%NA:$_A7P


TEC+#$8K-989]@96C$HEV#=NQ6A^TO\+/V=/B[^T7X$\*?
M%CX;?#CQQ\0/%^EZB_AMO$7@^VUB9K/3S#)=(MQ-XB1&O(V%EW&5BH)W4


%E;&X&OHOXI_\ !3G6-)_X+;21Q?$37XOAWI'B*#X-


MEUX%G#:.)Y$N]0LY_.5&W,YE#'8S* ?FW\)/V__ (]+^S;8^?&_C3QG'XS
M\.?LO^


I9KCPUKNI:O\ 9Y]%3642

S5]

$9OAIJ'@
MGPSX#\'^-=,T[7]<T:3X375AH,=K?RF&TFU=%L1;VN^2';F\;2@W;0
@ Z_
M_@BO\3K_ 


E_\ I#J%?1-<CV1G2^*?





P
=
#^I#]GNVUV+X)^%I?%5

!/A[XE\^ $

B!=LQD=I Y8D

M::RJL0\Z-F(#8R/-84 ?I%\*O\ @D%XM\*??PCX




F\.W%^S2+JO]H7(!
MDL;\SHC0)N3-C


M8=







MZ^*J^BZ^=/AO_P I8?C#_P!DL\%?^G7Q57T77;C_ .*O\
/_ $B)
=@KYSO/



?XUP




'?!ND^'/!6OR:3<^+_$<.HSZ+9N-#T?4K6VO




\..&'(ZUHT

M)?+D+/'
VE7$9EB#H@!)/*AM;]J?]A?XV?\ !0_Q-\1/B'XM^#UKX'FUCP[X
M*\67@G4?$FG:I+K5I9^+K76M5N[F:!_LZP))(XHRYDD59241G5#^IE% 'Y



(06R+'/#)



H
6]_F?XJ_



AB
M6



5\SZU_RF

5
MM5^&'I^K$CXC_9'\7^/_  %_P10MM9^%?A^V\4_$33M(UB;0-+N) D=W=#4;

L$R-Y4+D;LCY9_X)H?\ !%#XHV



MX-:!\6_$7A[5/#UP9=8DU/\ MJ[N=

(-5\+:'?Z99Z7%J-M96=G;74+?86N5:(:?9R
M*C3M%YDED9<H?1O@E_P35^#_PS+\:=(\<?#7PGIOP^U#3O#MQX9N[/P_9V
MUC9:[;22VTJ27J)%NEGA:V_=R;E($\P;?N&T ^5/V9_^KWCCQ-\+/&WQ2\8



U26&WUV32)]1.I:?;QRP)J
6EF]M(I9UEO8

M22Z


M(/$EM/:WEF6@O=9UNTUJ=BDMM)%*D5W90^7%


:V2F!UOYIY2]HT$DBR

LW]IV\NN
M&Q





9M:RZ']T(WD?=^X'F?0
IZ=

M%^A^*98KKQ1\
?C[X1\):A=Q0KFH1Q^,] NK*XV+PKO87=F9  %\WS=HX

MR9]H5#&56)(=N:X#]IG]GJ]^ '[#VMRZW?6VI^*O'OQS\(^+M=N;7?\ 9_/N

MUM(]/2)5C2


5IU4:DE%

(+S07_ +@TR+1=*O=$N&-K<7<L[7

MQQ_;'DU/1_A79_!;5/ GC'4?C'KUQH^C:]+?'4-!LH;6QO+VZNF:U;-QM%DT
*;KP

MQ4-/X_8Z_:V^ K^8K?X1Z;\0]6TCX':M\#Y-2F\6:?I^G6VS6G73M3G1I7
MFEMWTZ*WE:-%
H+

$\DCHJHS3Q(

MZ2+3Q=:BIMV^THQ9+:
#Y--@+;82]]H][:


MN=

M?@I=BS^/_P &?#WPZO=7\4^/=/NF\%SVYU2*[EOY$DDGOIDBOED\R%'\R09W

-*(HUC#'W.W/XUX+_ 
$A

UC
BC+
C*!ZDBI



M!\'/V9_CU\'M-^(OPN^'?PEU#PI\0-)98M2TWPG9VXU.SD=3)!
ODJ^/-B42

H9
#Y$\?L?M?LQ?3]B]\*^_!OCGQ9^SOH?B#2_$6C77BO^

MC:7HM]KFJ^)=


+B2#:H\MY?,DWLN^]LYR:R

\DDC

M93YD 


M)%=_^GFVKZ
KYSO/^4MNG?\ 9(KO_P!/-M4X/XI?X9?DSDQNT/\ $CZ
HHHK




MM*M=TNVLK*V@L[*SB6WMX(Q'%!&HJB*,!5    X %6** BBB@ HHHH *
M*** /F?6O^4QGAO_ +(UJW_I[TVOIBOF?6O^4QGAO_LC6K?^GO3:^F*VJ_##





SP$
3'))&QK_P#P1(^#GB'6Y]0DOO'T-T9BUDT.NE1I






MR




\D6NMI%K*-%O[K^TXY6

MJPOH]4TAM1BO89KBZ6-%E$
Z);%C/YAB3;ABZ^VG_@D'\#EO]+O(](\6P:AI
*;1XKJX\EKCSBL1UW3OE






M-/LGL[4S:C?S7KI'$\DC*BM

MY7^V1\!-7_:-^#

M =3@GFN
_P$&_:H_PBD? W_P (/4O_ ):5]#T4HUYQCR*UO1/\UY!RJ_-U

MI?\ RTKZ'HH]O+LON7^06/GC_A!OVJ/^BD? W_P@]2_^6E'_  @W[5'_ $4C
MX&_^$'J7_P M*^AZ*/;R[+[E_D%CYX_X0;]JC_HI'P-_\(/4O_EI1_P@W[5'

M@W[5'_12/@;_ .$'J7_RTKZ'HH]O+LON7^06/GC_ (0;]JC_ **1\#?_  @]



M&_\ A!ZE_P#+2C_A!OVJ/^BD? W_ 






M*/^$&_:H_

M*/\ A!OVJ/\ HI'P-_\ #U+_P6E?0]%'MY=E]R_P @L?/ \#_M4 _\E'^!




M_P#EI1_P@W[5'_12/@;_ .$'J7_RTKZ'HH]O+LON7^15CYX_X0;]JC_HI'P-


M*^AZ*/;R[+[E_D%CYX_X0;]JC_HI'P-_\(/4O_EI1_P (-^U1


#
M P8$! 

# P8# P8


M! 0   %] 0(#  01!1(A
4$&$U%A!R)Q%#*!D:$((T*QP152T? D
V)R@@D*


7&



B



G*TM/4


'3


\S'LD3'M0!^(?P9_PI7_!3S]H[PI+KWP]UWX[^/-#@N6LI-1\
M.^!AJEI'.JJS1&6S= X5T)7.0'4XY%+X-_X+2_MX^ OVM_/@#XD?$[XC^%


$)=#G@NXXGA,-ZD+RQ)_

MXO\ 9F_X+R?&+Q5^TSX ^*_C75/!MM^RE\;OB#J7P^\/Z0+6'5_#,2DQZ7J
M5PXD,J_:)HY4F\QC&@MYVJ#%0!^T=-FA6XA:.15='!5E89# ]017XW_ +?7
M_!7/]HOX=_M!_M+?#CX=^(O#&DWOAKXE?#KP-X-O=0TB*5=&37+^GN9)4?
MS=TMM$
NDA1&?:N[!&W\3O\ @NE\3[+]F#0/#U]9Z=\-_P!ISP#\5_#_ (#^





MWOAZ0//:W


M?%G]J;_@H9^RI^QM!^U%XM\:_LZ^*/!-IIVG^)-5\#6FG36S?8+QX1Y$%[_%
M
BSI@^:X)!VF;Y5D /U\HK\*_P!H7_@NM\6+W]N/XI^'-

/[IPC;51]


9?W<
841^6
AF.XNY8HH Z_]K?_ ()+?#K]LCXV


MJVWC#X;7\%W:WVD7
=J^K0PRB:.SO28W
MN) 6 4HZ[GNH9@2B@W^U'_P2


M+N.[%T(I89=MT'BC4.#MV*1L^9BQ10![+^TE_P $V_A_^U+^SE\/OA?XCNO$





6CC^S


#
M P8$! 

# P8# P8


M! 0   %] 0(#  01!1(A
4$&$U%A!R)Q%#*!D:$((T*QP152T? D
V)R@@D*


7&



B



G*TM/4

!  (1 Q$ /P#]_**** B
MBB@ HILLHAB9VX5023Z 5\T_\%2?^EG@W_@F+^RIK'Q(\0R_P!H:DJ&S\.:



SVTNY 9(PBPQ
N(((XP
EV





M_:J^+VB7ME^SY\

M/?Q.\7?\'


S@*YCE2T




M6_:]_PD_\ P2G\6?#?QS\?IK+XF?!JVO9(_%
/A#2;*YD-I$@3SKR[2TC:
3'_ !
PH CB.!QEMJCD@4 ?O1^QO^R;X3_8I_9F\&?##P99

F4C & /4J_F
G_ .#T+]J95*GP

M\5Y558C F
*

'^+@]/\]J_)C]N/_@F!_P %#_C7^UCX
M\\4_[]J71/!'P_UO4?.T+0F\1ZI;MIUL(T4(4CLW1#E6)
1DYSS0!Y.OA_
M_@MFO_



M5^;W_!=K_@JI\1_V2/\ A$/@I\$?!OB#Q'\=?C.DMOX=NX])D:QTR))-CS0L
MX


M64

[)!O@OHB2$NK:3:

I  
7]H_P 

M:G%X

MD!(]S,V4AXSM H ^R?^#H?QCX0T3]OB^^'O@?X5_#?P1H.CVMGKJ^(O#^D

UL\BA98=Q



7=!\$[)[Q% [@']##'[
M):'J_EIU9L;L#N?ZU^;?_!17_@X[^!'[#G[9GA3X8:I:7'BJ\LKMH/%FNZ6J

M?%C2OCQ^R;XLO&O--U/2KEKG4O!PE=E
QA 4JZE@9H579-@2Q;79HS_17\)/

?


MP^



R0:C$
L-.O3Y?
#
3L?DPNQ895GC8 _%W_ (*D



CX;:S;37Y@_%?_@I3^PC\+/BKXE\


K[9MJ%S&8XPQ!*EWR#\AG]LC]H _\
MXC/AY_X9F]_^1JXG_@DG_P $??C_ /'G_@K;X=^.7BOX.3?L]^ ?#WB]O%MQ


J W)*_87[)G_


#/M7\






M1O:O&W]G2HT4*W4Y$DIBWB7XT?M!_M'7GQ._:/T72?B=\2OSZYX@UC3O%P


CC!0DDHO]3O@S3FT;PI


5](4C+O4CGD8X.* /PF\:_\


M7WQTT?PZ9+KXD_&?0-1MG\:'X;#2(IY6\7^+;;QE+;6&CW2B)_M
V B6TH


end













							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }











Nov. 30
 2017
Mar. 12
 2018
May 31
 2017



















































































Entity Common Stock
 Shares Outstanding



311
887

























  2017






































If the value is true
 then the document is an amendment to previously-filed/accepted document.

























































This is focus fiscal period of the document report. For a first quarter 2006 quarterly report
 which may also provide financial information from prior periods
 the first fiscal quarter should be given as the fiscal period focus. Values: FY
 Q1
 Q2
 Q3
 Q4
 H1
 H2
 M9
 T1
 T2
 T3
 M8
 CY.




























This is focus fiscal year of the document report in CCYY format. For a 2006 annual report
 which may also provide financial information from prior periods
 fiscal 2006 should be given as the fiscal year focus. Example: 2006.




























The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data
 it is the date up through which that historical data is presented.  If there is no historical data in the report
 use the filing date. The format of the date is CCYY-MM-DD.




























The type of document being provided (such as 10-K
 10-Q
 485BPOS
 etc). The document type is limited to the same value as the supporting SEC submission type
 or the word Other.

























































Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests
 if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member]
 Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings
 Instrument.




























Indicate Yes or No whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports)
 and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.




























Indicate whether the registrant is one of the following: (1) Large Accelerated Filer
 (2) Accelerated Filer
 (3) Non-accelerated Filer
 (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.




























State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold
 or average bid and asked price of such common equity
 as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.




























The exact name of the entity filing the report as specified in its charter
 which is required by forms filed with the SEC.

























































Indicate Yes or No if the registrant is a well-known seasoned issuer
 as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K
 10-Q
 8-K
 20-F
 6-K
 10-K/A
 10-Q/A
 20-F/A
 6-K/A
 N-CSR
 N-Q
 N-1A.


































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }






Nov. 30
 2017
Nov. 30
 2016











143
788


527
624



Accounts Receivable
 net of allowance of $29
852 and $0
 respectively

071
576


053





951


221





528


332





584
843


879
230



Fixed Assets-Furniture &amp; Fixtures
 net

046







010





Intangible Assets - Licenses
 IP net

875


425
000





714
774


304
230












388
393


612





454
770


178



Loan Payable - Third Party
 net of discount of $0 and $8
812
 respectively



188





843
163


978



Convertible Debt
 net of discount of $1
954
594 and $1
285
836
 respectively

845
406


114
164





688
569


843
142










Common stock
 $0.001 par value
 300
000
000 shares authorized; 32
311
887 shares issued and outstanding as of November 30
 2017 and 31
000
000 as of November 30
 2016
 respectively

312


000





869
962


431
976





649)


786)





751
420)


936
102)





973
795)


538
912)





714
774


304
230




































Amount due from customers or clients
 within one year of the balance sheet date (or the normal operating cycle
 whichever is longer)
 for goods or services (including trade receivables) that have been delivered or sold in the normal course of business
 reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.




























Carrying value as of the balance sheet date of obligations incurred and payable
 pertaining to costs that are statutory in nature
 are incurred on contractual obligations
 or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes
 interest
 rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).




























Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital
 capital in excess of par
 capital surplus
 or paid-in capital.

























































Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash
 sold
 or consumed within one year (or the normal operating cycle
 if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
























































Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term
 highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.




























Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares
 par value and other disclosure concepts are in another section within stockholders' equity.




























The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security
 typically the entity's common stock
 at the option of the issuer or the holder.




























Amount after amortization of assets
 excluding financial assets and goodwill
 lacking physical substance with a finite life.




























Amount after valuation and LIFO reserves of inventory expected to be sold
 or consumed within one year or operating cycle
 if longer.

























































Amount of liabilities and equity items
 including the portion of equity attributable to noncontrolling interests
 if any.




























Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle
 if longer.





















































































Total of all stockholders' equity (deficit) items
 net of receivables from officers
 directors
 owners
 and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is
 noncontrolling interest
 previously referred to as minority interest).




























An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date more than one year from the balance sheet date
 net of any write-downs taken for collection uncertainty on the part of the holder. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium
 payable on demand
 secured
 or unsecured
 interest bearing or noninterest bearing
 among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale.




























Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods
 and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle
 if longer.




























Amount after accumulated depreciation
 depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include
 but are not limited to
 land
 buildings
 machinery and equipment
 office equipment
 and furniture and fixtures.

























































Total of all stockholders' equity (deficit) items
 net of receivables from officers
 directors
 owners
 and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest
 minority interest). This excludes temporary equity and is sometimes called permanent equity.





































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }






Nov. 30
 2017
Nov. 30
 2016











852









812





954
594


285
836



Common stock
 par value (in dollars per share)






Common stock
 shares authorized

000
000


000
000



Common stock
 shares issued

311
887


000
000



Common stock
 shares outstanding

311
887


000
000







For an unclassified balance sheet
 a valuation allowance for receivables due a company that are expected to be uncollectible.






















































































Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued
 repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners
 and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

























































Amount of debt discount to be amortized within one year or within the normal operating cycle
 if longer.




























Amount of debt discount to be amortized after one year or the normal operating cycle
 if longer.





































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2017
Nov. 30
 2016











743
421


042





648
022


738





399


304












323
369)


681
358)





125
000)







352
970)


611
054)










Interest Expense
 net

521
211)


073)





521
211)


073)





874
181)


187
127)





815
318)


135
984)





863)


143)












295
756


696
721

































































The aggregate total of expenses of managing and administering the affairs of an entity
 including affiliates of the reporting entity
 which are not directly or indirectly associated with the manufacture
 sale or creation of a product or product line.





























 -Subparagraph (SX 210.5-03.1
2)



























Amount of impairment loss resulting from write-down of assets
 excluding financial assets and goodwill
 lacking physical substance and having a projected indefinite period of benefit to fair value.





















































































The portion of profit or loss for the period
 net of income taxes
 which is attributable to the parent.

























































The aggregate amount of income or expense from ancillary business-related activities (that is to say
 excluding major activities considered part of the normal operations of the business).

















































































































The consolidated profit or loss for the period
 net of income taxes
 including the portion attributable to the noncontrolling interest.




























Aggregate revenue from the sale of minerals and related products
 and from rendering services such as exploration
 development
 mining
 processing and providing mining support activities.
 -Subparagraph (SX 210.5-03.1(a)
(d))





































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }













Balance at Nov. 30
 2015

000


177
540


800
118)


643)


609
221)



Balance (in shares) at Nov. 30
 2015

000
000




























366
667






366
667





000


697
000






700
000





000
000















994






994







775






775









135
984)


143)


187
127)



Balance at Nov. 30
 2016

000


431
976


936
102)


786)


538
912)



Balance (in shares) at Nov. 30
 2016

000
000








000
000




















466
667






466
667







500






000





000















855






667





887















964






964









815
318)


863)


874
181)



Balance at Nov. 30
 2017

312


869
962


751
420)


649)


973
795)



Balance (in shares) at Nov. 30
 2017

311
887








311
887



























































































































The consolidated profit or loss for the period
 net of income taxes
 including the portion attributable to the noncontrolling interest.










































































































































































































Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP)
 net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock
 the exercise of stock options
 stock issued under employee stock purchase plans
 and/or other employee benefit plans.




























Total of all stockholders' equity (deficit) items
 net of receivables from officers
 directors
 owners
 and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest
 minority interest). This excludes temporary equity and is sometimes called permanent equity.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2017
Nov. 30
 2016











874
181)


187
127)












721


025



Amortization of license
 IP

125


000





864







125
000







964


994












018
523)


053)





343)







196)


446)





270


741)





305
373


086





416
926)


480
262)












910)







000)







910)
















000)







000





000)


000)







000





400
000


100
000





200
000


820
000





616
164


339
738





527
624


886





143
788


527
624












466
667


366
667





000


700
000





667









775



















740


611






















































































































































The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense
 this element is added back to net income when calculating cash provided by or used in operations using the indirect method.




























Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term
 highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.




























Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term
 highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.






















































































Amount of impairment loss resulting from write-down of assets
 excluding financial assets and goodwill
 lacking physical substance and having a projected indefinite period of benefit to fair value.




























The amount of cash paid during the current period to foreign
 federal
 state
 and local authorities as taxes on income.



















































































































The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity
 associated with underlying transactions that are classified as operating activities.





















































































Amount of cash paid for interest. Includes
 but is not limited to
 payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.




























Amount of cash inflow (outflow) of financing activities
 excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on
 and a return of
 their investment; borrowing money and repaying amounts borrowed
 or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
























































Amount of cash inflow (outflow) from investing activities
 including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property
 plant
 and equipment and other productive assets.
























































Amount of cash inflow (outflow) from operating activities
 excluding discontinued operations. Operating activity cash flows include transactions
 adjustments
 and changes in value not defined as investing or financing activities.




















































































The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights
 excluding goodwill.




























The cash outflow associated with the acquisition of long-lived
 physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.




























The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security
 typically the entity's common stock
 at the option of the issuer or the holder.




























The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates
 owners or officers and their immediate families
 pension trusts
 and so forth. Alternate caption: Proceeds from Advances from Affiliates.




























The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle
 if longer.




























The consolidated profit or loss for the period
 net of income taxes
 including the portion attributable to the noncontrolling interest.




























The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates
 owners or officers and their immediate families
 pension trusts
 and so forth. Alternate caption: Payments for Advances from Affiliates.




























The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle
 if longer.




























The aggregate amount of noncash
 equity-based employee remuneration. This may include the value of stock or unit options
 amortization of restricted stock or units
 and adjustment for officers' compensation. As noncash
 this element is an add back when calculating net cash generated by operating activities using the indirect method.






































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017











 &#8220;our&#8221;
 &#8220;the Company&#8221;) was incorporated under the laws of the State of Nevada on November 5
 2007.&#160; The Company was formed to engage in the acquisition



 life sciences and food and beverage categories. The Company is in its early growth stage and has transitioned out of its shell status with the Super-8 filing at the end of August
 2014. Activities to date have focused on capital formation





































The entire disclosure for the nature of an entity's business
 major products or services
 principal markets including location
 and the relative importance of its operations in each business and the basis for the determination
 including but not limited to
 assets
 revenues
 or earnings. For an entity that has not commenced principal operations
 disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017











The Company&#8217;s financial statements are prepared using the accrual method of accounting.&#160; The Company has elected a November 30
 year-end.








The Company consolidated financial statements as of November 30
 2017 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd
 Sports Nutrition Products Inc.
 Brain Armor Inc.
 Trident Sports Nutrition Inc. and Trident Brands International Ltd.



ASC No. 260
 &#8220;Earnings Per Share&#8221;
 specifies the computation
 presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock.&#160;&#160; The Company has adopted the provisions of ASC No. 260.

Basic net earnings (loss) per share amounts are computed by dividing the net earnings (loss) by the weighted average number of common shares outstanding. Due to net losses during the years ended November 30
 2017 and 2016
 diluted earnings (loss) per share are the same as the basic earnings (loss) per share since inclusion of common stock equivalents would have been anti-dilutive.







As of November 30
 2017 and 2016
 the Company&#8217;s accounts receivable was netted against an allowance of $29
852 and $0 respectively.&#160;&#160;



Inventories are stated at the lower of cost or net realizable value. Cost is principally determined using the first-in
 first-out (FIFO) method. We regularly review inventory for obsolete and slow moving inventory and write it off as necessary.



We review our long-lived assets
 including intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include
 but are not limited to:
























































a current expectation that
 more likely than not
 the asset will be sold or otherwise disposed of before the end of its previously estimated useful life.&#160;





We continually evaluate whether such events and circumstances have occurred. When such events or circumstances exist
 the recoverability of the asset's carrying value shall be determined by estimating the undiscounted future cash flows (cash inflows less associated cash outflows) that are directly associated with and that are expected to arise as a direct result of the use and eventual disposition of the asset.

On January 20
 2015 the Company entered into a long-term Emulsion Supply Agreement (the &#8220;License&#8221;) with Oceans Omega LLC for the rights to purchase
 market
 sell and distribute patented nutritional emulsions produced by Oceans Omega LLC. Subsequently
 the Company initiated research and development to formulate a range of novel product applications. However
 related product applications have not yet been commercialized and as a result the Company has taken a one-time impairment charge of $2
125
000 to write-off the underlying book value of the License. The Company and Management remain committed to developing the commercial potential associated with the license.



The intrinsic value of a beneficial conversion feature inherent to a convertible note payable
 which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion
 is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term
 the unamortized discount is expensed in the period of retirement to interest expense. In general
 the beneficial conversion feature is measured by comparing the effective conversion price
 after considering the relative fair value of detachable instruments included in the financing transaction
 if any
 to the fair value of the common shares at the commitment date to be received upon conversion.



The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820
 &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820 clarifies the definition of fair value
 prescribes methods for measuring fair value
 and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1&#160; &#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives
 marketable securities and listed equities.

Level 2&#160; - Pricing inputs are other than quoted prices in active markets included in level 1
 which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions
 including&#160; quoted forward prices for commodities
 time value
 volatility factors
 and current market and
contractual prices for the underlying instruments
 as well as other relevant economic measures.

Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument
 can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps
 interest rate swaps
 options and collars.



The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents
 accounts receivable
 accounts payable and note payable. The fair value of the Company&#8217;s long-term debt is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value. As of November 30
 2017 and 2016
 the Company did not have any financial liabilities measured and recorded at fair value on the Company&#8217;s balance sheets on a recurring basis.



The Company maintains a portfolio of branded and private label consumer products including nutritional products and supplements under the Everlast&#174; and Brain Armor&#174; brands
 and functional food ingredients under the Oceans Omega brand.

Two customers accounted for 94.3% and 3.7% of total revenue
 compared to 48.9% and 27.2% in the prior year. Two customers accounted for 82.3% and 16.4% of total accounts receivable
 compared to 86.1% and 5.1% in the prior year.

The Company records revenue when all of the following criteria are met: a) persuasive evidence of an arrangement with the customer exists
 b) the price to the customer is fixed and determinable
 c) product is shipped or delivery is complete (depending on the terms) and collection probability is reasonably assured.





The Company purchased 99% of its products from one vendor for the year ended November 30
 2017 and two vendors provided 76% and 11% of the Company's services for the year ended November 30
 2016.



The Company accounts for employee stock-based compensation in accordance with ASC-718
 &#8220;Compensation-Stock Compensation&#8221;. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments
 including stock options
 based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award
 usually the vesting period.



The Company accounts for non-employee stock-based compensation in accordance with the provision of ASC 505-50
 &#8220;Equity Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;)
 which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.



Income taxes are provided in accordance with ASC No. 740
 Accounting for Income Taxes.&#160; A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carryforwards.&#160; Deferred tax expense (benefit) results from the net change during the year of deferred tax assets and liabilities.

Deferred tax assets are reduced by a valuation allowance when
 in the opinion of management
 it is more likely than not that some portion of all of the deferred tax assets will not be realized.&#160; Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company includes interest and penalties arising from the underpayment of income taxes in the statements of operation in the provision for income taxes. As of November 30
 2017 and 2016
 the Company had no accrued interest or penalties related to uncertain tax positions.



A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries
 controls
 is controlled by
 or is under common control with the Company.

Related parties also include principal owners of the Company
 its management
 members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.





In May 2016
 the FASB issued ASU 2016-12
&#160;Revenue from Contracts from Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&#160;The amendments in this update affect the guidance in ASU 2014-09
 which is not yet effective. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments in ASU 2016-12 do not change the core principle of the guidance in Topic 606
 but instead affect only the narrow aspects noted in Topic 606.&#160;ASU 2016-12 is effective January 1
 2018 to be in alignment with the effective date of ASU 2014-09. Management evaluated ASU 2016-12 and does not believe the adoption of ASU 2016-12 will have a material impact on the Company&#8217;s consolidated financial statements.

In May 2017
 the FASB issued ASU 2017-09
 Compensation-Stock Compensation (Topic 718)
 Scope of Modification Accounting. The amendments in this Update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The amendments in this Update are effective for all entities for annual periods
 and interim periods within those annual periods
 beginning after December&#160;15
 2017. Early adoption is permitted
 including adoption in any interim period
 for (1)&#160;public business entities for reporting periods for which financial statements have not yet been issued and (2)&#160;all other entities for reporting periods for which financial statements have not yet been made available for issuance.

In July 2017
 the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No.&#160;2017-11
 Earnings Per Share (Topic 260)
 Distinguishing Liabilities from Equity (Topic 480)
 Derivatives and Hedging (Topic 815). The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments
 a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&#8217;s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result
no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments
 the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20
 Debt&#8212;Debt with Conversion and Other Options)
 including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification
 to a scope exception. Those amendments do not have an accounting effect. For public business entities
 the amendments in Part I of this Update are effective for fiscal years
 and interim periods within those fiscal years
 beginning after December&#160;15
 2018. For all other entities
 the amendments in Part I of this Update are effective for fiscal years beginning after December&#160;15
 2019
 and interim periods within fiscal years beginning after December&#160;15
 2020. Early adoption is permitted for all entities
 including adoption in an interim period. If an entity early adopts the amendments in an interim period
 any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period.



































The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example
 US Generally Accepted Accounting Principles
 Other Comprehensive Basis of Accounting
 IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017











 which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. In accordance with Financial Accounting Standards Board
 or the FASB
 Accounting Standards Update No. 2014-15
 Presentation of Financial Statements - Going Concern (Subtopic 205-40)
 our management evaluates whether there are conditions or events
 considered in aggregate



 2017
 we had an accumulated deficit of $13
751



 as disclosed in Note 10
 on September 26
 2016
 the Company completed a long term financing with a non-US institutional investor
 receiving proceeds of $4
100.000 and $4
400
000 through the issuance of secured convertible promissory notes. The investor has agreed to make additional investments at the Company&#8217;s request of up to $1
500
000 ($10
000
000 in the aggregate). On November 30
 2017 the Company had $3
143
788 in cash and has access to $1
500





































The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes
 but is not limited to
 principal conditions or events that raised substantial doubt about the ability to continue as a going concern
 management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations
 and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017










 2017 the Company issued 500
000 of our common shares
 valued at $360
000
 for the acquisition of StreamPak Ltd. On September 12
 2017 the Company also issued 811
887 of our common shares
 valued at $605
667
 to Fengate for the purchase of the secured convertible promissory notes of Mycell Technologies LLC. In 2016
 the Company issued 3
000
000 of our common shares
 valued at $2
700
000 to acquire the right and license to purchase
 market
 promote
 sell and distribute Oceans Omega LLC&#8217;s omega-3 emulsions for use in the development
 production
 processing
 manufacture and sale of food and beverages and exclusive rights to purchase
 market
 promote
 sell and distribute Oceans Omega emulsions for meats
 for human or animal consumption.



































The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest
 including other comprehensive income. Includes
 but is not limited to
 balances of common stock
 preferred stock
 additional paid-in capital
 other capital and retained earnings
 accumulated balance for each classification of other comprehensive income and amount of comprehensive income.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017











 2014
 Trident granted an aggregate of 2
875
000 stock options to directors
 officers
 employees and consultants of the Company pursuant to Trident&#8217;s 2013 Stock Plan. The stock options are exercisable for five years from the date of grant at exercise prices of $0.75 per share for shares vesting 12 months from the date of issuance
 $1.00 per share for shares vesting 24 months from the date of issuance and $1.50 for shares vesting 36 months from the date of issuance. Of the 2
875
000 stock options granted
 Trident granted 1
125


 Michael Browne; 300
000 stock options to each of its directors at the time
 Donald MacPhee
 Scott Chapman
 Mark Holcombe; 150
000 stock options to its controller
 Peter Salvo; and 350
000 stock options to each of its special advisors
 Robert Campbell and Karen Arsenault. The stock options expire on May 5


 2015
 Michael Browne&#8217;s stock options were amended to 625



 2016 Karen Arseneault resigned as a special advisor to the company. As a result
 the unvested 116
667 options were immediately terminated and the remaining 233
333 options expired on December 31



 2016
 100
000 stock options were granted to Steve Bromley
 a Special Advisor to the Company and Chair of our Advisory Committee
 with 50
000 of the options exercisable at a price of $1.25 per share
 vesting May 1
 2017 and the remaining 50
000 options exercisable at a price of $1.50 per share
 vesting May 1
 2018. All 100
000 options expire on May 1
 2021.&#160; On June 1
 2016 the Company issued to Mr. Bromley an additional 200
000 stock options under the 2013 Stock Option Plan
 with 100
000 of the options exercisable at a price of $1.25 per share
 vesting June 1
 2017 and the remaining 100
000 options exercisable at a price of $1.50 per share
 vesting June 1
 2018. All 200
000 options were to expire on June 1
 2021. On November 1
 2016 an amended service contract with Steve Bromley was completed and the 200
000 stock options issued on June 1
 2016 were withdrawn. The original 100
000 stock options granted on May 1



 2017 Steve Bromley was terminated as a special advisor to the Company. As a result
 the unvested 100
000 options were immediately terminated. The total outstanding stock options as of November 30
 2017 are 2
025



610. In 2017
 the Company expensed $6
964 as compensation expense compared to $111
994 in the previous year. Following are the assumptions used for the shares vested 12
 24 and 36 months from the date of issuance: Discount rate .9%
 1.29%
 1.29%; Volatility 68.35%
 67.35%
 65.50%; and Term 3.0
 3.5

























































375
























































































































































358






























666






























































































































025
































025






























 2016
 the Company issued 125
000 warrants to purchase common shares of the Company along with the $250
000 secured third party promissory note. The relative fair value of the warrants is $43
526 which is recognized as debt discount. As of November 30
 2016
 the promissory note was paid and the full $43



 2016
 the Company issued 100
000 warrants to purchase common shares of the Company along with the $200
























































































































































































































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017

























































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017









On September 12
 2017 we entered into a Share Purchase Agreement&#160;dated September 6
 2017&#160;among our wholly owned subsidiary
 Trident Brands International Ltd. (&#8220;Trident International&#8221;)
 a Bahamas corporation
 StreamPak Ltd. (&#8220;StreamPak&#8221;)
 an Anguilla corporation
 and&#160;the sole shareholder of StreamPak
 pursuant to which
 in consideration for the payment of $125
000 in cash and 500
000 of our common shares valued at $360
000 based on our stock price on September 6
 2017
 Trident International purchased 100% of the issued and outstanding common shares of StreamPak.&#160; As a result of the share purchase StreamPak became a wholly owned subsidiary of Trident International. The acquisition was not deemed an acquisition of a business but rather an acquisition of a finite-lived intangible asset. The total consideration of $485
000 was recognized as an intangible asset related to intellectual property with an estimated useful life of 10 years. The amortized amount for 2017 was $12
125.







The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period
 including background
 timing
 and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).





































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017

Accounts
 Notes
 Loans and Financing Receivable
 Gross
 Allowance
 and Net [Abstract]








 2017 the Company entered into a note purchase agreement with Fengate Trident LP (&#8220;Fengate&#8221;) pursuant to which
 in consideration for the issuance of 811
887 of our common shares to Fengate
 we purchased outstanding secured convertible promissory notes of Mycell Technologies LLC (Mycell) having an aggregate balance due and payable of $511
141 in&#160;principal and $94
526 in&#160;interest accrued as at September 12
 2017.&#160; The purchased notes
 which were originally issued to LPF (MCTECH) Investment Corp. on January 22
 2016
 February 5
 2016
&#160;and May 19
 2016
 bear simple interest on unpaid principal at the rate of ten percent per annum.&#160; The outstanding principal and accrued interest is convertible at the option of the note holder into securities of Mycell.&#160;The accrued interest as at November 30
 2017 is $105
869.



































The entire disclosure for claims held for amounts due a entity
 excluding financing receivables. Examples include
 but are not limited to
 trade accounts receivables
 notes receivables
 loans receivables. Includes disclosure for allowance for credit losses.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017











000 bearing interest at the rate of 10.0% per annum
 payable on March 4
 2017. The Company issued 100
000 common stock warrants with the loan. The relative fair value of the warrants is $35
250 which was recognized as a debt discount. As of November 30
 2017 the promissory note was paid and the full $35
250 of debt discount was amortized. Amortization of the debt discount charged to interest amounted to $8
812 and $26
438 for the years ended November 30
 2017 and 2016
 respectively. The loan was fully repaid on March 3















































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017










 2015
 the Company entered into a securities purchase agreement with a non-US institutional investor whereby it agreed to sell an aggregate principal amount of $2
300
000 of senior secured convertible debentures



800
000 of the funds from the transaction on February 5
 2015. The balance of $500
000 was received on May 14



 for an aggregate of up to 3
239
437 shares. The debentures originally accrued interest at 6% per annum. On September 26
 2016 the Company entered into an amendment agreement related to these convertible debentures whereby the applicable interest rate was increased from 6% to 8% and provisions added to allow the investor to transfer
 sell or hypothecate the convertible notes subject to applicable securities laws. The maturity date of the notes was also extended through September 30
 2019. We considered ASC Topic 470-50
 Debt Modifications and Extinguishments
 and determined that the modification was not deemed substantial
 consequently



 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature was $647
888 which was recognized as debt discount. As of November 30
 2017



 2016
 the Company entered into a securities purchase agreement with a non-US institutional investor
 pursuant to which
 in consideration for proceeds of $4
100
000
 the Company issued a secured convertible promissory note in the amount of $4
100
000. Pursuant to the securities purchase agreement
 the investor has agreed
 from time to time after January 1
 2017
 to make additional investments at the Company&#8217;s request of up to $5
900
000 ($10
000
000 in the aggregate) in one or more tranches of not less than one tranche during any 60 day period. The funding of any tranche under the agreement (other than the first $4
100



 2017
 the Company received the second tranche of funding with proceeds of $4
400
000 for a total investment by the investor of $8
500
000. Under the terms of the securities purchase agreement
 the Company has an additional $1
500



 without limitation



 the Company issued to the investor a convertible promissory note of equal value
 maturing three years after issuance
 and bearing interest at the rate of 8% per annum. Each note is secured in first priority against the present and after acquired assets of the Company and is convertible in whole or in part at the option of the holder into common shares of the Company at a conversion price of $0.60 per share
 for an aggregate of up to 14
166
667 shares.

 a beneficial conversion feature analysis was performed. The intrinsic value of the conversion feature of the notes amounted to $2
833
334 and was recognized as a debt discount. Amortization of the debt discount charged to interest amounted to $797
909 and $80
831 for the years ended November 30
 2017 and 2016
 respectively. As of November 30
 2017 and 2016 the unamortized discount amounted to $1
954
594 and $1
285
836






































The entire disclosure for information about short-term and long-term debt arrangements
 which includes amounts of borrowings under each line of credit
 note payable
 commercial paper issue
 bonds indenture
 debenture issue
 own-share lending arrangements and any other contractual agreement to repay funds
 and about the underlying arrangements
 rationale for a classification as long-term
 including repayment terms
 interest rates
 collateral provided
 restrictions on use of assets and activities
 whether or not in compliance with debt covenants
 and other matters important to users of the financial statements
 such as the effects of refinancing and noncompliance with debt covenants.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017











 2015
 pursuant to a Deed of Assignment dated effective January 20
 2015
 the Company entered into an Emulsion Supply Agreement with Oceans Omega LLC which represents the rights acquired pursuant to the Deed of Assignment. The Emulsion Supply Agreement provides the Company with the non-exclusive right and license (without the right to sublicense) to purchase
 market
 promote
 sell and distribute Oceans Omega LLC&#8217;s omega-3 emulsions for use in the development
 production
 processing
 manufacture and sale of food and beverages and exclusive rights to purchase
 market
 promote
 sell and distribute Oceans Omega emulsions for meats
 for human or animal consumption. On January 6
 2016 the Company issued 3
000
000 shares to mark the closing of the Deed of Assignment and the Emulsion Supply Agreement
 which did not specify the amount of consideration payable by the Company when they were executed on January 20
 2015. The consideration payable was subsequently established by the parties at a market value of $2
700
000 and common shares issued as compensation based on the closing price of the common shares as quoted on the OTC Markets quotation systems on January 6
 2016. The value of the license is being amortized over the remaining contractual life which is 9 years. As of November 30
 2017
 the net value of the license was $0 after amortizing $300
000 in 2017 and $275
000 in the prior year and the recognition of an impairment loss of $2
125
000 during the year ended November 30















































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017












 2013
 the Company entered into a Deed of Assignment Agreement with Everlast&#160; World&#8217;s Boxing Headquarters Corporation
 International Brand Management Limited
 Sports Nutrition Products Incorporated and Manchester Capital Incorporated wherein Everlast
 International Brand
 Sports Nutrition and Manchester Capital are parties to a trade mark license and Sports Nutrition
 a New York corporation
 has assigned its interest in the trade mark license to the Company. Pursuant to the terms of the assignment agreement
 Sports Nutrition Products Incorporated
 a wholly owned subsidiary of Trident Brands Incorporated
 assigned all of its rights
 title
 interest and benefit to the trade mark license to the Company effective December 23
 2013 and the Company assumed all of the obligations of Sports Nutrition Products Incorporated under the license agreement. The Company shall remain responsible to Everlast and International Brand for all acts and omissions of the subsidiary



 or arising from its termination



 as per the terms of the agreement
&#160;are as follows: In 2013
 7% of Net Retail Sales and 7% of 60% of Direct Response Sales Revenue; in 2014
 8% of Net Retail Sales and 8% of 60% of Direct Response Sales Revenue; in 2015
 9% of Net Retail Sales and 9% of 60% of Direct Response Sales Revenue; in 2016 onwards
 10% of Net Retail Sales and 10% of 60% of Direct Response Sales Revenue. The Annual Minimum Guaranteed&#160;Royalty is $120
000 in 2014
 $235
000 in 2015
 $320
000 in 2016
 $345
000 in 2017 and in 2018 onwards
 if the&#160;Agreement remains in force
 will be 75% of the previous Year's Royalty Calculation or the&#160;previous Year's Annual Minimum Guaranteed Royalty plus 10%
 whichever is greater.



 that may arise
 were resolved against the Company in a reporting period for amounts in excess of management&#8217;s expectations
 the Company&#8217;s would reflect any potential claim in the consolidated financial statements for that reporting period.













































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017



















































915









313

































120







859












120









859






























 2017











































The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position
 net change during the year in the total valuation allowance
 approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets
 utilization of a tax carryback
 and tax uncertainties information.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017










On December 1
 2017
 Brain Armor
 a subsidiary of the Company
 issued 1
859
001 shares to Trident Brands Incorporated to convert the $1
394
251 loan to Brain Armor to equity at $0.75. As a result
 the Company&#8217;s ownership interest in Brain Armor&#160;increased to&#160;94.8%.


On December 6
 2017
 our Board of Directors authorized the issuance to its members and management stock options to purchase up to 2
615
000 share of our common stock.&#160; 1
307
500 of the options vest upon issuance and are exercisable for up to five years at $0.85 per share
 while the remaining 1
307
500 will vest 12 months following issuance and be exercisable for up to five years at $1.00 per share.&#160; The Options were issued pursuant to the Company&#8217;s 2013 Stock Option Plan
 which was registered with the Securities and Exchange Commission on Form S-8 in January
 2015.&#160; The 2013 Stock Option Plan authorizes Trident to issue incentive and non-qualified stock options to employees and consultants of the Company to purchase a number of shares not to exceed 15% of the Company&#8217;s currently issued and outstanding securities.&#160;

Also on December 6
 2017
 the Board of Directors authorized the issuance of 250
000 stock options to Sanitas
 LLC
 a consultant and founding shareholder of Brain Armor.&#160; The options vest immediately and are exercisable for a period of five (5) years to purchase common shares of Brain armor at $0.75 per share.





































The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue
 purchase of a business
 settlement of litigation
 catastrophic loss
 significant foreign exchange rate changes
 loans to insiders or affiliates
 and transactions not in the ordinary course of business.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017










 year-end.














 2017 include the accounts of Trident Brands Incorporated and its subsidiaries: Trident Brands Canada Ltd
 Sports Nutrition Products Inc.
 Brain Armor Inc.
 Trident Sports Nutrition Inc. and Trident Brands International Ltd.







 &#8220;Earnings Per Share&#8221;
 specifies the computation



 2017 and 2016
 diluted earnings (loss) per share are the same as the basic earnings (loss) per share since inclusion of common stock equivalents would have been anti-dilutive.













As of November 30
 2017 and 2016
 the Company&#8217;s accounts receivable was netted against an allowance of $29
852 and $0 respectively.







 first-out (FIFO) method. We regularly review inventory for obsolete and slow moving inventory and write it off as necessary.







 including intangible assets subject to amortization
 for recoverability whenever events or changes in circumstances indicate that the carrying amount of such long-lived asset or group of long-lived assets (collectively referred to as the asset) may not be recoverable. Such circumstances include


























































 more likely than not










 2015 the Company entered into a long-term Emulsion Supply Agreement (the &#8220;License&#8221;) with Oceans Omega LLC for the rights to purchase
 market
 sell and distribute patented nutritional emulsions produced by Oceans Omega LLC. Subsequently
 the Company initiated research and development to formulate a range of novel product applications. However
 related product applications have not yet been commercialized and as a result the Company has taken a one-time impairment charge of $2
125
000 to write-off the underlying book value of the License. The Company and Management remain committed to developing the commercial potential associated with the license.







 which is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion
 is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual term
 the unamortized discount is expensed in the period of retirement to interest expense. In general
 the beneficial conversion feature is measured by comparing the effective conversion price
 after considering the relative fair value of detachable instruments included in the financing transaction
 if any
 to the fair value of the common shares at the commitment date to be received upon conversion.







 &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820 clarifies the definition of fair value
 prescribes methods for measuring fair value






 which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions
 including&#160; quoted forward prices for commodities
 time value
 volatility factors



Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument
 can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps
 interest rate swaps





 accounts receivable
 accounts payable and note payable. The fair value of the Company&#8217;s long-term debt is estimated based on current rates that would be available for debt of similar terms which is not significantly different from its stated value. As of November 30
 2017 and 2016
 the Company did not have any financial liabilities measured and recorded at fair value on the Company&#8217;s balance sheets on a recurring basis.










 compared to 48.9% and 27.2% in the prior year. Two customers accounted for 82.3% and 16.4% of total accounts receivable



 b) the price to the customer is fixed and determinable
 c) product is shipped or delivery is complete (depending on the terms) and collection probability is reasonably assured.









 2017 and two vendors provided 76% and 11% of the Company's services for the year ended November 30
 2016.







 &#8220;Compensation-Stock Compensation&#8221;. ASC-718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments
 including stock options
 based on the grant-date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service in exchange for the award
 usually the vesting period.







 &#8220;Equity Based Payments to Non-Employees&#8221; (&#8220;ASC 505-50&#8221;)
 which requires that such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instruments vest.










 in the opinion of management
 it is more likely than not that some portion of all of the deferred tax assets will not be realized.&#160; Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The Company includes interest and penalties arising from the underpayment of income taxes in the statements of operation in the provision for income taxes. As of November 30
 2017 and 2016
 the Company had no accrued interest or penalties related to uncertain tax positions.







 controls
 is controlled by



 its management
 members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party.









 the FASB issued ASU 2016-12
&#160;Revenue from Contracts from Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients.&#160;The amendments in this update affect the guidance in ASU 2014-09
 which is not yet effective. The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments in ASU 2016-12 do not change the core principle of the guidance in Topic 606
 but instead affect only the narrow aspects noted in Topic 606.&#160;ASU 2016-12 is effective January 1



 the FASB issued ASU 2017-09
 Compensation-Stock Compensation (Topic 718)
 Scope of Modification Accounting. The amendments in this Update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. The amendments in this Update are effective for all entities for annual periods
 and interim periods within those annual periods
 beginning after December&#160;15
 2017. Early adoption is permitted
 including adoption in any interim period



 the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) No.&#160;2017-11
 Earnings Per Share (Topic 260)
 Distinguishing Liabilities from Equity (Topic 480)
 Derivatives and Hedging (Topic 815). The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features. When determining whether certain financial instruments should be classified as liabilities or equity instruments
 a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity&#8217;s own stock. The amendments also
 clarify existing disclosure requirements for equity-classified instruments. As a result



 the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20
 Debt&#8212;Debt with Conversion and Other Options)
 including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification
 to a scope exception. Those amendments do not have an accounting effect. For public business entities
 the amendments in Part I of this Update are effective for fiscal years
 and interim periods within those fiscal years
 beginning after December&#160;15
 2018. For all other entities
 the amendments in Part I of this Update are effective for fiscal years beginning after December&#160;15
 2019
 and interim periods within fiscal years beginning after December&#160;15
 2020. Early adoption is permitted for all entities
 including adoption in an interim period. If an entity early adopts the amendments in an interim period
 any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period.





























































































Disclosure of accounting policy for basis of accounting
 or basis of presentation
 used to prepare the financial statements (for example
 US Generally Accepted Accounting Principles
 Other Comprehensive Basis of Accounting
 IFRS).




























Disclosure of accounting policy for cash and cash equivalents
 including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents
 (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk
 (3) the classification of any negative balance accounts (overdrafts)
 and (4) the carrying basis of cash equivalents (for example
 at cost) and whether the carrying amount of cash equivalents approximates fair value.




























Disclosure of accounting policy for salaries
 bonuses
 incentive awards
 postretirement and postemployment benefits granted to employees
 including equity-based arrangements; discloses methodologies for measurement
 and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.
 -Subparagraph (b)
(f(1))



























Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements
 including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example
 common stock
 a partnership interest or other means of exerting influence) in other entities
 for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions
 noncontrolling interest
 and the income statement treatment in consolidation for issuances of stock by a subsidiary.




























Disclosure of accounting policy for recognition of costs in the period which correspond to the sales and revenue categories presented in the statement of operations. The accounting policy may include the amount and nature of costs incurred
 provisions associated with inventories
 purchase discounts
 freight and other costs included in cost of sales incurred and recorded in the period. This disclosure also includes the nature of costs of sales incurred and recorded in the statement of operations for the period relating to transactions with related parties.




























Disclosure of accounting policy related to debt. Includes
 but is not limited to
 debt issuance costs
 the effects of refinancings
 method of amortizing debt issuance costs and original issue discount
 and classifications of debt.




























Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors
 including any antidilutive items that have been excluded from the computation and takes into account stock dividends
 splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.

























































Disclosure of accounting policy for income taxes
 which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances
 recognizing investment tax credits
 operating loss carryforwards
 tax credit carryforwards
 and other carryforwards
 methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.

























































Disclosure of inventory accounting policy for inventory classes
 including
 but not limited to
 basis for determining inventory amounts
 methods by which amounts are added and removed from inventory classes
 loss recognition on impairment of inventories
 and situations in which inventories are stated above cost.




























Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes
 but is not limited to
 quantification of the expected or actual impact.




























Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances
 and when impairments
 charge-offs or recoveries are recognized.




























Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions
 the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example
 delivery of multiple products
 services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.






































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017



























































375


























































































































































358






























666































































































































025































025




































































































































































































































































































































































































































Tabular disclosure for stock option plans. Includes
 but is not limited to
 outstanding awards at beginning and end of year
 grants
 exercises
 forfeitures
 and weighted-average grant date fair value.




























Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company
 whereas options are exchange instruments and are not issued by the company. Also
 the lifetime of a warrant is often measured in years
 while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding
 the aggregate amount of securities called for by warrants and rights outstanding
 the date from which the warrants or rights are exercisable
 and the price at which the warrant or right is exercisable.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }








Nov. 30
 2017














































915









313

































120








859












120









859































































Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position
 including the following: the total of all deferred tax liabilities
 the total of all deferred tax assets
 the total valuation allowance recognized for deferred tax assets.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }












































852









125
000





















































































































































































































































































125
000





































































For an unclassified balance sheet
 a valuation allowance for receivables due a company that are expected to be uncollectible.




























Amount of write-down of assets recognized in the income statement. Includes
 but is not limited to
 losses from tangible assets
 intangible assets and goodwill.

























































For an entity that discloses a concentration risk in relation to quantitative amount
 which serves as the benchmark (or denominator) in the equation
 this concept represents the concentration percentage derived from the division.























































































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }











May 09
 2017
Sep. 26
 2016
Nov. 30
 2017
Nov. 30
 2016



















751
420)


936
102)











000



























400
000


100
000











500
000











000
000













143
788











500
000




























































































































Amount
 before unamortized (discount) premium and debt issuance costs
 of long-term debt. Includes
 but is not limited to
 notes payable
 bonds payable
 commercial loans
 mortgage loans
 convertible debt
 subordinated debt and other types of debt.

























































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }











Sep. 12
 2017
Jan. 06
 2016
Nov. 30
 2017

















000









667























000









000



























887









667





























000
000









700
000
























































































































































































































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2017
Nov. 30
 2016
Nov. 30
 2015











Outstanding - November
 30

358
333


375
000





Exercisable - November
 30

666
667


334









000
















333


667





Outstanding - November
 30

025
000


358
333


375
000



Exercisable - November
 30

025
000


666
667


334












Outstanding - November
 30








Exercisable - November
 30

















Outstanding - November
 30








Exercisable - November
 30





































167


500









Represents weighted average remaining contractual term for vested portions of options outstanding and currently granted or convertible
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.






















































































For presentations that combine terminations
 the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.

























































Number of options outstanding
 including both vested and non-vested options.












































































































































































Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























Weighted average remaining contractual term for option awards outstanding
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.






































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2017
Nov. 30
 2016











000
















000



















000


000



























































































































































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }















Jun. 01
 2016
May 01
 2016
Mar. 04
 2016
May 05
 2014
Jan. 29
 2016
Nov. 30
 2017
Nov. 30
 2016
Nov. 30
 2015
Dec. 31
 2016



































025
000


358
333


375
000

















610























000



















025
000


666
667


334






































964


994



















721


025
















































































526

















000




000













































































































526
















































































000



























































000





















250



























































































































































































































































































































































































































































875
000




















































































125
000








000























































000































































000































































000































































000































































000









































































667





















333











000



































































025
000





















000











000


000



















  2021


  2021

















































































































































000


000






































































































































































000


000






























































































































Value of options outstanding
 including both vested and non-vested options.






















































































Number of securities into which the class of warrant or right may be converted. For example
 but not limited to
 500
000 warrants may be converted into 1
000
000 shares.

























































Amount
 after accumulated amortization
 of debt discount (premium).

























































Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.  For example
 but not limited to
 weighted average cost of capital (WACC)
 cost of capital
 cost of equity and cost of debt.




























The aggregate amount of noncash
 equity-based employee remuneration. This may include the value of stock or unit options
 amortization of restricted stock or units
 and adjustment for officers' compensation. As noncash
 this element is an add back when calculating net cash generated by operating activities using the indirect method.




























Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition
 market condition or a performance condition
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























Date the equity-based award expires
 in CCYY-MM-DD format.




























The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends
 if any
 over the period.




























For each plan
 identification of the award pricing model or other valuation method used in calculating the weighted average fair values disclosed. The model is also used to calculate the compensation expense that is shown within the balance sheet
 income statement
 and cash flow. Examples of valuation techniques are lattice models (binomial model)
 closed-form models (Black-Scholes-Merton formula)
 and a Monte Carlo simulation technique. Fair value is the amount at which an asset or liability could be bought or incurred or sold or settled in a current transaction between willing parties
 that is
 other than in a forced or liquidation sale. May include disclosures about the assumptions underlying application of the method selected.



















































































































Number of options outstanding
 including both vested and non-vested options.

























































Period from grant date that an equity-based award expires
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























Expected term of share-based compensation awards
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.






















































































































































































































































































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }



































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }










Sep. 12
 2017
Nov. 30
 2017
Nov. 30
 2016















000









125


000























000









000









000




































000


















125











Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense
 this element is added back to net income when calculating cash provided by or used in operations using the indirect method.






















































































Amount of increase in assets
 excluding financial assets
 lacking physical substance with a definite life
 from an acquisition.

















































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }










Sep. 12
 2017
Nov. 30
 2017


Accounts
 Notes
 Loans and Financing Receivable [Line Items]








887







141







526
















869



























































































































Amount of interest payable on debt
 including
 but not limited to
 trade payables.























































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2017
Nov. 30
 2016











721


025





















000














000







250





250







812


438




































Number of securities into which the class of warrant or right may be converted. For example
 but not limited to
 500
000 warrants may be converted into 1
000
000 shares.

























































Contractual interest rate for funds borrowed
 under the debt agreement.



























































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }













May 09
 2017
May 14
 2015
Feb. 05
 2015
Sep. 26
 2016
Jan. 29
 2015
Nov. 30
 2017
Nov. 30
 2016































400
000


100
000















466
667


366
667















721


025

















000







































500
000








300
000









400
000


000


800
000


100
000









Common stock conversion
 shares







166
667


239
437
































833
334


888



















909


831















954
594


285
836











  2019

















100
000











500
000






900
000

















000
000






































































































































Amount
 before unamortized (discount) premium and debt issuance costs
 of long-term debt. Includes
 but is not limited to
 notes payable
 bonds payable
 commercial loans
 mortgage loans
 convertible debt
 subordinated debt and other types of debt.



















































































































Contractual interest rate for funds borrowed
 under the debt agreement.

























































Date when the debt instrument is scheduled to be fully repaid
 in CCYY-MM-DD format.




























Period of time between issuance and maturity of debt instrument
 in PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























Amount
 after accumulated amortization
 of debt discount.




























The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security
 typically the entity's common stock
 at the option of the issuer or the holder.




























































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }










Jan. 06
 2016
Nov. 30
 2017
Nov. 30
 2016















667


















875


425
000







000









125


000







125
000

























000
000









700
000











The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense
 this element is added back to net income when calculating cash provided by or used in operations using the indirect method.




























Amount of write-down of assets recognized in the income statement. Includes
 but is not limited to
 losses from tangible assets
 intangible assets and goodwill.




























Useful life of finite-lived intangible assets
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.




























Accumulated amount of amortization of assets
 excluding financial assets and goodwill
 lacking physical substance with a finite life.

























































Amount after amortization of assets
 excluding financial assets and goodwill
 lacking physical substance with a finite life.




















































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }












Nov. 30
 2017
Nov. 30
 2016
Nov. 30
 2015
Nov. 30
 2014















000


000


000


000





 if the&#160;Agreement remains in force
 will be 75% of the previous Year's Royalty Calculation or the&#160;previous Year's Annual Minimum Guaranteed Royalty plus 10%
 whichever is greater.






































































































































































































































































































































































































































































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }









Nov. 30
 2017
Nov. 30
 2016











915
112


313
340












120
289


859
669





120
289)


859
669)












































 -Subparagraph (b)
(c)

















































































































Amount of operating loss carryforward
 before tax effects
 available to reduce future taxable income under enacted tax laws.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }










Nov. 30
 2017
Nov. 30
 2016











915
112


313
340







































































Amount of operating loss carryforward
 before tax effects
 available to reduce future taxable income under enacted tax laws.









































							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }











Dec. 06
 2017
Dec. 01
 2017
Nov. 30
 2017
Nov. 30
 2016
Nov. 30
 2015























700
000


































































































615
000







































307
500

































































307
500



































































859
001













394
251



































Subsequent event | Brain Armor | Sanitas
 LLC



























000






































































The parent entity's interest in net assets of the subsidiary
 expressed as a percentage.




























The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors)
 net of any subsequent amendments and adjustments
 for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants
 the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).






















































































Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible
 in 'PnYnMnDTnHnMnS' format
 for example
 'P1Y5M13D' represents the reported fact of one year
 five months
 and thirteen days.



















































































































Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure
 which is further associated with dimension and member elements pertaining to a subsequent event.




























































































































































































































































begin 644 Financial_Report.xlsx
M4$L#!!0    ( /EH;DP?(\\#P    !






GD)8!.(6)=X6K?FCQ*C=V].6
MK1.!^ 8^Y?/GR4W.DH=$KZD$#&1Q7PSN




TPHP$[
M=.@I@R@%L'::&$]#U\ 5


[)(=LEU?=]V==S;MQ!


!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?
M
_@5RU2-9:
!$U=!)KF(M/+Y;

M5
+$P&IG/U9KQ]'22(R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C
K:=#1M






_Y/%_GM
T+
T.W


M4E5@
5O& RN0HGQ


MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE


G'G%$0%T10(C



U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+
MA=OB5

)%K/]8UA[Y
M



0QY@%CS#*%F.-^'19H:
M






Y'I/ 2$M#'Q-3$3V#Z2E(
M3PT]'=%S)T0^8@8+9*! YM$+1Z!'9 ;1]GN08C2/)V1R4;W9.:.C(] 
:PP
M Q5F/A\Y$@ $PQ(%*%'X?=;-@!D(EWFH,3
(
Q$N!%;X&F'/ G8.D:W%C#

M9^J;]SU)/YLL_U6-#1]J_]02P,$%     @ ^6AN3*V?ZBB P  2P\  !@









M]N



M)]URC#
Q[:51390
DLSC-/

MQ)XX2O4 7.IXCNPHH5;!?\(2#5&.(:IBB'+





MQNZ\'%V+V_EY\R]02P

F





7\D4R?T5P/\+VY^*_H

M$J\D\;VBL17)7TD@\B\0L1
B5OYD#5&X_8G3GRA_NO:71A%:DBG)H(LHV 6
M8JM-T?JY$@MCBPT.+0$.#-H!EM1%-$_MA
X


\E<@C=1
'JSI)O
MR#=(+]W O /AXOI3E]29$(Y$T/!!Q&O%L[4


MQ_H/4$L#!!0    ( /EH;DQ?2YY&'@


-
MW_C![C?@.@K.)7(:_MY#[J6GE2ZKE[^+);QJ@CDJ7<ZBY%;BX7N9%EV64R
M''^&I/%8LPN<WK]F_V2;-\T\Y:W<J/)WL=/'92SB:?W^;G4W]7ULQP:HG$T


MZU9O:P8



M10G%F7ODFY 2



MNQWX=L==NP/?QPP54%//I0HHB?DH


M4;?1D])F[++#T5XI+0THNC.(1S

M4$L#!!0    ( /EH;DRU'T*/X0


5#=]BVQ+XR36KK0K1;/:W6=BMV-KP'B
MQ+-_OPWT.-!5V



G@@O<@Q9$Q!U@<0NTTNZC$R7=?;IT%X'Z?80V4&.
M'83I)$FC#$*0F1!KA'C+OCSAU $/:) $(JTZ 9:P+&9&(8 [H,GP#QV4P
M01EZB C+







MIE/_LM?/F\L?P?4$L#!!0    ( /EH;DRRFJ.):@0  .


U45S7_/MJS/CW.:_VCX<GC;=WW#<KTZ%6_V
M+]M]/7UNW-WR$F5WJ.RQ/=3'66-?'^=/]+1O.\P*/X^V'-[=3WK2WFIZV_]



MKJZF*







/KFQVMMB
M=[DI[6O77VIWW8S';N--5Y^F(\7EY5QS_3]02P
$%     @ ^6AN3)\&%B:R
M 0  T@

_2N(
M'U!R7-I5IR12K]/42IMTZK3U

M*A!Y&:\S)UU2!N#Z_

H
C









#

1%[&Z\Q)




M3&

$%     @ ^6AN3(UR10*T 0  T@
  !@   !X


MDS;IU&GK9RYQ$E2(



&PO=V]R



MD


MP$\.DUV=4:CDJO53


O$Q:BUL7%$]
M6J=E4O&I2/8\[US%?4HWQT3;)M!$H OA&..0.5#
_-SKJ



M='





@#7YW?VS[%V7\M9


M965T


MEDWKHX


5_@ANH$!Z5A!PE*I=64O;.HYY8@A0M7L==
MFK0/X\WN.


M]JL$^T2P_V^):S$/?R5ABYYJL$V:)D=*[$V:Y(5W'MA'GM[D=_@X[9^%;:1Q
MY(H^O&SJ?XWH(4C9W(41:L
'FPT%M8_'AWVXYB-AL=N^D%L_L;%+U!+ P04
M     #Y:&Y


M



30N


M@IKWTM^;X1M


$XBO@/Q3N
GHOD.LG8


M0XI*!V-?70/@R;N2VF6T\;X[



M.UFTV
Q2M@JT:XTF%JJ

QK\'X4F9T$P2!A
('

-_QF@JT#^ 3@
M
^ VYF%CHJC\07B1I]8



T5


M01]0)4K69H%MH.DP;

MK'OR+4 @SUH9G]
,P.7YA?UCJAUKN0@/#U;]E%5H<WJ@I():]H\VN$33/6\

MV)@H*?\@@B@R9P?BQMYW(C[Q]LBQ-V5TIE:D.Q3OT7LMMK=W&;M&HBGF-
;P
/PL




MT@




M;:!I

MVF6T\;X[




7V&J9T_)5/QWN(#$

/&1%'Y@_ B


M.
D+[SRP=_$1V7OX..T_A*U;[
  !D   !X



M'D^[$!\#_K0PV
69A$HNB
_!^%YF=!


AH7+AN/=G
M

$%     @ ^6AN3 R536.U 0  T@
  !D   !X

M[PZ



WR%J9YK2J;BO\
%%
)#)ABC
M

K%E12]\T9/*IB*%J_C+MNX#^
-OYUHZP0^$?A
V

W\07N2I-0.Q





_TV,S.K(UWV.+!Q9N\,J:B][;IY#:^*M5O
MDD165]92^<1[UNDW9RY:JO107!+9T9/-JAM$H)0EK2T[N*RL'
'41;\IIJZ


M/'Z/I/&D:0+GSQ_LG^WB]6*.5+)GWORJ3^JZC?
X.K$SO37JA3^^L'%!RS@:

8!
 ;G5





MLKFFU\^LCDH.Q *NUW]?0
_:+5^$&=Z\-\
PYI/2KZ8#L.A-BMX4N+-V.!)B
MJ@XD
W=J@-Z=-$I+9IVI6V(&#:P.05(0NMO=$\EXC\L\^



M/#X 7CA

+5=X B$\D4OCU\*)5TD?N-V_

2ST91DOQ7^$*PL%])DZC4L*$
E6/4OC!/LHP3X0[/\I\?ZFQ!CF(2Z2146R
'A1B2&^7 C0C:-


M]%ULF9O1*]G#Q1(W:BWL[S
H
Q4TI:^.)]EV/CA8F0^BA6_@OP\7BQ9;66JI
MH7?2]

WVI9YWES%





GV[VLN2X
Y9LE+P.;
^'B&
X.SN(KB
MM3QR+JVW+


0EWXCT



MMI
&$]28O
'
9S[5]C)$N9B(#XGX0R+
U8CX0R*$^JYK6B P5@(4/R0^@@
MG![S&70P PRT:&X01GO1(X3Q
)$Y)#('#O37N


&Z1/!980 _7LF%[@

\WN
 U


A%2





M@\064EO()Q@E&*(P&*5Q(.-9%
/@1B;D+ E-2@IQ


K''O!

[-AXEF   !X   &0   'AL


MBK;J]ME)G( 6

M9Y7%Z7%I?\'/&QQJ X-XS6DC!F-+A[)C[$U/OA^6MJ




M[#^06[AE\+QGL(.G9UDPRZWG?%S&.XN''Y^#JP[T#YJN0 +30XT?6=_)/P



9#O;\RIO7]LB8\-ZJLFX7_E&(TT
0M-LCJ_)V





\
DL/K$3!UE
7 1%:'1E$I!)XC))K3BK
MY%

M^0;W6ESC&)0A

M;;?.LMA.WD7A&1[140P+*:93RM&!LF$@6W4
:ET$2ZP)F-(E#,[2NAP0;.$
MC@2M19#8NO4( (N368@MH8U,1*P8*,(45V*A5/:AP7Y=9S8U#QA'KPHTA
MY:8V8P@4VH0A4&3SA4 CFP(

 
J0
MO3(0:&S7!\LV 60[L[9U*P.Z[9@TQ
[V!(!%ZD-B$0IN=KT5:P[Z1-%Z6WZN



MLI4;N\Z1G/E$_T]HV8A +7
DW1PD_ 53DRFDVC07<:VJ ]-Z&0+80&S0P1]T





AKV9]@9XH%40R





M95[5'S=/L^UZ4^0/;:/E8B:SS
Z6^7PU/3]MO_NZ.3\M7ZK%?%5\W4RV+\ME
MOOGOHEB4;V=3








3F9Q-D@D


9DK2
3F

P532C4B
+DAA^(V%S1[& !+8CQ7$$BQ8:0H*K!




R-P




M]!P!YH5+P93@@/L2Z 9S(@ [ +#)XIR02

MSQ[W^A%#16CT@
:4@O0Q+;F'038 -;N! $H(O4$0G4 5!NRP 7:QCQ
0
XMR-V'JER?[=[PG.U?,SW_
M'U!+ P04     #Y:&Y

O

YX;6QM5-MNG# 0_17+'QSYI)J!4C95%4KM=(J5=MG+PP7Q1=J


MDXM2S][YTE8X\8* 0V
VJ_LGT+OKI<+


MR_ 8;J+;G7^@8:S_X/'!?&.Z'Z5!%V7=Y0@C[)2RX*0D=T[+X-[HYG#HK#?O
MG:WC38V.5=/Z,GV)ZC_ E!+ P04     #Y:&Y



#@@= %A
M'X#C?P9$+B!Z:T#L N)1 .JLV-ILB2)%+OC-$]W/VQ*SB_!CK*M_
(NVV/:=


M B:(0(+($L1W-D96-QTFM9C&B03Z ^O$H$X\T8G2Y4@GGNK@$(?)J&936)@E
ML^DD8#H)8'NF;BE(D+Z]\!E(D$T+D@6C/99-G.IJS#I=@#H+P.FH\.L.DPQT
MC


M0H

O



MVM: 0B/U-%%S/E_P.9!L7-XNM#Z@Q5]02P

S






M%$0]SK !2C63JN-O3^H.FCIQO+ZR?S7FE9D=$;!A]$^UE^7235UG#P=RHO*%

M^P0\)*#XTX2@3P@^$D)COJO






VJ=JT[3=-



);





M#%DDA!C1!!LG=IW3-2KL6F(41S&R_FW7 $X@0?&((M@YL6N=E(2V(NZN[I@S



Y:]RL0%-EK+.A]0C


M:]F)_^#Z9[N5IH=&E4-9\T:5HO$D/R[]3^1Q0Z@E.
1SR3MUU?9L*3LA7FSG
MZV'I8YN(5WROK00SKPM?\ZJR2B;'[T'4'STM\;K]IO[9%6^*V3'%UZ+Z51YT




M 2Q 
3FASM+H#\B$YD84/YCHA;E$QT[%C]HV$].6_4W2=[1HAUL2C5=U
M_A=02P

MG;#]^QK#T@0.*_H2;#
SYP(33E1S\2I3QI3U5N2E7-FI4M6SX\@D90653[QB
MI;YSYJ*@2F_%Q9&58/1D2$7N8-==. 7-2CN.S-E!Q!&_JCPKV4%8\EH45/S9

]]@0



M0U[DW!JA#K-I

L!TCR R T0_Q&S'V
\Y
.9
M$K 9Q B0!X$%+.! IX1\!X$@D$W6\S8
JV6

M.
@2#+($!



W



M7T4%(+VWAK9BZU=2=AN$1%E!0\03ZZ!5=\Z
-T2J+;\@T7$@)Y/44!0%08H:


M U&7&^R!4FVD





MTAG

MGUR$SF$#Y$R)U+F0)I5VF6+WH,9RR.%A43E[H!?C'S3W@EN[92OSZ3Z#AB
MGR
]%&;QG1J]=E)^V-BY_8/P2]T*[\BD&CEF
&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;'U4[6Z;,!1]%8L'J %#TD6
MU*2J-FF3HD[K?CMP^5#]P6PG=&\_VU!*$[0_V+X^Y]QS+[:S0:I7W0(8],:9
MT'G0&M/O,-9EYSJ.]F#L#NU5)P:NU0-UKT6GD29S@.PPWFM!-!D?G84169
M/!O63@JI

M0 KJ/'B(=H?4X3W@I8-!+^;(57*2\M4MOE5Y$#I#P* T3H':X0('8
P)61M_
M)LU@3NF(R_F[^I.OW=9RHAH.DOWN*M/FP7V *JCIF9EG.7R%J9XT0%/QW^$
MS,*=$YNCE$S[+RK/VD@^J5@KG+Z-8R?\.(P[23+1U@GQ1(AG0K3Y+X%,!/)!
M\!GPZ,R7^D@-+3(E!Z3&G]53=R:B';'-+%W0]\[OV6JUC5Z*) DS?'%$V8_




MZ@9?UE
[OJGO8M[-_IQO0ZJ<O
MLRABD^E(S*8^8A9YCH'+- &'Z.N;

J#?W ).%
MH[(B#

0PV!L%FF!
M!

M#C]8
01))AW[B8' 4\?J3+R2 **YZH_UA9)KV@A5@Y!TK%:F%W70HHU1L,+
M6@A!CA92+$0*A&BUT(!.5U;'DD,=VRN28.*@P!*D5TB08@E2),%1K@L*))CR
M+ Q=&6,)4K3U)6-?]HY%6!91UX).L0PID&'(QKZ0#)T?25B&%,DP&SLH-@U

J9+8*;;5#D$/M#.N0


$%     @ ^6AN3'[B1%H%4@   BP!

UT!E)K71+PY#*'[_?]5SZG):$[53MPSXD9M3=
MY_K=KW^IJF7R=3:=5W_]YFFY7+S][KMJ_)3-TJI3++(Y/'DHREFZA'^6C]]5


E^^).=S'C

:T_74[FRZ:1
M5V6)2[C)%D6YI&6Z7(5G/\O6?3C/!3



M19'.]7-8\-U37D[@W^7RQ=SK! 8IZ%K[?*-'K6.D+NLNU7_,M8L 8#]2P;$
ME?P(;M?QB?NM8X'!ZW!\0$OH-?J'PU:1_O#;1:Q9G(B9$_%= )D_
\P_4
^
MSH-K$J)7

MN]=0SUV ;8#'IVR9 UFN]IK)*0H%&9%P..RS? ZCY$C(BRK?( F-#$$N2F)
MD,R 62B@X_O-&-GX&:RFCD3K0=C ;K(+ESJ!BT[+*ED ,!& !F?A?QV ^%:O
M,\QO]6K1+$]X=VNNB!#BM9/0NH:'@GR9C'+[(=K;O$F ZZTBI&KBD#B%CAD

50MMVJ/)SEC\^


[LXOOT]&)W?G/Y$L
MUD1]0[KQSU6UY.F!%I?9N  9HYFKN0:?L6_Q[BP504+AHT6ADVF*,J2U/XV
MU-W1O/'O5 %@ IAF](5-+T\9HU IT2J; '+S/G5C!$ECFV%8%O#2PXA=C;$



MOT=XV
GH\@




84<@P@#&+Y L
M9)4_85XE\^(9YAP32REXJMIH3Z!2)8]E\;Q\2N[QO

4+!:
MS6!G



U9
MMGPJZ#I3

#[)!.IB3?)4XR8P$5SR8J.8N]I!J#
D'J
M-]I8:%761Q1^P[-




B.(85))P5A]I+H!(CG%2$G$CV[T8[8*5%I;UZ((@K^

Z$W(CE!P
M0\I/I+'
LF3&
4@ 7-.

^Q#L;I?/JRF]G7S1^E\

MF

M41?WP&5@=-I:!4L$/N
]C7\

\T_X\W#+W.\II9S/
\Y4'ZX
#$IA\+#J[A%!A;@7
M'A*J$'R1QEYHSJ&37

MN453R$LR J6=U;==_%ZD6_%$6B

ACN0%%3=:0AY &$9;


OV&U%:4]*QQ7/K<X;B

MRBQ;#1[H-2 I4V:9


MB!Q)05%G
\A!T#*'M RI3TO@U.[!W9E85R;*S65;9(19BF:
DYC5R0=D/Q'+

3!95]K (IZ68 AI8W=%(@




1M5HBH(A+P0[&IH^I7V1RRUX5H;S&QU&9WEAJ0\_JU8/B(
(C \E
94:W2&.R<S$8:
D1^(U]!/



M('HYL. 5S//2)MM=6D[T-='+F)#T4J(ZZKP-7CY2 ?.$Y/#Q1!D(C@A.X%


M1I
%B)HHZ

MUIT!]5CBL^E%C#51K6Z ;L4


#

)B1AX;3^\\/NCL

MQ;M79!V#Q\??6K.P8 WSLSG(4[!#. 5B/JU_I6EP!]_$UE0S\/AP)TO6]K



M]6_RTK$89@]-K#!.8JL*;JGW(0,35S%3[8:;-LH 7B$GL@R'$C
=P::8-)
M2!L!XFTS1)#8^6N@P@N=T
B)07?0'C@1(GPQO*!KC=&63#5=M5HP3)RH'4B-



J8C0Y*XBJ\
M/94UY&1(

MV0




M+
8=
M,RO:! U=6V@<MJQ6+* %BD2Y4&X3[?&KQA3$GXNZYZA#QEA9$%*PU*M5FCF
M(FFUHA +W#^6

M;-M8O\BUARDH\-\\5'(X(N2G?C):AV+_L/*.$Y!?%O




T\T




@]5SV)[27N:SS][
M-
DUH.R26?


MTBI#WDFZM=E0SF61=

DH
M@


A8UZ37!%@5R
+
&7'6;06N*+U!D

M#ZC%0).JS=GZ@-0EIX
9%!9 1#


).)K\ZZS!KL<HR5CM7+'R:
M3*RT4@F=;YOJ8/5@29C7AF5+:(W]82OB^-+XG8FDQ7$,K4W#X!0^@WX=$O2


M-_M#!B8;TQ


?9
M7[\A^E5^R;YA1!P E8O
A_B '@=69 YLE2
*W
 93 68R+;%(MGP$R]0<-
)E$8(W5 M+I&ZS2&0G\I



_
%^;52B0OYJ3M-W+4


[)Q6*'03

M9ILLM+G:X]N=2U-74@3U'=.]9R2E)T]5V
3
X&SGQ
D+O\!2T7 9V 2RVCDW
MY6JH0


M0-$HQ
#Z'A#F

M6%BU'0O3!6S#22)



0/%-'
CPCQO2
LSN!*GILQ+/Q?!N#!L








U**Z9*Q?4:M#1#6CV^%=2KL V;Y_9[UN





B^L

R'


L,Q;&3AV5Z'=;R9C5^A@)E:5D;)*VFK)

Y8_NC



\. 3Q^ZB1R6['8EN6A5H:&C)%

 =2B
1TUB.D-VKV!
MUF=M*.VA!5F;1.1P(4W%,;@T0F!0.+^\&UU^3[K_Z/;V]YP9'Y?%!/*3L(E




26ZR]5B67VI
$RZ-R
M;P4L3

IVZM!I2X^W

2J ;T,6C%R,
MH9EV+:2].4GI&#:S'<Q9XX^Y;CU47Q+GYLJ2'H(.[(A4<(

/%

'[%.E XZ%


.8?O


M-B/SK8RXZNI'$+IFJUGRO:+3Q-P7A8_T7=$(SNI-?W_@_ *[?;/OO3/$7PX&

 3\SU4
N+0R4OW5

-1))=I^F

+H#(^VCW.T8C\


M2XX8JT!H/TWN1O\K5 ULAYW7Z '[:).R@T;;N4A37SBJMSL-NEG#[\.=R'AO



C?R&DBKH_]?K
MJI[+:5
#(A(L;&]/0(PWQ\D
21972XW=^2].@*:QO- 25CM3Q(QL0O)5*#




)9:AEB#O9+TH+-F[-C:D294WHM
'


55:M:V8=*WEQV8U6I\$AL*@-


MH(KNEB/X4!S(-17
]K/'4ID+VH;;ADM:#)EB_5[K.8V.R[R5N?GCKG:WE&L
M;)AT,J[ET=_D9V(JE.P8TUKTS=]L[2I\:#1Z_=N%OY4B17?5^4FF6RI4L
M X4)9:L5%R E(]Z8M#26+U4:1J'*'%.T0K
V
L7TC*:.M6\N8H_U8_F6OI







M5KNSR[  @E(;FT/
+-
T









_NSY5%++Y$


'G+-;6S[U(ZK9'/V:_]LI+@)#HDU+OX(DW0G#D'+VQ4HRG7




&V '

M@H7(_R=G&M9:J46Q+\V/' PM=UV(








M^GS
#.]+






N+ZN8[Z.E=OV#EP)HOBG3OQT;#3XR\'^$=LWD@LNO:\
MI3AT)^_)QFB-4;TO\Y2H

P6U_
?*U
9?9LYAJ$W7T+3./RM_9YV=.+D/[_Z ]^8



8N]' #\-_O-0^IA9

MP49B:8R&HW-$%HLP$7%I:Z9

MQSN940'[(SD6ODT@=W(--'

?/_%&T






M93$OD
9$?4;W@]S$B0295)3EDL>R(OQ]P92JN$Y,Z.!WVXJ$]DV\NDK\Y X
MJ6J*J9)\3W,+ S-F?FR8PM!05/&GPL*:C$VQ=5*1!ZPI:UD .;-DY:/;3_2D
MC5U&U,)$MZY-XD3\.#$&D5TNN#WL#O?>)I



M








MF[YZLW.$S5T.DW5 *=U


M?:PIFI]N/R2[;X(1X#XZYH[D'37*_T0!8NN^&&[U!1 *](^(_?DFKSXG_W
!
MTE]RCJTI@J*$?BF(6




V%




'6PRYW\2+AX/.(&)LB%-U$6W_[-6^I\KS_Y%_-)1VQ@Z:][7KYX%





M59:O

0[O_MXJB9/H$08SW%Z&0_FV
Y7$M@H3TRM5.R4/*GU
M.EY+6S;U50X)%U8*7=BSH^]G\OVC_;Z

M_.[-I0







K16U603AE6P]/+9!)

/ KUG!5+&!H%3[($TKHG6
MH




M
;\L&!U9




W
MN3D4I&7ZSB[1!1


696W.B
!2
M_TJ&)_=A5P%[G=J9%%
LNR)OV3M.A8B[)<73:;Q72AEK+XD:U4JI_
LWPI2WV9/S:+
M5:[DK%@H52Z3IM-JG3:7
DZMZZM-7

M\2 ]?9TE\4Q_?49N9+3J2)1'1L#T $ G2\#)(VA-!= -+]1


M .0Y+F2?WX]XEXN)@7
!X%P@][Y@
-!-&(G NS/GYQ8T0;=PF7[1
-0-%]4=
M+:C[6&2R@?) MD?(^E2P+AG24$R(T)P1]?8((7O8R/J@GNY@$7\?F;IE0T8'
M0WI'^J)K

;(T&2 DVLA.J^8V+
M =M




2'KN
C6.9YF[S4ZN


!#LIT$=C9!G-O-7#RJS?;96%8]OX\MCYR;FN


MBMZ
UYL5O1FO-RMZ



9R75RJ?&4A
CA7&UK'K%LRJ;*D6Q,1H-&:9
M:0(U81C:',EL\D2%6E5A\+@;;U-/$V5MI3,5M&G8NLE_)1WN$Z:.JFZ.+[7U
M5W%








RYX;6Q02P$% ,4     #Y:&Y





M .

M;6Q02P$% ,4     #Y:&Y
GP86)K(!  #2 P  &               @ $I
&UL4$L! A0#%     @ ^6AN3'E;






T  'AL+W=O<FMS:&5E='

M970Q-2YX;6Q02P$% ,4     #Y:&Y
E%:&LK4!  #2 P  &0


M971S+W-H965T

  !D
M             ( !.3


M% 









M-RYX;6Q02P$% ,4     #Y:&Y
YK*SXI@  #%0  &0


M+W-H965T



YX;6Q02P$% 
4


Q+GAM;%!+ 0(4 Q0    ( /EH;DP;=D31\P$  $P%




M=#
T+GAM;%!+ 0(4 Q0    ( /EH;DS(8!EE3 (  +8'   9



M='

W


W+GAM;%!+ 0(4





M;6Q02P$% ,4     #Y:&Y

4     #Y:&Y,K$XIA#P

M   ( /EH;DQ-)/??;@
  )(9   /                :O$  !X;]W;W)K
M8F]O:RYX;6Q02P$% ,4     #Y:&Y
@TE%A9X!  !*&   &@




3.U:QD@D$OE/G[^7]\''KL3

MW(55):_CKZY

O

1%I5AM::Q&R:M.$/M1.J^JX13O0WNWI@?:9,/:O6#
M9CW]+ Y#. '3OC._EGSHEG^#?R KQ\67Q??G7[Y^_A+R?C2OQ
J*O]$_X8?
M-8L?^5PZJOP;^JED'B6=\@_@!WR]/O9Z- RGO ^_E'P0JX-;SH?I-SVNNK2'

MHV/Y%OA
&'AB]N%]


M







9E<X_MHCUNVWK</@0^]]Q/W!GVK=3;R2-'C91GOF
MMO7





MK;5;/&S

MKA2QD8_209+U;U
1KA+V5%!X]M]YMP#6LO
[%7W+\(ZIBM?S\2&V%[5W]0?M
M==H*FSZ S]6+OCT'T?KUM_-





I65$
M

2E+]PS'OK2O]V1 @1S4DWYXBRY/)Y



S GX- &_*[P3+FET3Z[)$,E.@@B&U884






M(
]6[T?Y7XB./LA0.%$0[@;ES+^PC(R**[2$



E*'DJQY;9(=G=1NO#\Y48)!M9+E/FIB]C<




MG
MY_#PT&FU6L[-_]?_]6^=\^.WYS^?USN=G]_5.S^W?ZN?M=NM^KN_'?_VV_GY
MV=&[XR,SB88FQNF1VA2&.P RS?.!XH.Q:\&3?1CLH+DM^1O'*-DQ-^O/TP

MP\Z+H
(0;XK0SU[Y

XMN#@M_O00'I&8SCPZ/@4Z^QGO+?65Y1=Q*U44 N%B



MQ!9SA2

@;M8!LE%)


MA8_-4PZ&QLXJ 3G_JPR


41YRU


X!U:_4O7G5RU@2ZXUFN]7H++&.C2

YQ S664@A^
(.]I9_BV5#]=N;8@.'C1;8X1FLLT%:
M
?#+(OJHT3EJ/09V_7 3#YLU@Y+Z/21PR)L-91_?#HZ' F


X$-8^%^E+PK/4J!V!N#\'X/NH4PT'

?YQ43;=S;4LPR#&K9SO7M^!Y*_HD9B\I
7(7%4E[RP5R*DR-NU[%(N.R2W,(RNK8+=5.H:G@;?.I:SZ.ZL
M?SDZ/HDCOI!B-NZ^EV9%IQ=


=6J,Q
M%W_A8%25V'0FW(-NE*<'=6:M9P)D)O[\2 MB:OC5O/X^&&0!%$=&/DG[D#Z



M#-










M0]X^T5$].CXZKAT_)0V/XR:AX:
5TW Q[W&)=8Y;GQL0-4?%TK:SX5D2\LPV


SU/L83'T!


\

V!5 HKHP?17-)HW)'RL!&U+8Z ]4&Z6I/U

M/&S/6D 1H!4#ORS^V\?UXY5!G[1YF%;8=:5X[[2.#NNS(
]!LTJPEPUZ.^XT




M'

MP PB?1=.Q5M6&WXW;_7X0'JCM^P_(SD0BOGBGH%NS/W_K#!Z4F$*1#&


+Y

ZX S!PH0PB9/BZQ^\5WKT;\H3P3\^BSON<A;X#&06Z<^L56%@
M9A]5,SIF-]EL- ,2)8P=!4SXM_Q6P)0T+,^B.M
?!]Z!H$
$ '2^$YXP1 U
M
YS9Q_WD'@.LP#H=P88Z
A2
@*H].)8_/M-MWA_^F.
9$M 8W -$3JR ;P2:

MKD3G$9!)U#?\R(^CT.2F

J+SP/WXUB#:CF
MQC$POH,.ZTFL#L=X1$\%C 6?G<2WL8J0)]</JRQS:+W=1$O?7XG\JAU=/X=
M
6FN67$0WG+?1)7#+WG$(\3BNW!BXM










M-^JAIF 6S8) ?2M7\DB=*_B3
38$0RR]V!6)OSI5_&8%A5*@#



-O$E

6F9D
=: ;O

!K?)Y/%C

B'DY
M8.K[.&:5?8@%WD7AN#A:\;H&8\@4)N3 J)/. &3SF$E2 1 ]@G;&XD+M-%!\

MB]GBP.]RBIA5M2R;LVS.JEH;4+62GCTLU_B
$@X\+[BGV$#T)GX(XF[4B[TD

ZP+E+)!.Z@NLLC_Q]=O8
MHY([H;B3
, BRF?.G1[I&.M%?SI244Z'\PP-@W[TN:/W$R(O .Z'$\'%6+




G
M'F!LH4

NTWSHT+V)W!G8X'$4
MK! ;C[LR6QH9'/Y*^T1@.T#=Y]9T!X$]^09=AA*)RWU1!)S(=2]R5/5&Z+.

#99K+KG@\DS^%L._V
WZ$;NRO0(


M+ZIZNJ0PI;%CHGB7XA%T$9$P0!=WFD2.M9!CU/OH72]P)$4D%OQVJ
)6*(

M4[P_?!8LH%EJ?9BW%[%6:+9)J+Y4R0J(@6WC22T82^[PMDA#IFP01 8/!I
M
9 :A %#G%?#''M[_P!89


M28AB -L$7.F.JLFX.8M[3@
9$9(8H/K
=G/C8=/Y(UHLY-B6R()&P(HB6-
M3'3V% \VH/?9*-26^UONOWFBN?39WSFP_G#$&CI7M97/4
7RI +#S:2/;$V'


M!^*6LX\?3RD$CP0#[@G57$E*ME3

('
MEBH
@*BD8T%]+2_&Y\3HN*X2_XIA &]4R
XUF
9QL=PK!TCTQ
UO68]+7
MLQ%[*#$Y\DI#0S




MR


M%WB@.=



M(5D$
47.QH


M)IX#K'XPD$[J.[ZC-5EKYCB69M1(
!RA&GR%C
00&NI!4(RC!)1;#69S(]

MJ&Q07?UX:!29;D'3(2V)+J=+;%^=

MZ

!A4C
CT811=\H7_TA_ID:J6*'$Q-K2A1\I9V=W(O2X2MP3
M1X=4^)2]#U'I/PD'09C[A2 R=]&]V'?




2==K6NOVSA
M/R;GM:?!LE#+0BT+W81ZJGU[*F&1U TV%WYA\IM0\W2P;!JLF:[=!@+PQU]C







CE;U R;UEZC(OY^\D=T'&IL


&P4


MW'C2&B)V49
1^LI





PC8[! B(5.5ZQ;F[V51*CDB.A*AR2U%.3:2CYB:F
M;B4;-)= .,F=%9YKDAZ8-2+4&6C!;2\ ]#SSI$@!E*H-UBUB5P:H
5F78
M@
NICGXJ@)#Z?9I*FNAWW09IY)N72]! B)[D<
M) ])G-'(*
_'/^B*6^G[%+W?@\_8!SI\4HHXP+UE@YPK+(S'F)-]D1V :!#
MK T/Y\;-EU')7O9#N#
PU

(LO2!9#S[5
M.UAJR9/X3)2Z+N8LY


9=W0'X%


M_L2^

A-O1&%

E80Z@@VD-

M9B5U7-+ZI

M0?X@T_JFTY9!&BF@)?R#+ @_N

K\PTZFG3!\\2;H!.PZ5=


1W




I
WQ$6-J);

M[&9ZAIY5&*


XUVI:3D%JKZ@$5D9713

















GX/GX3?VM\ #
MD[ +


B:TD+0V(J/B4CZ(!H$[ 0B@'7^0F-

6^D*W !_D'YIXL=HZ@G
M15]3-I3Y K!0BS;O]?USM9&S[BNI*9VMZJB$SR73S#-^JS9[_ ZP8S .$LR5

9/835!-+EPLIND1NE6Z3+GY#(_SZ


T=W3
:3^MLUJ(SNJ:=6E85O6\MWEO&%6^

3
MVL/(EANA-#$M59Y=I@YF[FD%DV*GB[1W<)#]_1O<7B%Y0O0:TR6?7X)[L
MJHWT?]ZQ/P(/5D$)!NU.M=F7]I'YG];H ?_I\N;C#VK5D%5MJLMBKLL&H9




MYN:5ZX7'!'B7Q)*7;\HD%U^$&
J@F-@L/[@/^?7%_I_UT.5\P#RO GU3WJ

O2VAV(^R1WT#_D(=VA*L)=@B






M&[= N=\\* _[-;9+N5]Y]/SX
I]





M$X0\DH&?($[Z




 T@4

6^D];&$!<4*-@R9SWL/

^!L'3C@8XK(4CNB^91\2
MS0A6*UCU^*=W[(\ 54!/ C


M'.%Y9OKT[R%W7?/W0X$AYM4#[82&I:_E
F0SLVBLI).8TX63
15XTGU\+XN9
MO
D!VA/ALK$NQ2/?#3Q7GZ+/





M2SZ6?*R3TM+*

*_OMS9NW
'NJT/6TVMDK;TV97:7ZK_$WK(<W&6MFQ32;?1TK<$KPL

MT-[Q4
J&J)
IA*
S@I?QYF\7

M?5
Q+F95+%SX6L_B! 
0K4!P*
005%X/:$JTPW<2FV<1Y%)IRS22ON^ /:S?J


L

Z
932$7 J7(L)I:]:A.?A\:ND(NB(+^

M:S&
M&NCT:Y
^K6*&B. !*JA2^IAIBB&^M(%P8-/U51D)KHBCL^'0T\ZW.!4
M@T=N




O?$



@G


&



:$+#
MQ0WG



MI76LD0%_-CHM@&Y\.GNHK6[W3+=Y;WCW34'M ![[;^

M2C$VP^S1&6;U*KOX?'/R^3=*
#NYOCZ[L15BK 1]KMN\-Q(TGV+62%+
\LX/



M[+E*DF-'1@T8A-TX$A.8*
1+!/CTH FJCEZ08DG5'1



MWU%.+6D!@ZD$4S&$Z4J7PDS0MI2]T5@T3E&I3*X=C+LQI;*^H#V#?\%) 2P+
M)XYT=M+XT=)47#XJ&OX8 9X$?3

SQ\+)1.3(X
MP^47G1Y)5!*E0PR!IO7D70KL#_P6E-WG$GBS T#W_\K#J+LF\N;4RRD\ U=
MB?B+'E:-53PSGEBKS4&LZ2Y!#*Q'N3^0B.W.%'8H!!]:G]7P02@[%VGBR

MLF[D
A#](5@$O[RHO6#8[=I





A=WFO<FVFIFW7C*35G


MN+1WIYMT;*
O38NX&#7K)R[+]N

OV%XNKW?LB5'TYS(I?PZYH;.]R9I;1T'V]/BP
MVC&G;,OV;6NH:KY(#O@=DG /<@IV@FG.*0O0^,H^$#*,U.%&+BQB$6BB3
M.LY)KPLJ0P]&PX!&T1H][ Z_U:JWBE#:Z'K*A9J$IM-#H]*NM[)2@#@ESI\4


M-
O@;ZH[KM4X1-;L.@W!
D!9:E%XQ$8DYB/4HOXOYD_Y
\^7'FQT3W\(X1

/9GP6_W

MX8S$K'J!:4]*[
=G[/E527O9.T\55X$EGI/__




MPHM=D9CJ7B=%6VL@VOG=


AHTR$E4[KJ$E-$;;@('H$[8S%A=H047P@




MZ[0!+WO$(:U!NS][F1[G

A
M2

MTQDC*RN/-Z7Z5


M)


:6B4+E@+ K/B/NWJ

6X^.K<Z8
MJ)BX3U;$LZ?I%.HN/M/RM0(T)H-(U-2M$(RFUKO-HUMO%]7_@_F:LNU1
MDNJ
CK-1(9./

ME.O


&2J#2MHJ/




/DH'

KM8?0*0E-E?PON

M-'K9:UH
8=C(2$2Z(@6#L N&AAG:BJ=\:PSWD1SVHA_PS(# [6 9X()N$W





X4.O
!U8
WE?CU



MX$Y[+EFH)0:&GT12$^L RHVW_$BM3[ICH0)/O;'DP7@E7I=GY8@(^L1L\.-;
MA#C[

MJ



M&*ZF&7 P4)2@1PYLNN&01@?!K:/(I3IEX5B(\WY*WM-901[R#'V9A_J!8ADD


M+

MA]1)
Z'W
HYK2]5![M
EK

MZNLV7MC4_2$#\R[;\-7'8\]]$DEDO#Y\LN%Y

!CW
B



MI=D+




9183CDM<31Q)+!X_1&@5_]M)&2;*?X)0O#EI^$JA<5'!$RZVV<
M@0YO^4-KC%YQ\M1@IP3O&1^C8*/V0F]

M
]0NWQU:[LPNE_7D:#^;VLG)STF53N%(Y/%M#M- #S1!XW

9G]-)%\GM(RTY



G^RE7'JA*&Z@/LHB0&F5I
MIUA:CGED_.I/6;66R#X6AS)9^)3B/AH#V%Z2U(-.@3X+'K'!@517S^'#)I6@





M!XQ5T7HTX S]122TP$J'\E;A(GXNX!XAMZ# 'E.&5Q 58\3JC135


MI (\937%=M.=M -6FH$;0W*NIYE*W;XI[6OOR;PSBMG=
-V*FW&7

M2_3)4XK/^PP4O0?&#W G40Y&W-O
















M#3RT_'.^%F*T23[639B6\ZQ_2-U%









M:J1;:#[Y:=B3P6CAN YR-B0K$:YWT?Q
]HAP7N2[;Y8G8&J'S=0GIWTF ]!8
M !.84IG'09)^/;=[Y)@O8-JE4!3H^4$YF;O*%XW9:LSU_DSYIF:[@R; .M2N




M\ @)
0W-#*)
&TK+
$


6R:/:Z
M7RW'MXR2LLU\MX0FZ[*D^]22GF0IQA:Q@&8VAK3 (5N.-5F#/_1*MKQBLN












MMP[)SGL;J^!KW'18XHQ4])64YO)Z**KMS*J0TJR\92H5O3Q
7KS2K/A[M[U\

4CY%_0
M%+N/_GNM]4$CT@0PO3]PO=%[0*3#YAIC]('EF
P)WFMT @F]5H_+VNLN-YX
M#
3(#8+ N;5_;%N6

'_\]
MUDU3_+W(C!2OUCGGPM+7(D W
PO'2CS)WQKT#TZF^:YMF2^O83?7-#: ]YBW
MJF7




KX9@]UQU
.7Q91Y&J




3<DPJ

MN/14YG.%F7









M'VU&(BHZ;)

-5CGGJ2$ ;;)



&L
0^6P7R!E8Q/[Y['C&^[<#RV


M9+6JR2MK/;*:O4XED2*)X1O/-4

M_EV@YK/KW ?

E\

5N&BDEV3-+XX@SUH-NV7@0GNO^
M\!






*7LGT\S6*_WE)XZAZW

M#2TO8

MWKNS KQWN +H'RPSU&TN_P(P

])E

M)(K:&3%T-AYH)


]R39ZB














4PMO&HKD
MQ-G7#K.FSU-M.*=L['QI%;FI7[6\J

9$YLK/:KQR+8H<

*]D\_=U-OQC[[XU5^/]IPS1NI% &]FQ84E
M
16T8ID?)#/KLS4 =?A/IN=J.93+;]K^


T&\5?$A'XA:3U)$4!+O2@
M4N%KN0-(L#IUL][HUAO- C)UT@C;- U*%ORS+ UZ&Z'!2YPNR9!S*GZ4
^^A
M*+?G) H*X6WZ/^&3Y\/.]S27[4K7
U6Y

M0 N?BI%; V'2330_Z09;W-PU3FA*J^F9S[?4\;8U69QOUCH+PT6.I*_9#4N1



9O7CGC






.*_;K?9)IWV49HG\.%@;

M]Z13':^Z $_;PH];4LV^PCS'12;YS4VS.=

M2N

%$['/U@

!ZZ!F9GR=15*7*=K/=[DB+F0U.@4O6BOR
MI-EM-EO+ GTY&(!9#62Z<@QWQ.[T)S1_OC& V+!LBWNL@D_,A,%LM(IL
&?



M[ELGQ]W62DM!


M@%*A 7B'RGUX%V#I1851N&_O*WNDGXJIIOB=//&(Q



)9[EJST+?



MN5Y2\KZDN$%ZR-






MM\SYC+JT$[2LN

M*.O
0&4GGPNFV4HKL8NA6L
:9MVT=?.MH=7N;G\-*P9EMLM AU4#C3LOH0/M
M&_G$_

/?VOV&A]B35WS
MV$BW'%^S'&W@ F@U[=&R;:W/M*

M)K\Y=9P03)$OED




M]RWCU#$O+#L


V(TL=RGZ9B^WV3KI'G5[
M12[W@L$N

MX6ZV.VVY%-AR &:5C[MSA1MX9HC'^I?5:9[(H1KY09N[H$EALP'R3(B^A2#)






P5C&%H-CM,:H &--S?T
M #D8GJYQI;2F/64LZGI@?93NT<OUM#RHX'TY#8<OXXOP[7/@7FH+08 3D(W











M?[3/=Q?$[#AR-*

TVV+O?(-$:^




M0BL/&O\T

MHX8*&^HWELGXH(G6RSU@.

M)M#50#W%1U.$2ZB1)D.D[YEPEC?BFR&A.B-4;N*RG@!)QL1A@C7M%+1+#5X(

P^4Z?C_^:JTK'S+


M=ED'4F[/?7![(CE#_(_+!^;9NA]HGX5G+5%&D?ZA
GK4AM]C
N_
A@?3%!0[

\V4Y[U

M39=_
=W\;ZA[
(4/



MEJAYB-Z%V#2F3Y@W\B.#4$^(JD=$S8OB6CYS
?8ZI+Z
%J7;-KZ
:^.7'[B;


?YR36



MP)ACCX+O^Z1[90.)#DP+T:L]


M2+SZ@

S.M




M?R^Z6OU\DPJR%C_+(=9+!49CM#$UZ89#?5Y^H91*B.J$%+LL!RFOF$RHO3G@


)?!%JASO+O/_ZW7MD^L&M();1GF@6KV.BJ)M

M[M^U&HWV._SY';YX@$._FQH;G^(7UGNLGJ%9)JB75
P7JVN)7T9@+\ */E*-


M%E9*G%CR1&M4O






'-DY5U?<]LV$G^_F?L./+]<.E-95IRDC2=IAY9EEU-9
M4D4Z?^ZE Y&0A D%J@!H6_WT!XD1!%+BK+3F+%F

MKJC!INX\\^MV0ERSAA7E?NK+@O.%D@IF0KE U-\H82B=FMAY^_9M6U
S5HIG
@:38'J


EQ)35R*!4WSS






MP+/L;G=X


U6
OD0:P\B1Q'?@[-4BJ

MW_9Z%];('GN?+4_BZ]K= T'6]F6\XR09RUW!

M.5^O4AIO8?R
/

-UE.%0



+U+6<D!@GMJ
MM-5&F6]2(JQLG(. .AZD1=RP(
DX59OY+?[1.[#\]EZD1ER2QD11MY
B#/Q
M0P367(A-

M)L
S3;!Q9Y\*/2-\'[:TN)66 N_A=@OL.N87%P\G#TT0$PJQI
.+PI!81H9Q


MP%

MJ(?61GA?7(QK'6K!4)1ZA&/@RRCV4R*B@X?H47W5Q\/'3%T6&*#2.WRT+M67
M6]@3+IANEBJI4S/#/^NQ)]-+?7'.F7Q'Z

+I5RR0!:KR:?FDM
]


MD^12!4G $R*^!B+JW/



V

*X@C^TO
MVC WYKY R3ZK!PW=P??45D%.%7@4
1JD#67F*JTS&,DD_[2\.0





M




VS
'^!1#T;=TLTR
HLP36

M*4YV+V)




M%*ONY@R@6I
M;!=6

ML;Z@P47AUHRVBFEK4?9)OY7
:WDA9\R^5)0OY1P0:U7'
D&F6W/+N@+UO/5-
Q5[7PVQZF6#:J4K[3<:<Q$0^%LQ
MXQPMD*4?0*=#S4 +6\1H0+/
/LF!E5H_@'3( +U7E

#$W
3$S

IC<'M6^WYS5/]6^?GG]ZO

  B
MG LI
\3@.5







$9\OHM0N.&PJ !ON#+3R)4ZLU6

M6W008W/9

MP1AA[W0V!L)!=O(K
0)F.CR;:-O/DA$&

M[I(2MW3P






_#[RM=O3/.F-GO[E )P=^G
\M+&0H4.YN!I^

\Z0W.-QKCTVPD

M






$QDN!T:* VW65]O4!A!\DN@B:F\5^;:)0;0 ;2


M4S?YU(%^YOK8@V9W;8
O(A[
H%T&BE4YM@*(5(3S)$3KIW[S&JGXW!;-HWS[
M#6V[?T+



8IV=(U

:?
ORNT!P]1+[\\U

M;] 


!8Q86_(@   8)0( %0   '1D;G0M
C Q
M-S$Q



M3KH@07+Q0
M


DCF5YL
M?OS\V
]7\X+DRO465YLR5[;OTR\Q&3XEJR7Y]5WL+98^V?YN'I&I$.+V^TSR
MGYC
?V*M7560AOY
 M9I+ETRM5

M?FZUKC]DK73#( Y]S[43XCXE]+]L9AY-NW







M-G*LNT.[C#&2C@U+IEG:@4+#UC 
V)Q

FJ67\V




M
IQURDSP6ZH1EQG^2!!G[N4E1S._
:L%:1)K9&B+@6][P4?P7J!SM/QJ1Y$=








M#S)-B HO6R-. :4RLS5_RG&HBJ+

MI6H4G\7XPK_=SV.XGQ?3PZ?S[?K][?K]/YAB):Q5W#]WEND/@/[EZ7_DKS

M#[H
YI A'GLU$HCD8&&227PI0)]LG\2/Y(4$*?DM#-UX2-0)0
65P._LE4-)




4S]OXI/9-[4:L-JH

N?W%TO8BYK/3G=O13!HWQJ]@M5$9VW3($N) ?/DZIMMF
M^@M[1EI%MAP'U:PVI+]9+:[8)V@
1O4



M%8.*O.!K1Z;!.H




M][9=.XI6







Q









M+]\]IM*U?9^XMZLMBDW!PHY.^BU;-Z_-'%VC8G8=Z(PMT/M1$L?I8KTU?B#)
M/'0_QT1YBJ[_B];-FR6ZL




M.@R28GGP8MO)9B+89[($4@TT'L%2505]XDJD[=O5T5^TG[
JT![ TU4:5(@6
MU9((S_L1*CVLBIA _490/6!5D&=^MRF$'4V S:%LRCBS?&'H)ZV**5U-'+Y'

1=6=DW]]Q_DB]V%N?2I^2B-B+I?UMD+BP
M&__;-*8JC.

7

=E'*?4; EZ#V]
MD!F!C;


2.M_Z


MYB#Q2)8;:^-HRA[GBS=[% E!PBKGPHT8
]+M?




XA9&L1_GN=
H$#R@6$FH;

#\ 7B#+P'*:R8+:+J%3'!0OK@$:9EAB.@@.)!)XY!^K=QP2+:[X0


M-2 SV^\%B2=
2


D8.I6-:.XZ3TY
;\I ]]R
I1*F@
M-M#-&
T2M'B\5HU%.T&&L%6C5(T

%I



MG8J?;)]KME#4
.0


MN^MD1(ZMCME-0

Z


H= AQXWN*]Z0K20B2U *QH);F2 X$CX
[$V@M'YO?-Y(R[[8M

[2X9Y;
Z^]J ILF$FET\8IC/V1T
 =A^MZZ[;NT\!E*:E$)W!9

Z?ZN@[

;1


XDSD'2\L#
M^J

Z$^Q[3#1U







ME
II3%S)E .G]NHCU;H^47LTJ$=1-::0K#1U4]; &G-/@AG]]B3R7.8JMY2O
M
_S2L&ZTBD[/663$*- 



M4F0;R
?



&$=








VT=$9VYF04$+715+\5V#Y_'@HM+$0 3HC.B??PQKHW+4


YP:KJ3C5_SFI#
M9EDOV:

Z #/



J

)-Y\X



??!2?X-.OYNA

M^9O/#VGT39(^?OOVS9MWWU8-ORA:_O5S%AZT?GY7M3W]]O]\N+[W-WCKG81Q
;%*_Y8XC2]%O:
M_]L8/WHY#BC]GRC]T[]0^O^K_/&U]XC+Q!M^?%N(83STP&MHM.W?T-3C/ 6
MIV$27

OS7N



RW+E'_B


+A
MR+R'W[_[^]O__



M?N-M


MP)8\U[1!MZ(*YS*;VB*?
IF$*5CHG_)QZT8(H
MV

MI+
^



M+8VYYW-
P+WKTX4D8*NZ(2I:@E).TN71]'[X:S

@XN


68
MAGL*O2;B'Z71[1*!X
/PH*EXJC19SKC*8JI-G1W18IERVMK+'AB^?7;RZ'D[
69%]%,9'2_P3C/T FZ]6A4?(/S
MD/G<Y5NPZQ<'6_!J=.)XCS+R.1+A(ZKD 2]72E](9B.O\D:.)2?GL._O[]<
MW8
Y530EPAP]X


Q(&)O;7M


M-DE?R!A


GICN'OF6R9C6!TDZ 1=ASZ.
ZI[%K=T P4B:&V
C/P4/=$8 ]WR
MY1N



@BA-R#X8!56%J=P)DW-3MJF3PE

MG[XK;

M+8F#N]5]CX0 '@(9'8GPCGG0/
_3\&&?LRU!GI1WC:'=?NN!\P*O0S]T7Z=+
MGP\5EZ7!'.:TZLS977\[[N_:E'  =7V9=F7!\NX:*_XX_-6G7I?7M*%D!91_







M$5MJ63


9'S(URAP*
MKLTR%U2/N!@&*H6M*4JA40Z@VE;S46+4!E;4!@95;Z#-VYTR


1/PID.1*_(F+8S?

M3/J$XSW^$






MJ\FA:^*5@7 !7@O$'C=FIX7H+D0Z@!3+XZC]1=C!WJ.(_M*5

S-B;
E.^D8+EVFG/*L

M8$![&TYX!M/44
X0JYDH%":2BSHNF@1Q*_E=P(

MMGJZMNP'('A/:Q]L

1T-7JLO)*N(9
M5[W0@3**3K$*?&@



;X&$]'6+NWMC3@]HM







7L1ILPKI!H)HTS54ZB@FA)B8T


%

.T

ZU6?F(

YVN2X*L0WIBG5H0W;'.!.A*^)5


MBY&W3?8 TTN


Z0H)
RS564/
8K(


M 
YM6L]M7)69)3^E?_?IM.Z+F43-

M(U3#-]_\#X NH.BLAL(YV]T5.[B&;H)X]?:$J;*T5R_
:QL4

M5?%FT\5)

]!2

LU(P=]7'E61P
_YJKVKQ'FO_[J




5D66/6-'3BCB0


P7[::0!Q
_9U 1

T:@._&^LC.K
M
E%T1U7_&6(49FP#4!
!$77IA[E59?
J_$S4YM!)[STB
I



2C1@0)+?XDD5R;







M



X%
3D%:3

MQ@GLIT6DGF O%3+ATRO[W2YBKVX3#5V^NKV(UTFZ94QG^M:+CE73I\^W,XQ
M;*MG\S([:G6&]K[0%BIU$9)1@PV%6ZVE5U3Y&%#LX+X;L+/5IS'BYAQO#








7$9^ -
M_IA5ZC:0&$0^]6+SSI]W4U881@O1[Q]MA'T<J5M.H


9HK)93]AO M&A2=6U5M
'K




M%  :NB&Y2^=

-3IO1#K%%L_N(:[-J.S6=8W)*

I).6TBK*RK)P *E=G3419PW(%\25-;?6N2(RKI6N&)[2




M[MY*F!GF88HETIO5_.8]

FU$]:Z3K;;
&=/!-&Z

6: V-S:W-D

DO)*]=9.1<%YV2<MR-268@)LIC=72*W4$P 1QQM)C_R.AY=J\*(!J
M

3=

NUTT9


():]IY:4RL(GUN]'[CI5@M6%+UHB+GVE2IX7;*XI4]Z'.[B/6!)'-C
M@?WJ.LFRKQO
X.R8)M]J&38]IG7^5K:ER=

M'IIPJ\U#V(ZEL77QZ^!6'6OM/E]?7GT*DDODOU#OMY'5:LA:DY'?3;KFWO



E;0?

JP%?&
]YCL+I-'8GGMSTS5A-P5

:Q7TB(277
M-E(*LIN?D.74'+#FKV1#9P\0G'U3
Z3F%30%-TYZSW2'XXRE2Y2UUNGHK ]$

M53?##9BX1[FSFR2N9IA-


0X9%78:M917:




4[+(;&
R_QP:%\#A$W%M(D70CEF:MF/LW+0L7FI-XA.O
M];/V8_+H-TK


3
U/YEV/_F
7GZ-L A-7W?T;]0/?%=R^*1'_U^


M6==0=/JY

H6F%_$R=1\AB276/D




MK$YN DL+BB@B0J:



M;=&]IAA2


][+KE(5J$?4

M@;9%U*+AY/!-#:SC1K



E.F 5C#FZJ[ ,Z^U%I7W2Q,G45UR;75<(QS,N5TP'CZ78!F
M7 HP35-K!<TV OSEFS#YA;Y.4#X)\CY)@NP&&VX?-BYUJ!2D)U(.FV
RM8S


MN&*Q+


/]1XSC

MOA?Y^\C=:S$F4JN
VZD$?CIS_\'[[R0]WV=YLB6291.NXU!P;=JYH#J:J_P]

6N1


M#3J]W&P).(
7


NJ$TO6AH ZX4'(Y'[B B;X7@



9)[47


5XB,)W<*-H0-2U1V11AI<N!NJUY.$6H[!X;/6()YRUL9QA_V$&.WJ
M!-N+VXH@7-ND_1D19ZS)A
4AQ:HJ5)QVML&M6F!LT*'0-5VB%7X*7L VE3W

M[74'FTGEH-LUE5/\Z*4LPRJJN@'9T/!91KQYX?*+JP)Q-F=2' JN30(7E*+.

MC^

M9+K+(-I_1 O6L4H':
&+'*]EZVN2+0%O$3SDAOS3B;N+L;\R^#TV&KJC&BK1%MCNKV
MSKT .R0^1<(2ML/1D%A83Q,P;0-:B'N*(_9.TTOI_B\&NXA4BAF52E3$LNJ

J)P^4#&I_

(Q?##\!UN&.



.\LIT1W9:PU
M6RW9



+I]JW1GG/BH3G=?TZ^#.XBIO6H4&M8

M#'_VMCO:\
O;TU^__W#Z[N)+
KZ#]\K)/\E0.TU&2D;38S1UEU0B%\PFA+
M0&SH.^-D0/DF)$TQV8EY+V[JPL%2YSH[


MK=LPNV5P=R3X)]^&#;


*=X_ 57$#
M?;G^Q4O9H8=!C51E?R?UV^6 !!?PEVM4M1^[Q*AYZ7
S1'.4TO&7V?LHS)!'

@*8\]K#CW^T' <M8ZXDXL2B:T#C

M.X!I[+/A@/Z(7[X

S:;3S'3JB.+3V



M*)35
A\JLN$3 I*




.NL[R'
MG
+.3:^2-A6;_G7]T&_L.YUXN_
TY

MN/NY@SZN D-' S]F=_IK1'^/?J


6J_HC0@!5%! A@2H:B!%!C!=_*^BX?0]K2-Q?


MR+6BET'LL'K9MG0SBM;.O

MO(5P[CLSAX(X'OX&+V.L%S&R(0G
TQ7 UB_25U3@*TD@0F

&P=4\WI
O3TXGQ*LQIYM B#L*G
M

M/ 2[_=MQ=]=JM NGD[E6M8!YV*



!:@Y;*[.%RP!%:


#IAE$ Z9AQ




MZ8F:KHCV!6B;^Z+-&=H=0[MKT
:D+R #;HM2:M$S]10 L_)&\JP1(#80YOY:




UO\_H;)Q%GO_'R;V_
M(2 RM$T/'T&-8S)J?1[ZXV\&0IC/]HSMGE(\@TJ30%]BZ1K&8%

?2=1I9
M(N

MA]






M+]4XRX;#78R^)QKMZ7_=&E?3G(JJLIHX(TW?O4EP.J'L-K!7MO:/B):F8C






M%-[@'RJ:TG5VZ&X^ ;(@1D4$M:FP^$7K!RZC%\.LEM9YKAT+]*WZ=EMF=
\?


YY^998$/B@E;23!_1HO5B0E4)F@
0





MJ=%P?X]2DK#58T.9^_3)#-VK)7T7'O8&H%9]YY4GDTJ.DU0ZP? ./4!V)U
M
+!+0Q^C




MF/J!I^4RR\
MRQ'?%S C#DQGMGP(X9!:]-Z2
?T]A_M-DN:T? *]QKPB7S/)
M.)W=E=\B@^EFWE'VIT06=FBW9?G;:%EM C71=%$2+QHCCD*[L$'!$9U[ZA

LN@97;VFM1]CO8VU^Z

M

LC!_KFX69

S$==OF4FD&*65S*$S@3(Z2#[4

W6'L&%@_




4*7:&T\2:X$CF& OE^
[[W4BW.
L_8H


N/97AT!)Y] JO?UMZ_8^-
MUY_RO7X'SDP_PU5%!QB/]1
)5[D-]2 ^#L6\BQV@




MW]/RP7X+5( ?B'TD/W9R\=^ 4W1TM(S'7+F=LB-: P]HT@-: \]*=CQ[Y&PZ


BQKJI@$A8&=



MP


^-86_7QQ=G%!7

M


?NR@DH]KY











KC:7





MI
?9RZZ78O+E





/

IGCGA<'E9PH$S^-@F6]P6ERM


5

*WE8OP^ 3EJ0@N)C


XKX7/LO$JTG;Q#P'LJB=O
7OWP






N
M)=%!A



:&_^/GBXO(#I?ZW@W3&


Q/B6;C1WN


M _
?Q^E^0*88 4:7

^$P)F\

M\D%4&TN_+E@)YXO)X^1Z

LRO_Z'/
S:AR;.JPI; :&WD
MY!/3'C-&QTIJSB

MSW?V
_*JXRR;Q3\5^LJ(WO_GFW.

?[%$G8^?HS@D
M!]Q#1QX%EG9O*=-:'[+E6FF

M[[?IB]H[9XV]HX78;#1Y]]A+($4R9L@=%'XVUMDT1DD$%ZM;.]LXC@FB )



&K_X3L

M^M1?04EP':3UXBT'I)G#SNW7FS[JG

M72*Y]M9%+V_90CQ'J7#NVN_++P)E_'5??AA)[6486E'SRE?D^C=RK:W5-^
M?H^\.#K\DCXFY%1C_[.5X&XQ3X9!R9,C)7%
B.1

MZ@ 6A#N3#3?#.@IYN:

MA1SH@4M7W(I0AK$/DSL_CM$=?D%N.9A%/*_%A%#O9[JREJ

M&R/Y1%#/C+4$*-4!!KA!V:SV0:_JUJHB =1KIJ*DQ.:J*I2AB#9
R$ KK!%+
METT#]33:5
!\- -9M.FU07GR




.8R/?8#\+40S9&1$2B




PO(!X(KX.(K!*?@\-

.ZOG\
@BA[8E\ 
JU KY_:@NN./36S+YG%-E^
MU_%7^[!BE=PT7!K@ZZ.V.$5 AG%/_(S2;6+LNV-W@_TTSW^

M[XOZ



3:_+:!3TZ+HT9^^Z2'2N9K0&OG;6WPL*$(Q=
 &W
1F*=EK3XV@<S%H+[[%H?,3_O='
M8C,4*QV0NV@4RSH;YKET?/+!?14=.

1FAERXU4G]U



_%RK?3C.#]S8Y@HCN:GOA
B.T W*_LLR#CR2

MCA-AB*^I3W3@A=J


-Y5I 7&,.VIU=.@Y.C,BE
M#P7(CU*IUEQ'V)U!%X\XRZ+AV[






^%]E[8,6;R\



$9D
K8(6YY#&0567(4!TLLV#GFP%';IQ74K C7ES
M 7F3=S#/(^SKZ7FUJ2&CC'F) ?FM:[^;L1^(8)]4SZLQ7!8

MM*-65TQ$^@EC




F@E%0+V9&_V



4]B-C77
JYX%NY)M9E\ 65 ,R+^.!C4Z-78*:NCB
MXO)#*A[Z2SX#4#;4VR \Y9^=!3$2.N)K]V%= IM!&PBV%ECHUS..W%.K/7Y!
MMS8.TZ/
?+G/V4=#!^B8W7&4C\?G5^[(^L2V.[95 -J(39W=P1,T9MLMUYZ
M:B*[U?[4-/670;C)9*B0T$JM!^NR(S4GM4Z'&N
)6PVNRBDQC
;[Q/#_H[L


M'7N2;365A@#3Y2EYINFO8VQ[-T'R'(^?@R3^'-HQ\!W4.BK3 [U3B#W'Q:[
MN1=;#4FE+ULYV@Q6?C1H'?N_27+U*ZPIQ0;0DR
2GYY:NFD!BXOB

MJ/8!O$-4FVR[ROBZ=VL.%@TR3XWWV8GZZ8[0;5+V9; I]: LKC$6FQC 1R

IVKT;= \S$=*3IF,FZ[=+QS.,UD_CU=SM:O77#9M84]%QYG-=


MP /1PPF0\VRE







MN!S1


M6'

/(OU5^

B&E5 OX&#E8SV+

U1SC Y$HVY
M5]!ZZZDT]G%!%+66R)5Z@*Y87D_^RM.RMQU(FSP)]LMEZP0R@- ;ZR(PKB

M.+'*_BPG@JZIK3UAI6B.LFML
0.NS_.:XTT8^.2/#LK=-]1GK6Y7T6SZ\SF
M.AB/FM*^:V]I!?CQ\?Q;/$TGMW

M:%EE'T]W]\

M=?L$\I@QH4;:0%NK1=!B--;1(UUW4?[AEUY5F9N]D





I610'LDZTN#^4(APM=6++WVW(Z0\]





E

M_;X


MG6R7(M.M4@?6J&
FHJ(
]=TL[5Q2/U4KM=VN!*&-[$)


5I!9H5E




MX[_VO).!@'4:Y\V]%QM[:6X=.UK3%6-*KHI1+#!=\RF@//TU9Z!P_*VE$C(B



@)^O;;Z?T$AX

N[%D$MXN$8Z3






N
MVM9L




\Z:$1]B/L//5]A)A\K_V/@J5?;T+RLM@A3$7AC
F5N.&
M-UWT-[Y)DNSO\!5QU)&

M[X1'D!3I:9[L_S42%ONHTQ]HOCP36M

M$6CB/?UE7XH%^AU

MJ+B.G;]E*&4/ L?VG9&3?-;Q
FJL




M#@^^0!450 ZOWZ?(!R*7U(0JW0Y*+:&R2S21%



M6'+;6B-8XY(AJ?&@&:L.8?BH$J


M0DY/DF=UHBZAO'N@4#'412$NUD02ZXA2L36-96(Q0&:QU6!=5-.\U^^.G^



LRX['?(.H9Y5'T,Y P$:#$T.R
M':8-LT#Y&]8E<#QZ)R_^+X-P_.IOH5;NQ9[DW758$7X2]A7*-BUURP?#U/@




5Q*T%C=2^U@K'[4^_GC3
MJ

M)UU#ZY97
Z/%O%$):K*IDH(69^
-[FI7^!?E0FP:_0$57=


W&?9Q4OP.UYZJ[]?83&

R@\Q2&R-UO[C[O8A;TX
M7241$4$4D;OP
_9MU4N3B STPG086([=9!')_4W]KJ36%? U22((Z15)&62_

E[8F@6,_I$<H*0;@I06
MN V0&CJ4BX#ZMIE(+6D/:26-%F%DG)+Z.+52NQFG?692(:Y[JH\<XC(H(M2







P.6M^






4M?S5N;K@#_/O=I

M*
K#EF6\D1

M
\_GL50/#3SY:G0!Y4+35




I);&J^0CY;8P;9W
MFBJWR(Z34%T_U+J#CN)KJGJ((=7<\IXIO0N65L4-$$)D;$@C<YL'E]\.P..


*14?E:F-KU$
K

N=_/[W^5

MYPV]Y_Z2.4 T(F=&1G[Z94'^%)$C#\$CG\N:/0%[6'+%R7FZT0;7
0_VP91\
+L<8;)A<8JPFO#$#1U-P

9^A!J&EPEY.:/HFCL_)G@*'V7



M.:_)4\ZFNHN$M&


MW\EM.@UR.'MTPW$$6D7X!%0@&8\S^9+Q'*O[*H 0D0%'4(CYRYDR$CP#N.'-
MMRBT:0;TNR*TD#&91FU6 $8N83@2=9%LN++64AG$&D/9PLE\B)\0LZS@*:









_$EU%36QTY ^=7$NY60EZ@W

M[VNY'50R#B9W&&L+:[P=6D.





MF379Y3ZB-E54XI-

MGZ3

-W'F49@77;**MKJV4&?


MO.GL%)T/U/OHF0II


MG43
#PRD  !K#0D $0              @ $     =&1N=TR,#$W,3$S,YX
M;6Q02P$% ,4     #Y:&Y
%7E5^FH.  #/A@  $0              @ $[


#$W
3$S

M A0#%     @ ^6AN3 6
6%OR(   &4 !4              ( !XKH  '1D
M;G0M
C Q-S$Q
S!?9&5F+GAM;%!+ 0(4 Q0    ( /EH;DR/;W][65@  #\Y

M% 
4     #Y:&Y, $P$F0@W   =Q@, %0              @ &3- $ =&1N
H=TR
#$W
3$S

YK 0    $!
end



